LOKIASV2_0167_ESMFold_hypothetical_protein	4ep3-assembly1.cif.gz_A	4ep3-assembly1.cif.gz_A Crystal Structure of inactive single chain wild-type HIV-1 Protease in Complex with the substrate CA-p2	2.788E-10	1.000	326	21	260	263	10	195	198	242	0.913	0.939
LOKIASV2_0167_ESMFold_hypothetical_protein	4eq0-assembly1.cif.gz_A	4eq0-assembly1.cif.gz_A Crystal Structure of inactive single chain variant of HIV-1 Protease in Complex with the substrate p2-NC	1.728E-10	1.000	324	21	263	263	10	197	198	245	0.924	0.949
LOKIASV2_0167_ESMFold_hypothetical_protein	4eqj-assembly1.cif.gz_A	4eqj-assembly1.cif.gz_A Crystal Structure of inactive single chain variant of HIV-1 Protease in Complex with the substrate RT-RH	1.822E-10	1.000	324	21	260	263	10	197	200	245	0.913	0.940
LOKIASV2_0167_ESMFold_hypothetical_protein	1hvc-assembly1.cif.gz_A	1hvc-assembly1.cif.gz_A CRYSTAL STRUCTURE OF A TETHERED DIMER OF HIV-1 PROTEASE COMPLEXED WITH AN INHIBITOR	2.027E-10	1.000	318	21	260	263	10	200	203	243	0.913	0.941
LOKIASV2_0167_ESMFold_hypothetical_protein	4qlh-assembly1.cif.gz_A	4qlh-assembly1.cif.gz_A Crystal structure of drug resistant V82S/V1082S HIV-1 Protease	5.274E-10	1.000	311	21	246	263	10	189	198	231	0.859	0.909
LOKIASV2_0167_ESMFold_hypothetical_protein	3kt2-assembly1.cif.gz_A	3kt2-assembly1.cif.gz_A Crystal Structure of N88D mutant HIV-1 Protease	8.973E-10	1.000	308	2	246	263	1	189	198	249	0.932	0.955
LOKIASV2_0167_ESMFold_hypothetical_protein	1g6l-assembly1.cif.gz_A	1g6l-assembly1.cif.gz_A 1.9A CRYSTAL STRUCTURE OF TETHERED HIV-1 PROTEASE	9.462E-10	1.000	301	21	246	263	10	189	198	233	0.859	0.909
LOKIASV2_0167_ESMFold_hypothetical_protein	3dox-assembly1.cif.gz_A	3dox-assembly1.cif.gz_A X-ray structure of HIV-1 protease in situ product complex	1.447E-09	1.000	298	2	247	263	1	190	198	253	0.935	0.960
LOKIASV2_0167_ESMFold_hypothetical_protein	4q5m-assembly1.cif.gz_A	4q5m-assembly1.cif.gz_A D30N tethered HIV-1 protease dimer/saquinavir complex	2.739E-09	1.000	295	2	246	263	1	189	198	249	0.932	0.955
LOKIASV2_0167_ESMFold_hypothetical_protein	3n3i-assembly1.cif.gz_A	3n3i-assembly1.cif.gz_A Crystal Structure of G48V/C95F tethered HIV-1 Protease/Saquinavir complex	1.991E-09	1.000	293	21	247	263	10	190	198	228	0.863	0.914
LOKIASV2_0167_ESMFold_hypothetical_protein	3kt5-assembly1.cif.gz_A	3kt5-assembly1.cif.gz_A Crystal Structure of N88S mutant HIV-1 Protease	6.077E-09	1.000	286	2	246	263	1	189	198	249	0.932	0.955
LOKIASV2_0167_ESMFold_hypothetical_protein	3nxn-assembly1.cif.gz_A	3nxn-assembly1.cif.gz_A X-ray structure of ester chemical analogue 'covalent dimer' [Ile50,O-Ile50']HIV-1 protease complexed with KVS-1 inhibitor	6.758E-09	1.000	272	7	246	263	1	190	198	242	0.913	0.960
LOKIASV2_0167_ESMFold_hypothetical_protein	3hlo-assembly1.cif.gz_A	3hlo-assembly1.cif.gz_A Crystal structure of chemically synthesized 'covalent dimer' [Gly51/D-Ala51']HIV-1 protease	8.814E-09	1.000	268	2	246	263	1	191	199	255	0.932	0.960
LOKIASV2_0167_ESMFold_hypothetical_protein	3iaw-assembly1.cif.gz_A	3iaw-assembly1.cif.gz_A Crystal structure of a chemically synthesized 203 amino acid 'covalent dimer' [Gly51;Aib51']HIV-1 protease molecule complexed with MVT-101 reduced isostere inhibitor at 1.6 A resolution	1.348E-08	1.000	267	21	247	263	10	191	198	234	0.863	0.919
LOKIASV2_0167_ESMFold_hypothetical_protein	5kos-assembly1.cif.gz_A	5kos-assembly1.cif.gz_A Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor	4.418E-09	1.000	266	2	262	263	3	327	331	347	0.992	0.982
LOKIASV2_0167_ESMFold_hypothetical_protein	2o40-assembly1.cif.gz_A	2o40-assembly1.cif.gz_A Crystal Structure of a Chemically Synthesized 203 Amino Acid 'Covalent Dimer' HIV-1 Protease Molecule	1.150E-08	1.000	265	21	246	263	10	191	199	236	0.859	0.915
LOKIASV2_0167_ESMFold_hypothetical_protein	3ka2-assembly1.cif.gz_A	3ka2-assembly1.cif.gz_A Crystal structure of chemically synthesized 203 amino acid 'covalent dimer' [L-Ala;Gly51']HIV-1 protease molecule complexed with MVT-101 reduced isostere inhibitor at 1.4 A resolution	1.422E-08	1.000	257	21	247	263	10	192	199	242	0.863	0.920
LOKIASV2_0167_ESMFold_hypothetical_protein	3fsm-assembly1.cif.gz_A	3fsm-assembly1.cif.gz_A CRYSTAL STRUCTURE OF A CHEMICALLY SYNTHESIZED 203 AMINO ACID 'COVALENT DIMER' [L-Ala51,D-Ala51'] HIV-1 PROTEASE MOLECULE	1.668E-08	1.000	252	2	263	263	1	197	199	276	0.996	0.990
LOKIASV2_0167_ESMFold_hypothetical_protein	5vpm-assembly2.cif.gz_B	5vpm-assembly2.cif.gz_B Crystal Structure of Human Renin in Complex with a biphenylpipderidinylcarbinol	6.758E-09	1.000	252	2	262	263	3	331	335	351	0.992	0.982
LOKIASV2_0167_ESMFold_hypothetical_protein	4gj6-assembly1.cif.gz_A	4gj6-assembly1.cif.gz_A Crystal structure of renin in complex with NVP-AYZ832 (compound 6a)	2.294E-08	1.000	243	2	262	263	5	329	333	346	0.992	0.976
LOKIASV2_0167_ESMFold_hypothetical_protein	3cms-assembly1.cif.gz_A	3cms-assembly1.cif.gz_A ENGINEERING ENZYME SUB-SITE SPECIFICITY: PREPARATION, KINETIC CHARACTERIZATION AND X-RAY ANALYSIS AT 2.0-ANGSTROMS RESOLUTION OF VAL111PHE SITE-MUTATED CALF CHYMOSIN	3.387E-09	1.000	241	1	262	263	1	316	320	346	0.996	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	1qrp-assembly1.cif.gz_E	1qrp-assembly1.cif.gz_E Human pepsin 3A in complex with a phosphonate inhibitor IVA-VAL-VAL-LEU(P)-(O)PHE-ALA-ALA-OME	1.581E-08	1.000	241	3	262	263	3	322	326	338	0.989	0.982
LOKIASV2_0167_ESMFold_hypothetical_protein	1ize-assembly1.cif.gz_A	1ize-assembly1.cif.gz_A Crystal structure of Aspergillus oryzae Aspartic proteinase complexed with pepstatin	1.348E-08	1.000	238	1	262	263	1	319	323	343	0.996	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	5sy2-assembly1.cif.gz_A	5sy2-assembly1.cif.gz_A Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors	4.577E-08	1.000	238	1	262	263	4	331	335	349	0.996	0.979
LOKIASV2_0167_ESMFold_hypothetical_protein	4gj6-assembly2.cif.gz_B	4gj6-assembly2.cif.gz_B Crystal structure of renin in complex with NVP-AYZ832 (compound 6a)	3.700E-08	1.000	237	2	262	263	6	329	333	344	0.992	0.973
LOKIASV2_0167_ESMFold_hypothetical_protein	5sz9-assembly2.cif.gz_B	5sz9-assembly2.cif.gz_B Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors	4.340E-08	1.000	236	2	262	263	3	328	332	353	0.992	0.982
LOKIASV2_0167_ESMFold_hypothetical_protein	6r6a-assembly1.cif.gz_A	6r6a-assembly1.cif.gz_A Major aspartyl peptidase 1 from C. neoformans	4.115E-08	1.000	234	2	262	263	1	341	345	360	0.992	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	3f9q-assembly1.cif.gz_A-2	3f9q-assembly1.cif.gz_A-2 Re-refinement of uncomplexed plasmepsin II from Plasmodium falciparum.	5.464E-09	1.000	233	1	262	263	1	318	325	340	0.996	0.978
LOKIASV2_0167_ESMFold_hypothetical_protein	5sy3-assembly2.cif.gz_B	5sy3-assembly2.cif.gz_B Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors	2.551E-08	1.000	233	2	262	263	5	331	335	346	0.992	0.976
LOKIASV2_0167_ESMFold_hypothetical_protein	3k1w-assembly2.cif.gz_B	3k1w-assembly2.cif.gz_B New Classes of Potent and Bioavailable Human Renin Inhibitors	5.660E-08	1.000	233	2	262	263	6	332	337	347	0.992	0.970
LOKIASV2_0167_ESMFold_hypothetical_protein	5sxn-assembly1.cif.gz_A	5sxn-assembly1.cif.gz_A Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors	7.001E-08	1.000	231	2	262	263	5	332	336	349	0.992	0.976
LOKIASV2_0167_ESMFold_hypothetical_protein	4cku-assembly2.cif.gz_D	4cku-assembly2.cif.gz_D Three dimensional structure of plasmepsin II in complex with hydroxyethylamine-based inhibitor	9.295E-09	1.000	230	2	262	263	1	316	323	340	0.992	0.978
LOKIASV2_0167_ESMFold_hypothetical_protein	5t4s-assembly1.cif.gz_A	5t4s-assembly1.cif.gz_A Novel Approach of Fragment-Based Lead Discovery applied to Renin Inhibitors	4.115E-08	1.000	230	2	262	263	5	330	334	349	0.992	0.976
LOKIASV2_0167_ESMFold_hypothetical_protein	4ybf-assembly1.cif.gz_A	4ybf-assembly1.cif.gz_A Aspartic Proteinase Sapp2 Secreted from Candida Parapsilosis at 1.25 A Resolution	5.660E-08	1.000	230	3	262	263	4	320	334	341	0.989	0.949
LOKIASV2_0167_ESMFold_hypothetical_protein	1rne-assembly1.cif.gz_A	1rne-assembly1.cif.gz_A THE CRYSTAL STRUCTURE OF RECOMBINANT GLYCOSYLATED HUMAN RENIN ALONE AND IN COMPLEX WITH A TRANSITION STATE ANALOG INHIBITOR	5.090E-08	1.000	229	1	262	263	1	325	329	351	0.996	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	5i70-assembly1.cif.gz_B	5i70-assembly1.cif.gz_B Crystal Structure of plasmepsin IV	3.902E-08	1.000	227	4	262	263	2	316	321	339	0.985	0.981
LOKIASV2_0167_ESMFold_hypothetical_protein	1w6h-assembly2.cif.gz_B	1w6h-assembly2.cif.gz_B Novel plasmepsin II-inhibitor complex	1.090E-08	1.000	227	3	262	263	3	318	325	341	0.989	0.972
LOKIASV2_0167_ESMFold_hypothetical_protein	4gja-assembly2.cif.gz_B	4gja-assembly2.cif.gz_B Crystal structure of renin in complex with NVP-AYL747 (compound 5)	5.969E-08	1.000	226	1	262	263	5	333	337	349	0.996	0.976
LOKIASV2_0167_ESMFold_hypothetical_protein	2ren-assembly1.cif.gz_A	2ren-assembly1.cif.gz_A STRUCTURE OF RECOMBINANT HUMAN RENIN, A TARGET FOR CARDIOVASCULAR-ACTIVE DRUGS, AT 2.5 ANGSTROMS RESOLUTION	5.090E-08	1.000	225	2	262	263	3	316	320	335	0.992	0.981
LOKIASV2_0167_ESMFold_hypothetical_protein	1lf4-assembly1.cif.gz_A	1lf4-assembly1.cif.gz_A STRUCTURE OF PLASMEPSIN II	1.212E-08	1.000	225	3	262	263	5	318	325	336	0.989	0.966
LOKIASV2_0167_ESMFold_hypothetical_protein	1fq6-assembly1.cif.gz_A	1fq6-assembly1.cif.gz_A X-RAY STRUCTURE OF GLYCOL INHIBITOR PD-133,450 BOUND TO SACCHAROPEPSIN	1.855E-08	1.000	225	2	262	263	3	325	329	347	0.992	0.982
LOKIASV2_0167_ESMFold_hypothetical_protein	2v0z-assembly1.cif.gz_C	2v0z-assembly1.cif.gz_C Crystal Structure of Renin with Inhibitor 10 (Aliskiren)	1.071E-07	1.000	225	2	262	263	6	334	338	350	0.992	0.973
LOKIASV2_0167_ESMFold_hypothetical_protein	4cku-assembly2.cif.gz_C	4cku-assembly2.cif.gz_C Three dimensional structure of plasmepsin II in complex with hydroxyethylamine-based inhibitor	3.902E-08	1.000	224	2	262	263	1	315	322	334	0.992	0.978
LOKIASV2_0167_ESMFold_hypothetical_protein	4cku-assembly1.cif.gz_A-2	4cku-assembly1.cif.gz_A-2 Three dimensional structure of plasmepsin II in complex with hydroxyethylamine-based inhibitor	8.659E-08	1.000	224	1	262	263	1	316	323	341	0.996	0.978
LOKIASV2_0167_ESMFold_hypothetical_protein	4gj5-assembly2.cif.gz_B	4gj5-assembly2.cif.gz_B Crystal structure of renin in complex with NVP-AMQ838 (compound 5)	8.211E-08	1.000	224	2	262	263	6	327	331	343	0.992	0.973
LOKIASV2_0167_ESMFold_hypothetical_protein	3vuc-assembly2.cif.gz_B	3vuc-assembly2.cif.gz_B Human renin in complex with compound 5	1.473E-07	1.000	224	2	262	263	6	334	338	350	0.992	0.973
LOKIASV2_0167_ESMFold_hypothetical_protein	4aa8-assembly1.cif.gz_A	4aa8-assembly1.cif.gz_A Bovine chymosin at 1.8A resolution	3.509E-08	1.000	223	1	262	263	1	319	323	345	0.996	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	6xcy-assembly1.cif.gz_A	6xcy-assembly1.cif.gz_A Porcine pepsin in complex with ritonavir	2.992E-08	1.000	223	1	262	263	1	321	325	345	0.996	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	4y9w-assembly1.cif.gz_A	4y9w-assembly1.cif.gz_A Aspartic Proteinase Sapp2 Secreted from Candida Parapsilosis at 0.82 A Resolution.	7.001E-08	1.000	223	1	262	263	1	313	327	334	0.996	0.957
LOKIASV2_0167_ESMFold_hypothetical_protein	3km4-assembly1.cif.gz_B	3km4-assembly1.cif.gz_B Optimization of Orally Bioavailable Alkyl Amine Renin Inhibitors	5.660E-08	1.000	223	2	262	263	3	329	333	343	0.992	0.982
LOKIASV2_0167_ESMFold_hypothetical_protein	5n71-assembly1.cif.gz_A	5n71-assembly1.cif.gz_A CRYSTAL STRUCTURE OF MATURE CATHEPSIN D FROM THE TICK IXODES RICINUS (IRCD1)	2.419E-08	1.000	223	3	262	263	5	333	337	355	0.989	0.976
LOKIASV2_0167_ESMFold_hypothetical_protein	4pep-assembly1.cif.gz_A	4pep-assembly1.cif.gz_A THE MOLECULAR AND CRYSTAL STRUCTURES OF MONOCLINIC PORCINE PEPSIN REFINED AT 1.8 ANGSTROMS RESOLUTION	5.367E-08	1.000	222	1	262	263	1	322	326	337	0.996	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	5t4s-assembly2.cif.gz_B	5t4s-assembly2.cif.gz_B Novel Approach of Fragment-Based Lead Discovery applied to Renin Inhibitors	1.015E-07	1.000	222	1	262	263	3	327	331	350	0.996	0.982
LOKIASV2_0167_ESMFold_hypothetical_protein	4cku-assembly2.cif.gz_E	4cku-assembly2.cif.gz_E Three dimensional structure of plasmepsin II in complex with hydroxyethylamine-based inhibitor	2.551E-08	1.000	221	2	262	263	1	315	322	335	0.992	0.978
LOKIASV2_0167_ESMFold_hypothetical_protein	8cik-assembly1.cif.gz_A	8cik-assembly1.cif.gz_A Altai wapiti (Cervus elaphus sibiricus) chymosin at 2.2 A resolution	1.759E-08	1.000	221	1	262	263	1	319	323	345	0.996	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	1sme-assembly1.cif.gz_A	1sme-assembly1.cif.gz_A PLASMEPSIN II, A HEMOGLOBIN-DEGRADING ENZYME FROM PLASMODIUM FALCIPARUM, IN COMPLEX WITH PEPSTATIN A	2.175E-08	1.000	221	3	262	263	3	322	329	346	0.989	0.973
LOKIASV2_0167_ESMFold_hypothetical_protein	4gj5-assembly1.cif.gz_A	4gj5-assembly1.cif.gz_A Crystal structure of renin in complex with NVP-AMQ838 (compound 5)	1.015E-07	1.000	221	2	262	263	6	328	332	344	0.992	0.973
LOKIASV2_0167_ESMFold_hypothetical_protein	5sxn-assembly2.cif.gz_B	5sxn-assembly2.cif.gz_B Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors	1.325E-07	1.000	221	2	262	263	5	332	336	350	0.992	0.976
LOKIASV2_0167_ESMFold_hypothetical_protein	6xd2-assembly1.cif.gz_A	6xd2-assembly1.cif.gz_A Porcine pepsin in complex with darunavir	1.397E-07	1.000	220	1	262	263	1	319	323	342	0.996	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	1qs8-assembly2.cif.gz_B	1qs8-assembly2.cif.gz_B Crystal structure of the P. vivax aspartic proteinase plasmepsin complexed with the inhibitor pepstatin A	2.837E-08	1.000	220	3	262	263	4	323	328	343	0.989	0.976
LOKIASV2_0167_ESMFold_hypothetical_protein	4cku-assembly2.cif.gz_B	4cku-assembly2.cif.gz_B Three dimensional structure of plasmepsin II in complex with hydroxyethylamine-based inhibitor	2.175E-08	1.000	219	1	262	263	1	320	327	342	0.996	0.979
LOKIASV2_0167_ESMFold_hypothetical_protein	4gjb-assembly1.cif.gz_A	4gjb-assembly1.cif.gz_A Crystal structure of renin in complex with NVP-BBV031 (compound 6)	2.026E-07	1.000	219	2	262	263	6	331	335	346	0.992	0.973
LOKIASV2_0167_ESMFold_hypothetical_protein	5n7q-assembly2.cif.gz_B	5n7q-assembly2.cif.gz_B CRYSTAL STRUCTURE OF MATURE CATHEPSIN D FROM THE TICK IXODES RICINUS (IRCD1) IN COMPLEX WITH THE INHIBITOR PEPSTATIN A	8.211E-08	1.000	219	1	262	263	1	333	337	356	0.996	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	3sfc-assembly1.cif.gz_A	3sfc-assembly1.cif.gz_A Structure-Based Optimization of Potent 4- and 6-Azaindole-3-Carboxamides as Renin Inhibitors	1.473E-07	1.000	219	2	262	263	6	336	340	351	0.992	0.974
LOKIASV2_0167_ESMFold_hypothetical_protein	6xct-assembly1.cif.gz_A	6xct-assembly1.cif.gz_A Porcine pepsin in complex with amprenavir	1.822E-07	1.000	218	1	262	263	1	319	323	342	0.996	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	1ls5-assembly2.cif.gz_B	1ls5-assembly2.cif.gz_B Crystal structure of plasmepsin IV from P. falciparum in complex with pepstatin A	8.659E-08	1.000	218	1	262	263	1	322	328	350	0.996	0.982
LOKIASV2_0167_ESMFold_hypothetical_protein	1hrn-assembly1.cif.gz_A	1hrn-assembly1.cif.gz_A HIGH RESOLUTION CRYSTAL STRUCTURES OF RECOMBINANT HUMAN RENIN IN COMPLEX WITH POLYHYDROXYMONOAMIDE INHIBITORS	2.506E-07	1.000	218	2	262	263	3	330	334	348	0.992	0.982
LOKIASV2_0167_ESMFold_hypothetical_protein	2v0z-assembly2.cif.gz_O	2v0z-assembly2.cif.gz_O Crystal Structure of Renin with Inhibitor 10 (Aliskiren)	1.822E-07	1.000	218	2	262	263	6	332	336	348	0.992	0.973
LOKIASV2_0167_ESMFold_hypothetical_protein	2g27-assembly1.cif.gz_A	2g27-assembly1.cif.gz_A Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring	2.253E-07	1.000	217	2	262	263	1	324	328	349	0.992	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	5yic-assembly1.cif.gz_A	5yic-assembly1.cif.gz_A Crystal Structure of KNI-10333 bound Plasmepsin II (PMII) from Plasmodium falciparum	2.175E-08	1.000	217	2	262	263	1	321	328	343	0.992	0.979
LOKIASV2_0167_ESMFold_hypothetical_protein	1dp5-assembly1.cif.gz_A	1dp5-assembly1.cif.gz_A THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT INHIBITOR	3.509E-08	1.000	217	4	262	263	3	325	329	346	0.985	0.982
LOKIASV2_0167_ESMFold_hypothetical_protein	5tmk-assembly2.cif.gz_B	5tmk-assembly2.cif.gz_B Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor	9.131E-08	1.000	217	2	262	263	3	326	330	352	0.992	0.982
LOKIASV2_0167_ESMFold_hypothetical_protein	6i3f-assembly1.cif.gz_B	6i3f-assembly1.cif.gz_B Crystal structure of the complex of human angiotensinogen and renin at 2.55 Angstrom	1.397E-07	1.000	217	1	262	263	3	334	338	353	0.996	0.982
LOKIASV2_0167_ESMFold_hypothetical_protein	5n7n-assembly3.cif.gz_C	5n7n-assembly3.cif.gz_C CRYSTAL STRUCTURE OF CATHEPSIN D ZYMOGEN FROM THE TICK IXODES RICINUS (IRCD1)	4.340E-08	1.000	217	1	262	263	1	357	361	375	0.996	0.989
LOKIASV2_0167_ESMFold_hypothetical_protein	1fmu-assembly1.cif.gz_A	1fmu-assembly1.cif.gz_A STRUCTURE OF NATIVE PROTEINASE A IN P3221 SPACE GROUP.	4.577E-08	1.000	213	3	262	263	4	318	322	339	0.989	0.978
LOKIASV2_0167_ESMFold_hypothetical_protein	1apt-assembly1.cif.gz_E	1apt-assembly1.cif.gz_E CRYSTALLOGRAPHIC ANALYSIS OF A PEPSTATIN ANALOGUE BINDING TO THE ASPARTYL PROTEINASE PENICILLOPEPSIN AT 1.8 ANGSTROMS RESOLUTION	1.015E-07	1.000	212	1	262	263	1	319	323	342	0.996	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	6r61-assembly1.cif.gz_A	6r61-assembly1.cif.gz_A Major aspartyl peptidase 1 from C. neoformans in complex with Inhibitor LP258	6.638E-08	1.000	212	2	262	263	1	346	350	365	0.992	0.989
LOKIASV2_0167_ESMFold_hypothetical_protein	5jod-assembly1.cif.gz_B	5jod-assembly1.cif.gz_B Structure of proplasmepsin IV from Plasmodium falciparum	2.419E-08	1.000	212	9	262	263	46	369	375	338	0.966	0.864
LOKIASV2_0167_ESMFold_hypothetical_protein	4cms-assembly1.cif.gz_A	4cms-assembly1.cif.gz_A X-RAY ANALYSES OF ASPARTIC PROTEINASES IV. STRUCTURE AND REFINEMENT AT 2.2 ANGSTROMS RESOLUTION OF BOVINE CHYMOSIN	1.071E-07	1.000	211	1	262	263	1	316	320	345	0.996	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	1uh9-assembly1.cif.gz_A	1uh9-assembly1.cif.gz_A Crystal structure of rhizopuspepsin at pH 7.0	1.822E-07	1.000	211	3	262	263	5	320	325	337	0.989	0.972
LOKIASV2_0167_ESMFold_hypothetical_protein	3qrv-assembly1.cif.gz_A	3qrv-assembly1.cif.gz_A Crystal structure of plasmepsin I (PMI) from Plasmodium falciparum	5.367E-08	1.000	210	3	262	263	4	316	323	343	0.989	0.969
LOKIASV2_0167_ESMFold_hypothetical_protein	2iko-assembly1.cif.gz_B	2iko-assembly1.cif.gz_B Crystal Structure of Human Renin Complexed with Inhibitor	2.787E-07	1.000	210	2	262	263	4	328	332	353	0.992	0.979
LOKIASV2_0167_ESMFold_hypothetical_protein	3q70-assembly1.cif.gz_A	3q70-assembly1.cif.gz_A Secreted aspartic protease in complex with ritonavir	2.376E-07	1.000	210	2	262	263	1	319	334	345	0.992	0.955
LOKIASV2_0167_ESMFold_hypothetical_protein	1flh-assembly1.cif.gz_A	1flh-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN UROPEPSIN AT 2.45 A RESOLUTION	2.506E-07	1.000	209	1	262	263	1	322	326	349	0.996	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	1smr-assembly1.cif.gz_A	1smr-assembly1.cif.gz_A The 3-d structure of mouse submaxillary renin complexed with a decapeptide inhibitor ch-66 based on the 4-16 fragment of rat angiotensinogen	1.921E-07	1.000	209	2	262	263	3	327	331	344	0.992	0.982
LOKIASV2_0167_ESMFold_hypothetical_protein	5i70-assembly2.cif.gz_A	5i70-assembly2.cif.gz_A Crystal Structure of plasmepsin IV	2.376E-07	1.000	208	4	262	263	2	310	315	337	0.985	0.981
LOKIASV2_0167_ESMFold_hypothetical_protein	5nfg-assembly2.cif.gz_B	5nfg-assembly2.cif.gz_B Structure of recombinant cardosin B from Cynara cardunculus	9.629E-08	1.000	208	3	262	263	7	324	328	344	0.989	0.970
LOKIASV2_0167_ESMFold_hypothetical_protein	2qzx-assembly1.cif.gz_A	2qzx-assembly1.cif.gz_A Secreted aspartic proteinase (Sap) 5 from Candida albicans	4.826E-08	1.000	208	2	262	263	1	327	342	349	0.992	0.956
LOKIASV2_0167_ESMFold_hypothetical_protein	5koq-assembly1.cif.gz_A	5koq-assembly1.cif.gz_A Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor	4.263E-07	1.000	207	1	262	263	1	331	335	352	0.996	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	1g0v-assembly1.cif.gz_A	1g0v-assembly1.cif.gz_A THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT, MVV	1.553E-07	1.000	206	2	262	263	1	325	329	345	0.992	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	7agc-assembly1.cif.gz_A	7agc-assembly1.cif.gz_A Protease Sapp1p from Candida parapsilosis in complex with KB74	1.015E-07	1.000	206	2	262	263	1	325	339	352	0.992	0.959
LOKIASV2_0167_ESMFold_hypothetical_protein	3qs1-assembly1.cif.gz_C	3qs1-assembly1.cif.gz_C Crystal structure of KNI-10006 complex of Plasmepsin I (PMI) from Plasmodium falciparum	9.131E-08	1.000	205	1	262	263	1	320	326	339	0.996	0.982
LOKIASV2_0167_ESMFold_hypothetical_protein	8fxq-assembly1.cif.gz_A	8fxq-assembly1.cif.gz_A The Crystal Sturucture of Rhizopuspepsin with a bound modified peptide inhibitor generated by de novo drug design.	5.560E-07	1.000	204	2	262	263	1	319	324	348	0.992	0.985
LOKIASV2_0167_ESMFold_hypothetical_protein	5bwy-assembly1.cif.gz_A	5bwy-assembly1.cif.gz_A Structure of proplasmepsin II from Plasmodium falciparum, Space Group P43212	2.419E-08	1.000	204	6	262	263	43	369	376	348	0.977	0.870
LOKIASV2_0167_ESMFold_hypothetical_protein	7adg-assembly1.cif.gz_A	7adg-assembly1.cif.gz_A Cocktail experiment G: fragments 216 and 338 at 90 mM concentration in complex with Endothiapepsin	4.741E-07	1.000	202	2	262	263	1	327	330	343	0.992	0.991
LOKIASV2_0167_ESMFold_hypothetical_protein	5sy2-assembly2.cif.gz_B	5sy2-assembly2.cif.gz_B Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors	2.137E-07	1.000	202	2	262	263	6	326	330	355	0.992	0.973
LOKIASV2_0167_ESMFold_hypothetical_protein	3qvc-assembly1.cif.gz_A	3qvc-assembly1.cif.gz_A Crystal structure of histo-aspartic protease (HAP) zymogen from Plasmodium falciparum	1.071E-07	1.000	202	15	262	263	50	362	368	332	0.943	0.851
LOKIASV2_0167_ESMFold_hypothetical_protein	5ux4-assembly2.cif.gz_B	5ux4-assembly2.cif.gz_B Crystal Structure of Rat Cathepsin D with (5S)-3-(5,6-dihydro-2H-pyran-3-yl)-1-fluoro- 7-(2-fluoropyridin-3-yl)spiro[chromeno[2,3- c]pyridine-5,4'-[1,3]oxazol]-2'-amine	3.833E-07	1.000	199	3	262	263	4	334	340	349	0.989	0.974
LOKIASV2_0167_ESMFold_hypothetical_protein	6apr-assembly1.cif.gz_E	6apr-assembly1.cif.gz_E STRUCTURES OF COMPLEXES OF RHIZOPUSPEPSIN WITH PEPSTATIN AND OTHER STATINE-CONTAINING INHIBITORS	8.066E-07	1.000	198	3	262	263	5	320	325	337	0.989	0.972
LOKIASV2_0167_ESMFold_hypothetical_protein	2anl-assembly2.cif.gz_B	2anl-assembly2.cif.gz_B X-ray crystal structure of the aspartic protease plasmepsin 4 from the malarial parasite plasmodium malariae bound to an allophenylnorstatine based inhibitor	6.184E-07	1.000	198	2	262	263	4	322	327	339	0.992	0.976
LOKIASV2_0167_ESMFold_hypothetical_protein	1fmx-assembly2.cif.gz_B	1fmx-assembly2.cif.gz_B STRUCTURE OF NATIVE PROTEINASE A IN THE SPACE GROUP P21	1.728E-07	1.000	197	3	262	263	4	321	325	343	0.989	0.978
LOKIASV2_0167_ESMFold_hypothetical_protein	1ibq-assembly2.cif.gz_B	1ibq-assembly2.cif.gz_B ASPERGILLOPEPSIN FROM ASPERGILLUS PHOENICIS	3.447E-07	1.000	197	2	262	263	1	321	325	341	0.992	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	1htr-assembly1.cif.gz_B	1htr-assembly1.cif.gz_B CRYSTAL AND MOLECULAR STRUCTURES OF HUMAN PROGASTRICSIN AT 1.62 ANGSTROMS RESOLUTION	1.822E-07	1.000	197	21	262	263	15	325	329	326	0.920	0.945
LOKIASV2_0167_ESMFold_hypothetical_protein	6rsv-assembly1.cif.gz_A	6rsv-assembly1.cif.gz_A Endothiapepsin in complex with 017	5.273E-07	1.000	196	2	262	263	1	326	329	341	0.992	0.991
LOKIASV2_0167_ESMFold_hypothetical_protein	5ux4-assembly1.cif.gz_A	5ux4-assembly1.cif.gz_A Crystal Structure of Rat Cathepsin D with (5S)-3-(5,6-dihydro-2H-pyran-3-yl)-1-fluoro- 7-(2-fluoropyridin-3-yl)spiro[chromeno[2,3- c]pyridine-5,4'-[1,3]oxazol]-2'-amine	6.184E-07	1.000	196	2	262	263	1	331	337	355	0.992	0.982
LOKIASV2_0167_ESMFold_hypothetical_protein	5pep-assembly1.cif.gz_A	5pep-assembly1.cif.gz_A X-RAY ANALYSES OF ASPARTIC PROTEASES. II. THREE-DIMENSIONAL STRUCTURE OF THE HEXAGONAL CRYSTAL FORM OF PORCINE PEPSIN AT 2.3 ANGSTROMS RESOLUTION	7.252E-07	1.000	195	4	262	263	2	322	326	343	0.985	0.985
LOKIASV2_0167_ESMFold_hypothetical_protein	5nfg-assembly1.cif.gz_A	5nfg-assembly1.cif.gz_A Structure of recombinant cardosin B from Cynara cardunculus	2.506E-07	1.000	195	3	262	263	7	329	333	350	0.989	0.970
LOKIASV2_0167_ESMFold_hypothetical_protein	1j71-assembly1.cif.gz_A	1j71-assembly1.cif.gz_A Structure of the extracellular aspartic proteinase from Candida tropicalis yeast.	2.643E-07	1.000	195	2	262	263	1	320	334	343	0.992	0.958
LOKIASV2_0167_ESMFold_hypothetical_protein	1miq-assembly1.cif.gz_A	1miq-assembly1.cif.gz_A Crystal structure of proplasmepsin from the human malarial pathogen Plasmodium vivax	6.638E-08	1.000	195	9	262	263	45	368	373	336	0.966	0.869
LOKIASV2_0167_ESMFold_hypothetical_protein	4yct-assembly1.cif.gz_A	4yct-assembly1.cif.gz_A Endothiapepsin in complex with fragment 216	6.521E-07	1.000	194	2	262	263	1	325	328	344	0.992	0.991
LOKIASV2_0167_ESMFold_hypothetical_protein	2bks-assembly2.cif.gz_B	2bks-assembly2.cif.gz_B crystal structure of Renin-PF00074777 complex	3.447E-07	1.000	193	2	262	263	1	325	329	348	0.992	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	2qzw-assembly2.cif.gz_B	2qzw-assembly2.cif.gz_B Secreted aspartic proteinase (Sap) 1 from Candida albicans	2.787E-07	1.000	193	2	262	263	1	326	341	353	0.992	0.956
LOKIASV2_0167_ESMFold_hypothetical_protein	6kud-assembly1.cif.gz_A-2	6kud-assembly1.cif.gz_A-2 Crystal structure of Plasmodium falciparum histo-aspartic protease (HAP) zymogen (Form 3)	1.129E-07	1.000	193	15	262	263	55	367	373	327	0.943	0.839
LOKIASV2_0167_ESMFold_hypothetical_protein	5koq-assembly2.cif.gz_B	5koq-assembly2.cif.gz_B Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor	5.000E-07	1.000	192	2	262	263	3	329	333	352	0.992	0.982
LOKIASV2_0167_ESMFold_hypothetical_protein	2h6s-assembly1.cif.gz_A	2h6s-assembly1.cif.gz_A Secreted aspartic proteinase (Sap) 3 from Candida albicans	6.638E-08	1.000	192	2	262	263	1	325	340	359	0.992	0.956
LOKIASV2_0167_ESMFold_hypothetical_protein	1tzs-assembly1.cif.gz_A-2	1tzs-assembly1.cif.gz_A-2 Crystal Structure of an activation intermediate of Cathepsin E	8.970E-07	1.000	191	21	262	263	13	318	322	323	0.920	0.950
LOKIASV2_0167_ESMFold_hypothetical_protein	8dsr-assembly2.cif.gz_B	8dsr-assembly2.cif.gz_B Structure of Plasmepsin X (PM10, PMX) from Plasmodium falciparum 3D7 in complex with UCB7362	1.256E-07	1.000	191	3	262	263	4	327	332	343	0.989	0.976
LOKIASV2_0167_ESMFold_hypothetical_protein	5mlg-assembly1.cif.gz_A	5mlg-assembly1.cif.gz_A Crystal structure of rat prorenin	6.877E-07	1.000	191	15	262	263	45	358	364	329	0.943	0.863
LOKIASV2_0167_ESMFold_hypothetical_protein	4aa9-assembly1.cif.gz_A	4aa9-assembly1.cif.gz_A Camel chymosin at 1.6A resolution	3.268E-07	1.000	190	21	262	263	7	309	313	324	0.920	0.968
LOKIASV2_0167_ESMFold_hypothetical_protein	4rld-assembly1.cif.gz_A	4rld-assembly1.cif.gz_A Crystal structure of kkf mutant of bla G 2 protein	6.184E-07	1.000	190	1	262	263	8	325	330	343	0.996	0.964
LOKIASV2_0167_ESMFold_hypothetical_protein	3psg-assembly1.cif.gz_A	3psg-assembly1.cif.gz_A THE HIGH RESOLUTION CRYSTAL STRUCTURE OF PORCINE PEPSINOGEN	1.921E-07	1.000	190	15	262	263	54	361	365	325	0.943	0.844
LOKIASV2_0167_ESMFold_hypothetical_protein	3q6y-assembly1.cif.gz_A	3q6y-assembly1.cif.gz_A Endothiapepsin in complex with a pyrrolidine based inhibitor	3.635E-07	1.000	189	2	262	263	1	302	305	327	0.992	0.990
LOKIASV2_0167_ESMFold_hypothetical_protein	5mkt-assembly1.cif.gz_A	5mkt-assembly1.cif.gz_A Crystal structure of mouse prorenin	8.506E-07	1.000	185	2	262	263	1	323	329	348	0.992	0.982
LOKIASV2_0167_ESMFold_hypothetical_protein	4amt-assembly1.cif.gz_A-2	4amt-assembly1.cif.gz_A-2 Crystal structure at 2.6A of human prorenin	1.109E-06	1.000	185	3	262	263	5	345	349	359	0.989	0.977
LOKIASV2_0167_ESMFold_hypothetical_protein	1gvt-assembly1.cif.gz_A	1gvt-assembly1.cif.gz_A Endothiapepsin complex with CP-80,794	2.596E-06	1.000	184	2	262	263	1	325	328	341	0.992	0.991
LOKIASV2_0167_ESMFold_hypothetical_protein	3liz-assembly1.cif.gz_A	3liz-assembly1.cif.gz_A crystal structure of bla g 2 complexed with Fab 4C3	3.268E-07	1.000	184	7	262	263	1	323	329	346	0.973	0.982
LOKIASV2_0167_ESMFold_hypothetical_protein	3pvk-assembly1.cif.gz_A	3pvk-assembly1.cif.gz_A Secreted aspartic protease 2 in complex with benzamidine	6.877E-07	1.000	183	1	262	263	1	316	330	338	0.996	0.958
LOKIASV2_0167_ESMFold_hypothetical_protein	4ehc-assembly1.cif.gz_A	4ehc-assembly1.cif.gz_A Crystal structure of the C-terminal domain of Rv0977 of Mycobacterium tuberculosis	1.301E-06	1.000	182	2	261	263	17	279	280	312	0.989	0.939
LOKIASV2_0167_ESMFold_hypothetical_protein	3fnt-assembly1.cif.gz_A	3fnt-assembly1.cif.gz_A Crystal structure of pepstatin A bound histo-aspartic protease (HAP) from Plasmodium falciparum	8.970E-07	1.000	182	2	262	263	1	319	323	341	0.992	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	1wkr-assembly1.cif.gz_A	1wkr-assembly1.cif.gz_A Crystal structure of aspartic proteinase from Irpex lacteus	3.571E-06	1.000	182	2	262	263	3	329	340	352	0.992	0.962
LOKIASV2_0167_ESMFold_hypothetical_protein	7nkw-assembly1.cif.gz_A	7nkw-assembly1.cif.gz_A Endothiapepsin structure obtained at 298K after a soaking with fragment JFD03909 from a dataset collected with JUNGFRAU detector	2.213E-06	1.000	181	2	262	263	1	323	326	340	0.992	0.991
LOKIASV2_0167_ESMFold_hypothetical_protein	1am5-assembly1.cif.gz_A	1am5-assembly1.cif.gz_A THE CRYSTAL STRUCTURE AND PROPOSED AMINO ACID SEQUENCE OF A PEPSIN FROM ATLANTIC COD (GADUS MORHUA)	6.521E-07	1.000	180	5	262	263	2	320	324	336	0.981	0.985
LOKIASV2_0167_ESMFold_hypothetical_protein	3vcm-assembly2.cif.gz_B	3vcm-assembly2.cif.gz_B Crystal structure of human prorenin	3.211E-06	1.000	179	21	262	263	12	321	325	327	0.920	0.954
LOKIASV2_0167_ESMFold_hypothetical_protein	1eag-assembly1.cif.gz_A-2	1eag-assembly1.cif.gz_A-2 Secreted aspartic proteinase (SAP2) from Candida albicans complexed with A70450	6.877E-07	1.000	179	2	262	263	1	324	339	342	0.992	0.956
LOKIASV2_0167_ESMFold_hypothetical_protein	1avf-assembly2.cif.gz_J	1avf-assembly2.cif.gz_J ACTIVATION INTERMEDIATE 2 OF HUMAN GASTRICSIN FROM HUMAN STOMACH	8.970E-07	1.000	178	6	262	263	3	318	322	339	0.977	0.981
LOKIASV2_0167_ESMFold_hypothetical_protein	3aup-assembly1.cif.gz_C	3aup-assembly1.cif.gz_C Crystal structure of Basic 7S globulin from soybean	4.826E-08	1.000	178	1	262	263	2	359	372	374	0.996	0.962
LOKIASV2_0167_ESMFold_hypothetical_protein	6kub-assembly1.cif.gz_A	6kub-assembly1.cif.gz_A Crystal structure of Plasmodium falciparum histo-aspartic protease (HAP) zymogen (Form 1)	2.939E-07	1.000	178	17	262	263	64	374	380	328	0.935	0.818
LOKIASV2_0167_ESMFold_hypothetical_protein	4pph-assembly1.cif.gz_E	4pph-assembly1.cif.gz_E Crystal structure of conglutin gamma, a unique basic 7S globulin from lupine seeds	1.473E-07	1.000	178	3	262	263	4	371	391	381	0.989	0.941
LOKIASV2_0167_ESMFold_hypothetical_protein	3emy-assembly1.cif.gz_A	3emy-assembly1.cif.gz_A Crystal structure of Trichoderma reesei aspartic proteinase complexed with pepstatin A	9.292E-06	1.000	177	2	262	263	1	326	329	345	0.992	0.991
LOKIASV2_0167_ESMFold_hypothetical_protein	7tbc-assembly1.cif.gz_A	7tbc-assembly1.cif.gz_A Crystal structure of Plasmepsin X from Plasmodium falciparum in complex with WM382	2.506E-07	1.000	175	2	262	263	1	332	338	353	0.992	0.982
LOKIASV2_0167_ESMFold_hypothetical_protein	7tbb-assembly1.cif.gz_A	7tbb-assembly1.cif.gz_A Crystal structure of Plasmepsin X from Plasmodium falciparum	3.268E-07	1.000	174	1	262	263	1	327	332	350	0.996	0.985
LOKIASV2_0167_ESMFold_hypothetical_protein	2asi-assembly1.cif.gz_A	2asi-assembly1.cif.gz_A ASPARTIC PROTEINASE	2.643E-07	1.000	174	2	262	263	1	346	356	356	0.992	0.972
LOKIASV2_0167_ESMFold_hypothetical_protein	1psa-assembly1.cif.gz_A	1psa-assembly1.cif.gz_A STRUCTURE OF A PEPSIN(SLASH)RENIN INHIBITOR COMPLEX REVEALS A NOVEL CRYSTAL PACKING INDUCED BY MINOR CHEMICAL ALTERATIONS IN THE INHIBITOR	3.045E-06	1.000	173	1	262	263	1	322	326	340	0.996	0.988
LOKIASV2_0167_ESMFold_hypothetical_protein	4bel-assembly2.cif.gz_B	4bel-assembly2.cif.gz_B BACE2 XAPERONE COMPLEX	1.609E-06	1.000	173	3	262	263	6	326	357	351	0.989	0.899
LOKIASV2_0167_ESMFold_hypothetical_protein	1avf-assembly1.cif.gz_A	1avf-assembly1.cif.gz_A ACTIVATION INTERMEDIATE 2 OF HUMAN GASTRICSIN FROM HUMAN STOMACH	1.609E-06	1.000	172	21	262	263	14	316	320	321	0.920	0.947
LOKIASV2_0167_ESMFold_hypothetical_protein	7tbe-assembly4.cif.gz_D	7tbe-assembly4.cif.gz_D Crystal structure of Plasmepsin X from Plasmodium vivax in complex with WM4	1.990E-06	1.000	172	3	263	263	9	337	340	347	0.992	0.968
LOKIASV2_0167_ESMFold_hypothetical_protein	1zap-assembly1.cif.gz_A	1zap-assembly1.cif.gz_A SECRETED ASPARTIC PROTEASE FROM C. ALBICANS	3.571E-06	1.000	172	2	262	263	1	326	341	343	0.992	0.956
LOKIASV2_0167_ESMFold_hypothetical_protein	3kyr-assembly2.cif.gz_B	3kyr-assembly2.cif.gz_B Bace-1 in complex with a norstatine type inhibitor	3.833E-07	1.000	171	3	262	263	6	335	363	355	0.989	0.909
LOKIASV2_0167_ESMFold_hypothetical_protein	3tpl-assembly3.cif.gz_C	3tpl-assembly3.cif.gz_C APO Structure of BACE1	1.447E-06	1.000	171	3	262	263	6	339	370	361	0.989	0.903
LOKIASV2_0167_ESMFold_hypothetical_protein	4pph-assembly1.cif.gz_A	4pph-assembly1.cif.gz_A Crystal structure of conglutin gamma, a unique basic 7S globulin from lupine seeds	9.629E-08	1.000	171	2	262	263	3	370	390	384	0.992	0.944
LOKIASV2_0167_ESMFold_hypothetical_protein	5kr8-assembly1.cif.gz_A	5kr8-assembly1.cif.gz_A (4~{S},6~{S})-4-[2,4-bis(fluoranyl)phenyl]-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-methyl-5,6-dihydro-1,3-thiazin-2-amine (compound 5) bound to BACE1	3.045E-06	1.000	170	3	262	263	5	328	359	351	0.989	0.903
LOKIASV2_0167_ESMFold_hypothetical_protein	3qvi-assembly2.cif.gz_A	3qvi-assembly2.cif.gz_A Crystal structure of KNI-10395 bound histo-aspartic protease (HAP) from Plasmodium falciparum	1.372E-06	1.000	169	21	262	263	16	317	323	316	0.920	0.935
LOKIASV2_0167_ESMFold_hypothetical_protein	3aup-assembly1.cif.gz_B	3aup-assembly1.cif.gz_B Crystal structure of Basic 7S globulin from soybean	3.833E-07	1.000	169	1	262	263	2	353	372	373	0.996	0.946
LOKIASV2_0167_ESMFold_hypothetical_protein	4ycy-assembly1.cif.gz_A	4ycy-assembly1.cif.gz_A Endothiapepsin in complex with fragment 218	7.124E-06	1.000	167	2	262	263	1	320	323	342	0.992	0.991
LOKIASV2_0167_ESMFold_hypothetical_protein	3hvg-assembly3.cif.gz_C	3hvg-assembly3.cif.gz_C Structure of bace (beta secretase) in Complex with EV0	1.887E-06	1.000	166	3	262	263	8	342	373	362	0.989	0.898
LOKIASV2_0167_ESMFold_hypothetical_protein	1odx-assembly1.cif.gz_B	1odx-assembly1.cif.gz_B HIV-1 Proteinase mutant A71T, V82A	3.446E-04	1.000	165	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3aup-assembly1.cif.gz_A	3aup-assembly1.cif.gz_A Crystal structure of Basic 7S globulin from soybean	6.184E-07	1.000	165	1	262	263	2	356	377	366	0.996	0.942
LOKIASV2_0167_ESMFold_hypothetical_protein	2psg-assembly1.cif.gz_A-2	2psg-assembly1.cif.gz_A-2 REFINED STRUCTURE OF PORCINE PEPSINOGEN AT 1.8 ANGSTROMS RESOLUTION	1.887E-06	1.000	163	17	262	263	56	366	370	326	0.935	0.841
LOKIASV2_0167_ESMFold_hypothetical_protein	3vlb-assembly2.cif.gz_C	3vlb-assembly2.cif.gz_C Crystal structure of xeg-edgp	6.877E-07	1.000	163	3	262	263	4	386	403	412	0.989	0.950
LOKIASV2_0167_ESMFold_hypothetical_protein	1c6y-assembly1.cif.gz_B	1c6y-assembly1.cif.gz_B ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP.	7.646E-04	1.000	162	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3aup-assembly1.cif.gz_D	3aup-assembly1.cif.gz_D Crystal structure of Basic 7S globulin from soybean	1.170E-06	1.000	162	1	262	263	2	346	360	362	0.996	0.958
LOKIASV2_0167_ESMFold_hypothetical_protein	3kyr-assembly3.cif.gz_C	3kyr-assembly3.cif.gz_C Bace-1 in complex with a norstatine type inhibitor	2.596E-06	1.000	162	4	262	263	5	329	360	347	0.985	0.903
LOKIASV2_0167_ESMFold_hypothetical_protein	3kyr-assembly1.cif.gz_A	3kyr-assembly1.cif.gz_A Bace-1 in complex with a norstatine type inhibitor	3.571E-06	1.000	162	3	262	263	6	335	365	355	0.989	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	6uj0-assembly1.cif.gz_A	6uj0-assembly1.cif.gz_A Unbound BACE2 mutant structure	3.386E-06	1.000	162	1	262	263	1	336	367	360	0.996	0.916
LOKIASV2_0167_ESMFold_hypothetical_protein	3hw1-assembly1.cif.gz_A	3hw1-assembly1.cif.gz_A Structure of Bace (beta secretase) in complex with ligand EV2	1.990E-06	1.000	162	3	262	263	7	339	370	359	0.989	0.900
LOKIASV2_0167_ESMFold_hypothetical_protein	2zji-assembly1.cif.gz_A	2zji-assembly1.cif.gz_A Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(2,6-dimethoxy-benzyl)-piperidin-4-yl]-4-mercapto-butyramide	3.766E-06	1.000	162	3	262	263	8	339	370	355	0.989	0.897
LOKIASV2_0167_ESMFold_hypothetical_protein	4bfb-assembly1.cif.gz_A	4bfb-assembly1.cif.gz_A BACE2 XAPERONE COMPLEX	4.657E-06	1.000	162	3	262	263	5	342	373	360	0.989	0.906
LOKIASV2_0167_ESMFold_hypothetical_protein	1w51-assembly1.cif.gz_A	1w51-assembly1.cif.gz_A BACE (Beta Secretase) in complex with a nanomolar non-peptidic inhibitor	7.513E-06	1.000	162	3	262	263	5	343	374	367	0.989	0.906
LOKIASV2_0167_ESMFold_hypothetical_protein	5qd9-assembly2.cif.gz_B	5qd9-assembly2.cif.gz_B Crystal structure of BACE complex with BMC005	2.334E-06	1.000	162	3	262	263	6	346	377	366	0.989	0.905
LOKIASV2_0167_ESMFold_hypothetical_protein	3vlb-assembly1.cif.gz_A	3vlb-assembly1.cif.gz_A Crystal structure of xeg-edgp	3.099E-07	1.000	162	3	262	263	4	387	404	409	0.989	0.950
LOKIASV2_0167_ESMFold_hypothetical_protein	4dh6-assembly1.cif.gz_A	4dh6-assembly1.cif.gz_A Structure of Bace-1 (Beta-Secretase) in Complex with (2R)-N-((2S,3R)-1-(benzo[d][1,3]dioxol-5-yl)-3-hydroxy-4-((S)-6'-neopentyl-3',4'-dihydrospiro[cyclobutane-1,2'-pyrano[2,3-b]pyridine]-4'-ylamino)butan-2-yl)-2-methoxypropanamide	2.099E-06	1.000	161	3	262	263	5	336	367	366	0.989	0.905
LOKIASV2_0167_ESMFold_hypothetical_protein	2wez-assembly1.cif.gz_A	2wez-assembly1.cif.gz_A Human BACE-1 in complex with 1-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-(phenylmethyl)propyl)-4-(2-oxo-1- pyrrolidinyl)-1H-indole-6-carboxamide	2.596E-06	1.000	161	1	262	263	1	343	372	367	0.996	0.922
LOKIASV2_0167_ESMFold_hypothetical_protein	4ivs-assembly1.cif.gz_A	4ivs-assembly1.cif.gz_A Crystal structure of BACE1 with its inhibitor	1.609E-06	1.000	161	3	262	263	7	342	373	358	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	3tpj-assembly1.cif.gz_A	3tpj-assembly1.cif.gz_A APO structure of BACE1	6.521E-07	1.000	161	3	262	263	8	345	377	354	0.989	0.897
LOKIASV2_0167_ESMFold_hypothetical_protein	2aof-assembly1.cif.gz_A	2aof-assembly1.cif.gz_A Crystal structure analysis of HIV-1 Protease mutant V82A with a substrate analog P1-P6	5.862E-04	1.000	160	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4k4r-assembly1.cif.gz_A	4k4r-assembly1.cif.gz_A TL-3 inhibited Trp6Ala HIV Protease with 1-bromo-2-napthoic acid bound in exosite	6.875E-04	1.000	160	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2zjh-assembly1.cif.gz_A	2zjh-assembly1.cif.gz_A Crystal structure of the human BACE1 catalytic domain in complex with N-(1-benzyl-piperidin-4-yl)-4-mercapto-butyramide	3.211E-06	1.000	160	3	262	263	7	325	356	345	0.989	0.896
LOKIASV2_0167_ESMFold_hypothetical_protein	6nv7-assembly3.cif.gz_C	6nv7-assembly3.cif.gz_C BACE1 in complex with a macrocyclic inhibitor	2.099E-06	1.000	160	3	262	263	6	343	374	367	0.989	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	4azy-assembly1.cif.gz_A	4azy-assembly1.cif.gz_A Design and Synthesis of BACE1 Inhibitors with In Vivo Brain Reduction of beta-Amyloid Peptides (COMPOUND 10)	4.188E-06	1.000	160	3	262	263	7	345	375	361	0.989	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	3em3-assembly1.cif.gz_B	3em3-assembly1.cif.gz_B Crystal structure of amprenavir (APV) in complex with a drug resistant HIV-1 protease variant (I50L/A71V).	6.519E-04	1.000	159	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4rvi-assembly2.cif.gz_D	4rvi-assembly2.cif.gz_D Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL0519	6.875E-04	1.000	159	21	110	263	10	92	99	90	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	5ie1-assembly1.cif.gz_A	5ie1-assembly1.cif.gz_A Crystal structure of BACE1 in complex with 3-(2-amino-6-(o-tolyl)quinolin-3-yl)-N-(3,3-dimethylbutyl)propanamide	3.971E-06	1.000	159	3	262	263	5	330	361	356	0.989	0.903
LOKIASV2_0167_ESMFold_hypothetical_protein	7dcz-assembly1.cif.gz_A	7dcz-assembly1.cif.gz_A Crystal Structure of BACE1 in complex with N-{3-[(4S)-2-amino-4-methyl-4H-1,3-thiazin-4-yl]-4- fluorophenyl}-5-cyanopyridine-2-carboxamide	5.760E-06	1.000	159	3	262	263	8	348	379	366	0.989	0.900
LOKIASV2_0167_ESMFold_hypothetical_protein	1k1t-assembly1.cif.gz_B	1k1t-assembly1.cif.gz_B Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance	8.967E-04	1.000	158	21	110	263	10	92	99	90	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3tkg-assembly2.cif.gz_D	3tkg-assembly2.cif.gz_D crystal structure of HIV model protease precursor/saquinavir complex	8.503E-04	1.000	158	21	110	263	10	92	99	90	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3vv7-assembly1.cif.gz_A	3vv7-assembly1.cif.gz_A Crystal Structure of beta secetase in complex with 2-amino-6-((1S,2R)-2-(3'-methoxybiphenyl-3-yl)cyclopropyl)-3-methylpyrimidin-4(3H)-one	3.571E-06	1.000	158	4	262	263	6	330	361	347	0.985	0.900
LOKIASV2_0167_ESMFold_hypothetical_protein	4frk-assembly1.cif.gz_A	4frk-assembly1.cif.gz_A Crystal structure of BACE1 in complex with aminooxazoline xanthene 11a	6.406E-06	1.000	158	3	262	263	5	338	369	357	0.989	0.905
LOKIASV2_0167_ESMFold_hypothetical_protein	5dqc-assembly3.cif.gz_C	5dqc-assembly3.cif.gz_C Co-crystal of BACE1 with compound 0211	3.386E-06	1.000	158	3	262	263	7	342	373	365	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	3msj-assembly1.cif.gz_A	3msj-assembly1.cif.gz_A Structure of bace (beta secretase) in complex with inhibitor	2.887E-06	1.000	158	3	262	263	7	342	373	365	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	5qd0-assembly1.cif.gz_A	5qd0-assembly1.cif.gz_A Crystal structure of BACE complex withBMC006	5.179E-06	1.000	158	3	262	263	6	343	373	365	0.989	0.906
LOKIASV2_0167_ESMFold_hypothetical_protein	3n4l-assembly1.cif.gz_A	3n4l-assembly1.cif.gz_A BACE-1 in complex with ELN380842	1.447E-06	1.000	158	4	262	263	5	343	375	360	0.985	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	4d8c-assembly3.cif.gz_C	4d8c-assembly3.cif.gz_C Crystal Structure of Human Beta Secretase in Complex with NVP-BXD552, derived from a co-crystallization experiment	1.447E-06	1.000	158	3	262	263	6	352	381	373	0.989	0.911
LOKIASV2_0167_ESMFold_hypothetical_protein	3rvi-assembly1.cif.gz_A	3rvi-assembly1.cif.gz_A Structure of Bace-1 (Beta-Secretase) in Complex with 2-((2-Amino-6-o-tolylquinolin-3-yl)methyl)-N-(cyclohexylmethyl)pentanamide	9.799E-06	1.000	157	3	262	263	5	338	369	356	0.989	0.905
LOKIASV2_0167_ESMFold_hypothetical_protein	4d85-assembly1.cif.gz_A	4d85-assembly1.cif.gz_A Crystal Structure of Human Beta Secretase in Complex with NVP-BVI151	3.045E-06	1.000	157	3	262	263	7	343	374	369	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	4dqb-assembly1.cif.gz_B	4dqb-assembly1.cif.gz_B Crystal Structure of wild-type HIV-1 Protease in Complex with DRV	6.182E-04	1.000	156	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2p3b-assembly1.cif.gz_B	2p3b-assembly1.cif.gz_B Crystal Structure of the subtype B wild type HIV protease complexed with TL-3 inhibitor	4.739E-04	1.000	156	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4qj7-assembly1.cif.gz_B	4qj7-assembly1.cif.gz_B Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with p1-p6 substrate variant (R452S)	9.972E-04	1.000	156	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4dus-assembly1.cif.gz_A	4dus-assembly1.cif.gz_A Structure of Bace-1 (Beta-Secretase) in complex with N-((2S,3R)-1-(4-fluorophenyl)-3-hydroxy-4-((6'-neopentyl-3',4'-dihydrospiro[cyclobutane-1,2'-pyrano[2,3-b]pyridin]-4'-yl)amino)butan-2-yl)acetamide	7.513E-06	1.000	156	3	262	263	5	334	365	360	0.989	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	2zjn-assembly1.cif.gz_A	2zjn-assembly1.cif.gz_A Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(5-chloro-2-isopropoxy-3-methoxy-benzyl)-piperidin-4-yl]-2-(2-methyl-4-sulfamoyl-phenoxy)-acetamide	1.887E-06	1.000	156	4	262	263	6	336	367	353	0.985	0.902
LOKIASV2_0167_ESMFold_hypothetical_protein	3lhg-assembly1.cif.gz_A	3lhg-assembly1.cif.gz_A Bace1 in complex with the aminohydantoin Compound 4g	2.334E-06	1.000	156	3	262	263	6	342	369	360	0.989	0.913
LOKIASV2_0167_ESMFold_hypothetical_protein	6jt4-assembly1.cif.gz_A	6jt4-assembly1.cif.gz_A Crystal Structure of BACE1 in complex with N-{3-[(4S,6S)-2-amino-4-methyl-6-(trifluoromethyl)-5,6-dihydro-4H-1,3-thiazin-4-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide	1.149E-05	1.000	156	3	262	263	7	339	370	362	0.989	0.900
LOKIASV2_0167_ESMFold_hypothetical_protein	5dqc-assembly1.cif.gz_A	5dqc-assembly1.cif.gz_A Co-crystal of BACE1 with compound 0211	3.211E-06	1.000	156	3	262	263	6	341	372	358	0.989	0.903
LOKIASV2_0167_ESMFold_hypothetical_protein	4fgx-assembly1.cif.gz_A	4fgx-assembly1.cif.gz_A Crystal structure of bace1 with novel inhibitor	1.790E-06	1.000	156	3	262	263	6	342	374	356	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	6e3z-assembly1.cif.gz_A	6e3z-assembly1.cif.gz_A Structure of Bace-1 in complex with Ligand 8	2.887E-06	1.000	156	3	262	263	8	347	378	365	0.989	0.899
LOKIASV2_0167_ESMFold_hypothetical_protein	3oxx-assembly2.cif.gz_C	3oxx-assembly2.cif.gz_C Crystal Structure of HIV-1 I50V, A71V Protease in Complex with the Protease Inhibitor Atazanavir	8.503E-04	1.000	155	21	110	263	10	92	99	90	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2qd6-assembly1.cif.gz_A	2qd6-assembly1.cif.gz_A HIV-1 Protease Mutant I50V with potent Antiviral inhibitor GRL-98065	8.063E-04	1.000	155	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3s43-assembly1.cif.gz_A	3s43-assembly1.cif.gz_A HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug amprenavir	8.503E-04	1.000	155	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1mpp-assembly1.cif.gz_A	1mpp-assembly1.cif.gz_A X-RAY ANALYSES OF ASPARTIC PROTEINASES. V. STRUCTURE AND REFINEMENT AT 2.0 ANGSTROMS RESOLUTION OF THE ASPARTIC PROTEINASE FROM MUCOR PUSILLUS	4.657E-06	1.000	155	2	262	263	1	347	357	374	0.992	0.972
LOKIASV2_0167_ESMFold_hypothetical_protein	3zl7-assembly1.cif.gz_A	3zl7-assembly1.cif.gz_A BACE2 FYNOMER COMPLEX	6.406E-06	1.000	155	2	262	263	1	332	363	362	0.992	0.915
LOKIASV2_0167_ESMFold_hypothetical_protein	3dm6-assembly2.cif.gz_B	3dm6-assembly2.cif.gz_B Beta-secretase 1 complexed with statine-based inhibitor	1.790E-06	1.000	155	3	262	263	6	340	368	353	0.989	0.910
LOKIASV2_0167_ESMFold_hypothetical_protein	3exo-assembly1.cif.gz_A	3exo-assembly1.cif.gz_A Crystal structure of BACE1 bound to inhibitor	3.045E-06	1.000	155	3	262	263	7	342	373	359	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	5ezx-assembly1.cif.gz_A	5ezx-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH {(1R,2R)-2-[(R)-2-Amino-4-(4-difluoromethoxy-phenyl)-4,5-dihydro-oxazol-4-yl]-cyclopropyl}-(5-chloro-pyridin-3-yl)-methanone	8.811E-06	1.000	155	3	262	263	8	343	374	360	0.989	0.898
LOKIASV2_0167_ESMFold_hypothetical_protein	3n4l-assembly2.cif.gz_B	3n4l-assembly2.cif.gz_B BACE-1 in complex with ELN380842	8.506E-07	1.000	155	4	262	263	5	342	375	358	0.985	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	3ekq-assembly1.cif.gz_B	3ekq-assembly1.cif.gz_B Crystal structure of inhibitor saquinavir (SQV) in complex with multi-drug resistant HIV-1 protease (L63P/V82T/I84V) (referred to as ACT in paper)	1.052E-03	1.000	154	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2rmp-assembly1.cif.gz_A	2rmp-assembly1.cif.gz_A RMP-pepstatin A complex	5.179E-06	1.000	154	3	262	263	3	348	358	356	0.989	0.966
LOKIASV2_0167_ESMFold_hypothetical_protein	3vv6-assembly1.cif.gz_A	3vv6-assembly1.cif.gz_A Crystal Structure of beta secetase in complex with 2-amino-3-methyl-6-((1S, 2R)-2-phenylcyclopropyl)pyrimidin-4(3H)-one	7.513E-06	1.000	154	3	262	263	7	329	360	350	0.989	0.897
LOKIASV2_0167_ESMFold_hypothetical_protein	6nv7-assembly2.cif.gz_B	6nv7-assembly2.cif.gz_B BACE1 in complex with a macrocyclic inhibitor	3.971E-06	1.000	154	3	262	263	7	338	370	360	0.989	0.897
LOKIASV2_0167_ESMFold_hypothetical_protein	4k8s-assembly3.cif.gz_C	4k8s-assembly3.cif.gz_C Hydroxyethylamine-based inhibitors of BACE1: P1-P3 macrocyclization can improve potency, selectivity, and cell activity	5.462E-06	1.000	154	3	262	263	6	340	371	358	0.989	0.903
LOKIASV2_0167_ESMFold_hypothetical_protein	6nv9-assembly3.cif.gz_C	6nv9-assembly3.cif.gz_C BACE1 in complex with a macrocyclic inhibitor	6.756E-06	1.000	154	3	262	263	5	340	371	364	0.989	0.906
LOKIASV2_0167_ESMFold_hypothetical_protein	3veu-assembly1.cif.gz_A	3veu-assembly1.cif.gz_A Crystal Structure of Human Beta Secretase in Complex with NVP-AVI326	4.657E-06	1.000	154	3	262	263	6	348	380	362	0.989	0.903
LOKIASV2_0167_ESMFold_hypothetical_protein	3nu4-assembly1.cif.gz_A	3nu4-assembly1.cif.gz_A Crystal Structure of HIV-1 Protease Mutant V32I with Antiviral Drug Amprenavir	9.972E-04	1.000	153	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4rce-assembly1.cif.gz_A	4rce-assembly1.cif.gz_A Crystal structure of BACE1 in complex with aminooxazoline xanthene inhibitor 2	7.923E-06	1.000	153	3	262	263	5	333	364	361	0.989	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	5qdc-assembly1.cif.gz_A	5qdc-assembly1.cif.gz_A Crystal structure of BACE complex with BMC019 hydrolyzed	5.760E-06	1.000	153	3	262	263	6	338	367	357	0.989	0.907
LOKIASV2_0167_ESMFold_hypothetical_protein	6ej3-assembly1.cif.gz_A	6ej3-assembly1.cif.gz_A BACE1 compound 23	1.348E-05	1.000	153	1	262	263	1	335	368	359	0.996	0.910
LOKIASV2_0167_ESMFold_hypothetical_protein	2zjk-assembly3.cif.gz_C	2zjk-assembly3.cif.gz_C Crystal structure of the human BACE1 catalytic domain in complex with 4-(4-fluoro-benzyl)-piperazine-2-carboxylic acid(3-mercapto-propyl)-amide	1.149E-05	1.000	153	3	262	263	8	340	371	355	0.989	0.898
LOKIASV2_0167_ESMFold_hypothetical_protein	5qcq-assembly3.cif.gz_C	5qcq-assembly3.cif.gz_C Crystal structure of BACE complex with BMC025	7.923E-06	1.000	153	3	262	263	6	345	374	366	0.989	0.909
LOKIASV2_0167_ESMFold_hypothetical_protein	6dhc-assembly3.cif.gz_C	6dhc-assembly3.cif.gz_C X-ray structure of BACE1 in complex with a bicyclic isoxazoline carboxamide as the P3 ligand	4.416E-06	1.000	153	3	262	263	7	346	377	366	0.989	0.902
LOKIASV2_0167_ESMFold_hypothetical_protein	4hzt-assembly1.cif.gz_A	4hzt-assembly1.cif.gz_A Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates	1.697E-06	1.000	153	3	262	263	7	348	393	367	0.989	0.870
LOKIASV2_0167_ESMFold_hypothetical_protein	5qcq-assembly1.cif.gz_A	5qcq-assembly1.cif.gz_A Crystal structure of BACE complex with BMC025	6.075E-06	1.000	152	3	262	263	6	339	370	357	0.989	0.903
LOKIASV2_0167_ESMFold_hypothetical_protein	4rcf-assembly1.cif.gz_A	4rcf-assembly1.cif.gz_A Crystal structure of BACE1 in complex with 2-aminooxazoline 4-fluoroxanthene inhibitor 49	1.348E-05	1.000	152	3	262	263	5	338	370	363	0.989	0.903
LOKIASV2_0167_ESMFold_hypothetical_protein	5qd0-assembly3.cif.gz_C	5qd0-assembly3.cif.gz_C Crystal structure of BACE complex withBMC006	7.513E-06	1.000	152	3	262	263	6	346	375	366	0.989	0.909
LOKIASV2_0167_ESMFold_hypothetical_protein	6od6-assembly1.cif.gz_A	6od6-assembly1.cif.gz_A Structure of BACE-1 in complex with Ligand 13	4.911E-06	1.000	152	3	262	263	9	346	377	359	0.989	0.897
LOKIASV2_0167_ESMFold_hypothetical_protein	3bva-assembly1.cif.gz_A	3bva-assembly1.cif.gz_A Cystal structure of HIV-1 Active Site Mutant D25N and p2-NC analog inhibitor	1.233E-03	1.000	151	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3d20-assembly1.cif.gz_A	3d20-assembly1.cif.gz_A Crystal structure of HIV-1 mutant I54V and inhibitor DARUNAVIA	1.109E-03	1.000	151	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1ff0-assembly1.cif.gz_D	1ff0-assembly1.cif.gz_D STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES.	1.696E-03	1.000	151	21	110	263	10	92	99	90	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4m8x-assembly1.cif.gz_A	4m8x-assembly1.cif.gz_A GS-8374, a Novel Phosphonate-Containing Inhibitor of HIV-1 Protease, Effectively Inhibits HIV PR Mutants with Amino Acid Insertions	5.271E-04	1.000	151	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1tcw-assembly1.cif.gz_B	1tcw-assembly1.cif.gz_B SIV PROTEASE COMPLEXED WITH INHIBITOR SB203386	1.233E-03	1.000	151	21	110	263	10	92	99	90	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3vfb-assembly1.cif.gz_B	3vfb-assembly1.cif.gz_B Crystal Structure of HIV-1 Protease Mutant N88D with novel P1'-Ligands GRL-02031	1.109E-03	1.000	151	21	106	263	10	88	99	87	0.327	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	2zjk-assembly2.cif.gz_B	2zjk-assembly2.cif.gz_B Crystal structure of the human BACE1 catalytic domain in complex with 4-(4-fluoro-benzyl)-piperazine-2-carboxylic acid(3-mercapto-propyl)-amide	1.090E-05	1.000	151	3	262	263	7	338	369	356	0.989	0.900
LOKIASV2_0167_ESMFold_hypothetical_protein	5mxd-assembly2.cif.gz_B	5mxd-assembly2.cif.gz_B BACE-1 IN COMPLEX WITH LIGAND 32397778	7.923E-06	1.000	151	20	262	263	18	339	370	336	0.924	0.870
LOKIASV2_0167_ESMFold_hypothetical_protein	2xfk-assembly1.cif.gz_A	2xfk-assembly1.cif.gz_A Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(ethylamino)-5-((methylsulfonyl)(phenyl)amino)benzamide	8.355E-06	1.000	151	1	262	263	1	340	371	363	0.996	0.916
LOKIASV2_0167_ESMFold_hypothetical_protein	3nsh-assembly1.cif.gz_A	3nsh-assembly1.cif.gz_A BACE-1 in complex with ELN475957	2.462E-06	1.000	151	3	262	263	6	341	372	361	0.989	0.903
LOKIASV2_0167_ESMFold_hypothetical_protein	4i12-assembly1.cif.gz_A	4i12-assembly1.cif.gz_A Design and synthesis of thiophene dihydroisoquinolins as novel BACE-1 inhibitors	5.462E-06	1.000	151	2	262	263	1	334	374	354	0.992	0.893
LOKIASV2_0167_ESMFold_hypothetical_protein	2va7-assembly1.cif.gz_A-2	2va7-assembly1.cif.gz_A-2 X-ray crystal structure of beta secretase complexed with compound 27	7.513E-06	1.000	151	5	262	263	4	343	374	360	0.981	0.909
LOKIASV2_0167_ESMFold_hypothetical_protein	4j1f-assembly1.cif.gz_A	4j1f-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,6S)-2-amino-4-methyl-6-trifluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide	1.149E-05	1.000	151	3	262	263	8	345	376	360	0.989	0.899
LOKIASV2_0167_ESMFold_hypothetical_protein	4lxk-assembly2.cif.gz_B	4lxk-assembly2.cif.gz_B Crystal Structure of Human Beta Secretase in Complex with compound 11d	5.462E-06	1.000	151	3	262	263	6	347	378	372	0.989	0.905
LOKIASV2_0167_ESMFold_hypothetical_protein	2fxe-assembly1.cif.gz_B	2fxe-assembly1.cif.gz_B X-ray crystal structure of HIV-1 protease CRM mutant complexed with atazanavir (BMS-232632)	1.696E-03	1.000	150	21	110	263	10	92	99	90	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2fdp-assembly2.cif.gz_B	2fdp-assembly2.cif.gz_B Crystal structure of beta-secretase complexed with an amino-ethylene inhibitor	6.756E-06	1.000	150	3	262	263	6	338	369	356	0.989	0.902
LOKIASV2_0167_ESMFold_hypothetical_protein	4zpe-assembly1.cif.gz_A	4zpe-assembly1.cif.gz_A BACE1 in complex with 4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(3-isopropoxybenzyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one	7.513E-06	1.000	150	3	262	263	7	341	369	358	0.989	0.908
LOKIASV2_0167_ESMFold_hypothetical_protein	4zpg-assembly1.cif.gz_A	4zpg-assembly1.cif.gz_A BACE1 in complex with 8-benzyl-4-(cyclohexylamino)-1-(3-fluorophenyl)-7-methyl-1,3,8-triazaspiro[4.5]dec-3-en-2-one	3.971E-06	1.000	150	3	262	263	7	341	369	356	0.989	0.908
LOKIASV2_0167_ESMFold_hypothetical_protein	2zdz-assembly1.cif.gz_A	2zdz-assembly1.cif.gz_A X-ray structure of Bace-1 in complex with compound 3.b.10	8.811E-06	1.000	150	3	262	263	6	341	370	360	0.989	0.908
LOKIASV2_0167_ESMFold_hypothetical_protein	4b05-assembly1.cif.gz_A	4b05-assembly1.cif.gz_A Preclinical characterization of AZD3839, a novel clinical candidate BACE1 inhibitor for the treatment of Alzheimer Disease	5.462E-06	1.000	150	3	262	263	8	344	371	362	0.989	0.908
LOKIASV2_0167_ESMFold_hypothetical_protein	4bfd-assembly1.cif.gz_A	4bfd-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND	5.179E-06	1.000	150	3	262	263	8	341	372	357	0.989	0.898
LOKIASV2_0167_ESMFold_hypothetical_protein	2vnn-assembly1.cif.gz_A	2vnn-assembly1.cif.gz_A Human BACE-1 in complex with 7-ethyl-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluoromethyl)phenyl)methyl)amino)propyl)-1- methyl-3,4-dihydro-1H-(1,2,5)thiadiazepino(3,4,5-hi)indole-9- carboxamide 2,2-dioxide	6.756E-06	1.000	150	1	262	263	1	343	374	372	0.996	0.917
LOKIASV2_0167_ESMFold_hypothetical_protein	3uqr-assembly1.cif.gz_A	3uqr-assembly1.cif.gz_A Crystal structure of BACE1 with its inhibitor	1.212E-05	1.000	150	3	262	263	6	345	377	367	0.989	0.902
LOKIASV2_0167_ESMFold_hypothetical_protein	3udk-assembly1.cif.gz_A	3udk-assembly1.cif.gz_A Crystal Structure of BACE with Compound 6	3.971E-06	1.000	150	3	262	263	5	350	394	373	0.989	0.878
LOKIASV2_0167_ESMFold_hypothetical_protein	2r43-assembly1.cif.gz_B	2r43-assembly1.cif.gz_B I50V HIV-1 protease in complex with an amino decorated pyrrolidine-based inhibitor	1.696E-03	1.000	149	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3ttp-assembly1.cif.gz_B	3ttp-assembly1.cif.gz_B Structure of multiresistant HIV-1 protease in complex with darunavir	1.233E-03	1.000	149	21	110	263	10	92	99	90	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	5ufz-assembly1.cif.gz_B	5ufz-assembly1.cif.gz_B HIV-1 Protease complexed with Inhibitor: (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(1S,2S)-1-(1-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}cyclopropyl)-1-hydroxy-3-phenylpropan-2-yl]carbamate	1.696E-03	1.000	149	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	7d5a-assembly1.cif.gz_A	7d5a-assembly1.cif.gz_A Crystal Structure of BACE1 in complex with N-{3-[(9S)-7-amino-2,2-difluoro-9-(prop-1-yn-1-yl)-6-oxa-8-azaspiro[3.5]non-7-en-9-yl]-4-fluorophenyl}-5-cyanopyridine-2-carboxamide	1.758E-05	1.000	149	3	262	263	7	334	365	359	0.989	0.899
LOKIASV2_0167_ESMFold_hypothetical_protein	3zki-assembly1.cif.gz_A	3zki-assembly1.cif.gz_A BACE2 MUTANT STRUCTURE WITH LIGAND	1.090E-05	1.000	149	3	262	263	6	334	365	350	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	7n4n-assembly1.cif.gz_A	7n4n-assembly1.cif.gz_A BACE-2 in complex with ligand 36	1.667E-05	1.000	149	3	262	263	7	334	366	355	0.989	0.896
LOKIASV2_0167_ESMFold_hypothetical_protein	3hw1-assembly2.cif.gz_B	3hw1-assembly2.cif.gz_B Structure of Bace (beta secretase) in complex with ligand EV2	6.756E-06	1.000	149	3	262	263	8	340	371	365	0.989	0.898
LOKIASV2_0167_ESMFold_hypothetical_protein	1d4s-assembly1.cif.gz_B	1d4s-assembly1.cif.gz_B HIV-1 PROTEASE V82F/I84V DOUBLE MUTANT/TIPRANAVIR COMPLEX	1.696E-03	1.000	148	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4heg-assembly1.cif.gz_B	4heg-assembly1.cif.gz_B Crystal Structure of HIV-1 protease mutants R8Q complexed with inhibitor GRL-0519	1.372E-03	1.000	148	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3dm6-assembly3.cif.gz_C	3dm6-assembly3.cif.gz_C Beta-secretase 1 complexed with statine-based inhibitor	7.923E-06	1.000	148	3	262	263	6	341	367	363	0.989	0.916
LOKIASV2_0167_ESMFold_hypothetical_protein	6uj1-assembly1.cif.gz_A	6uj1-assembly1.cif.gz_A BACE2 mutant in complex with a macrocyclic compound	1.149E-05	1.000	148	3	262	263	4	339	367	359	0.989	0.916
LOKIASV2_0167_ESMFold_hypothetical_protein	2qu3-assembly1.cif.gz_A	2qu3-assembly1.cif.gz_A BACE1 with Compound 2	9.799E-06	1.000	148	3	262	263	5	339	368	357	0.989	0.910
LOKIASV2_0167_ESMFold_hypothetical_protein	2vij-assembly1.cif.gz_A	2vij-assembly1.cif.gz_A Human BACE-1 in complex with 3-(1,1-dioxidotetrahydro-2H-1,2-thiazin- 2-yl)-5-(ethylamino)-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(1,2,3,4- tetrahydro-1-naphthalenylamino)propyl)benzamide	1.278E-05	1.000	148	1	262	263	1	342	373	367	0.996	0.917
LOKIASV2_0167_ESMFold_hypothetical_protein	4bfb-assembly2.cif.gz_B	4bfb-assembly2.cif.gz_B BACE2 XAPERONE COMPLEX	9.292E-06	1.000	148	4	262	263	6	343	374	362	0.985	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	5tol-assembly1.cif.gz_A	5tol-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BETA-SITE APP-CLEAVING ENZYME 1 COMPLEXED WITH N-(3-((4AS,7AS)-2-AMINO-4,4A,5,6-TETRAHYDRO-7AH-FURO[2,3-D][1,3]THIAZIN-7A-YL)-4-FLUOROPHENYL)-5-BROMO-2-PYRIDINECARBOXAMIDE	2.293E-05	1.000	148	4	262	263	6	343	374	364	0.985	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	3uqp-assembly1.cif.gz_A	3uqp-assembly1.cif.gz_A Crystal structure of Bace1 with its inhibitor	3.211E-06	1.000	148	3	262	263	7	343	374	365	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	4pzx-assembly1.cif.gz_A	4pzx-assembly1.cif.gz_A Synthesis, Characterization and PK/PD Studies of a Series of Spirocyclic Pyranochromene BACE1 Inhibitors	3.571E-06	1.000	148	3	262	263	8	356	400	371	0.989	0.873
LOKIASV2_0167_ESMFold_hypothetical_protein	1a94-assembly2.cif.gz_E	1a94-assembly2.cif.gz_E STRUCTURAL BASIS FOR SPECIFICITY OF RETROVIRAL PROTEASES	7.646E-04	1.000	147	21	106	263	10	88	99	90	0.327	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	4q1y-assembly1.cif.gz_B	4q1y-assembly1.cif.gz_B Mutations Outside the Active Site of HIV-1 Protease Alter Enzyme Structure and Dynamic Ensemble of the Active Site to Confer Drug Resistance	1.887E-03	1.000	147	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4rvx-assembly1.cif.gz_A	4rvx-assembly1.cif.gz_A Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL079	8.503E-04	1.000	147	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3zkg-assembly2.cif.gz_B	3zkg-assembly2.cif.gz_B BACE2 MUTANT APO STRUCTURE	1.348E-05	1.000	147	20	262	263	15	328	359	332	0.924	0.875
LOKIASV2_0167_ESMFold_hypothetical_protein	2ph8-assembly1.cif.gz_A	2ph8-assembly1.cif.gz_A Crystal Structure of Human Beta Secretase Complexed with inhibitor	2.689E-05	1.000	147	5	262	263	6	339	365	353	0.981	0.915
LOKIASV2_0167_ESMFold_hypothetical_protein	4b0q-assembly1.cif.gz_A	4b0q-assembly1.cif.gz_A Lead Generation of BACE1 Inhibitors by Coupling Non-amidine New Warheads to a Known Binding Scaffold	7.923E-06	1.000	147	1	262	263	1	341	369	365	0.996	0.924
LOKIASV2_0167_ESMFold_hypothetical_protein	2zjj-assembly1.cif.gz_A	2zjj-assembly1.cif.gz_A Crystal structure of the human BACE1 catalytic domain in complex with 4-(4-fluoro-benzyl)-piperazine-2-carboxylic acid (2-mercapto-ethyl)-amide	1.348E-05	1.000	147	3	262	263	7	339	370	358	0.989	0.900
LOKIASV2_0167_ESMFold_hypothetical_protein	3zlq-assembly1.cif.gz_B	3zlq-assembly1.cif.gz_B BACE2 XAPERONE COMPLEX	6.406E-06	1.000	147	20	262	263	16	339	370	341	0.924	0.876
LOKIASV2_0167_ESMFold_hypothetical_protein	4l7g-assembly1.cif.gz_A	4l7g-assembly1.cif.gz_A Diethylaminosulfur Trifluoride-Mediated Intramolecular Cyclization of 2-hydroxy-benzylureas to Fused Bicyclic Aminooxazoline Compounds and Evaluation of Their Biochemical Activity Against Beta-Secretase-1 (BACE1)	8.811E-06	1.000	147	3	262	263	5	345	373	366	0.989	0.914
LOKIASV2_0167_ESMFold_hypothetical_protein	5qct-assembly1.cif.gz_A	5qct-assembly1.cif.gz_A Crystal structure of BACE complex with BMC001	4.188E-06	1.000	147	3	262	263	6	350	379	363	0.989	0.910
LOKIASV2_0167_ESMFold_hypothetical_protein	3ivi-assembly1.cif.gz_A	3ivi-assembly1.cif.gz_A Design and Synthesis of Potent BACE-1 Inhibitors with Cellular Activity: Structure-Activity Relationship of P1 Substituents	6.756E-06	1.000	147	3	262	263	6	350	380	368	0.989	0.908
LOKIASV2_0167_ESMFold_hypothetical_protein	2j9k-assembly1.cif.gz_B	2j9k-assembly1.cif.gz_B Atomic-resolution Crystal Structure of Chemically-Synthesized HIV-1 Protease Complexed with Inhibitor MVT-101	1.609E-03	1.000	146	21	106	263	10	86	96	86	0.327	0.802
LOKIASV2_0167_ESMFold_hypothetical_protein	1sip-assembly1.cif.gz_A-2	1sip-assembly1.cif.gz_A-2 ALTERNATIVE NATIVE FLAP CONFORMATION REVEALED BY 2.3 ANGSTROMS RESOLUTION STRUCTURE OF SIV PROTEINASE	1.301E-03	1.000	146	21	104	263	10	86	99	84	0.319	0.778
LOKIASV2_0167_ESMFold_hypothetical_protein	4ke1-assembly1.cif.gz_A	4ke1-assembly1.cif.gz_A Crystal structure of BACE1 in complex with hydroxyethylamine-macrocyclic inhibitor 19	7.923E-06	1.000	146	3	262	263	5	324	355	355	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	6jsz-assembly1.cif.gz_A	6jsz-assembly1.cif.gz_A BACE2 xaperone complex with N-{3-[(5R)-3-amino-5-methyl-9,9-dioxo-2,9lambda6-dithia-4-azaspiro[5.5]undec-3-en-5-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide	1.212E-05	1.000	146	20	262	263	16	331	363	339	0.924	0.871
LOKIASV2_0167_ESMFold_hypothetical_protein	3fkt-assembly1.cif.gz_A	3fkt-assembly1.cif.gz_A Crystal Structure of Human Beta Secretase Complexed with Spiropiperdine Iminohydantoin Inhibitor	8.355E-06	1.000	146	3	262	263	7	341	368	363	0.989	0.910
LOKIASV2_0167_ESMFold_hypothetical_protein	4rcd-assembly1.cif.gz_A	4rcd-assembly1.cif.gz_A Crystal structure of BACE1 in complex with a 2-aminooxazoline 4-azaxanthene inhibitor	1.499E-05	1.000	146	3	262	263	5	337	368	360	0.989	0.905
LOKIASV2_0167_ESMFold_hypothetical_protein	1t6g-assembly1.cif.gz_A	1t6g-assembly1.cif.gz_A Crystal structure of the Triticum aestivum xylanase inhibitor-I in complex with aspergillus niger xylanase-I	9.799E-06	1.000	146	2	262	263	1	356	368	370	0.992	0.967
LOKIASV2_0167_ESMFold_hypothetical_protein	5v0n-assembly1.cif.gz_A	5v0n-assembly1.cif.gz_A BACE1 in complex with inhibitor 5g	1.667E-05	1.000	146	3	262	263	5	340	371	362	0.989	0.906
LOKIASV2_0167_ESMFold_hypothetical_protein	4acu-assembly1.cif.gz_A	4acu-assembly1.cif.gz_A Aminoimidazoles as BACE-1 Inhibitors. X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 14	1.758E-05	1.000	146	3	262	263	7	344	372	360	0.989	0.909
LOKIASV2_0167_ESMFold_hypothetical_protein	4rrs-assembly1.cif.gz_A	4rrs-assembly1.cif.gz_A 8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors	4.657E-06	1.000	146	3	262	263	5	349	393	370	0.989	0.878
LOKIASV2_0167_ESMFold_hypothetical_protein	2aqu-assembly1.cif.gz_A	2aqu-assembly1.cif.gz_A Structure of HIV-1 protease bound to atazanavir	9.972E-04	1.000	145	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1izi-assembly1.cif.gz_B	1izi-assembly1.cif.gz_B Inhibitor of HIV protease with unusual binding mode potently inhibiting multi-resistant protease mutants	9.972E-04	1.000	145	21	110	263	10	92	99	93	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4bel-assembly1.cif.gz_A	4bel-assembly1.cif.gz_A BACE2 XAPERONE COMPLEX	1.278E-05	1.000	145	20	262	263	17	327	358	336	0.924	0.869
LOKIASV2_0167_ESMFold_hypothetical_protein	3ine-assembly1.cif.gz_A	3ine-assembly1.cif.gz_A Bace1 with the aminohydantoin Compound S-34	8.811E-06	1.000	145	3	262	263	6	338	367	356	0.989	0.907
LOKIASV2_0167_ESMFold_hypothetical_protein	4k9h-assembly2.cif.gz_B	4k9h-assembly2.cif.gz_B Bace-1 inhibitor complex	1.581E-05	1.000	145	3	262	263	6	338	369	357	0.989	0.902
LOKIASV2_0167_ESMFold_hypothetical_protein	3u6a-assembly1.cif.gz_A	3u6a-assembly1.cif.gz_A Rational Design and Synthesis of Aminopiperazinones as Beta Secretase (BACE) Inhibitors	1.033E-05	1.000	145	3	262	263	6	343	374	361	0.989	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	4di2-assembly2.cif.gz_B	4di2-assembly2.cif.gz_B Crystal structure of BACE1 in complex with hydroxyethylamine inhibitor 37	6.406E-06	1.000	145	3	262	263	6	346	375	369	0.989	0.909
LOKIASV2_0167_ESMFold_hypothetical_protein	4dqh-assembly1.cif.gz_B	4dqh-assembly1.cif.gz_B Crystal Structure of (R14C/E65C) HIV-1 Protease in complex with DRV	9.972E-04	1.000	144	21	110	263	10	92	99	93	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1fb7-assembly1.cif.gz_A-2	1fb7-assembly1.cif.gz_A-2 CRYSTAL STRUCTURE OF AN IN VIVO HIV-1 PROTEASE MUTANT IN COMPLEX WITH SAQUINAVIR: INSIGHTS INTO THE MECHANISMS OF DRUG RESISTANCE	2.098E-03	1.000	144	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3lzv-assembly1.cif.gz_B	3lzv-assembly1.cif.gz_B Structure of Nelfinavir-resistant HIV-1 protease (D30N/N88D) in complex with Darunavir.	2.213E-03	1.000	144	21	106	263	10	88	99	87	0.327	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	2p3a-assembly1.cif.gz_B	2p3a-assembly1.cif.gz_B Crystal Structure of the multi-drug resistant mutant subtype B HIV protease complexed with TL-3 inhibitor	1.109E-03	1.000	144	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	5kqf-assembly1.cif.gz_A	5kqf-assembly1.cif.gz_A (4~{S},6~{S})-4-[2,4-bis(fluoranyl)phenyl]-4-methyl-6-pyrimidin-5-yl-5,6-dihydro-1,3-thiazin-2-amine (compound 12) bound to BACE1	3.699E-05	1.000	144	3	262	263	5	327	358	356	0.989	0.902
LOKIASV2_0167_ESMFold_hypothetical_protein	4xkx-assembly1.cif.gz_A	4xkx-assembly1.cif.gz_A Crystal structure of BACE1 in complex with 2-aminooxazoline 3-azaxanthene inhibitor 28	1.667E-05	1.000	144	3	262	263	5	332	363	368	0.989	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	3rtn-assembly1.cif.gz_A	3rtn-assembly1.cif.gz_A Structure of Bace-1 (Beta-Secretase) in Complex with 3-(2-Amino-6-o-tolylquinolin-3-yl)-N-cyclohexylpropanamide	1.955E-05	1.000	144	3	262	263	5	336	367	359	0.989	0.905
LOKIASV2_0167_ESMFold_hypothetical_protein	6uj0-assembly2.cif.gz_B	6uj0-assembly2.cif.gz_B Unbound BACE2 mutant structure	6.406E-06	1.000	144	2	262	263	1	337	367	367	0.992	0.918
LOKIASV2_0167_ESMFold_hypothetical_protein	3duy-assembly2.cif.gz_B	3duy-assembly2.cif.gz_B Crystal structure of human beta-secretase in complex with NVP-AFJ144	1.278E-05	1.000	144	3	262	263	6	339	370	361	0.989	0.903
LOKIASV2_0167_ESMFold_hypothetical_protein	2zhv-assembly1.cif.gz_A	2zhv-assembly1.cif.gz_A Crystal structure of BACE1 at pH 7.0	1.348E-05	1.000	144	3	262	263	5	339	370	358	0.989	0.905
LOKIASV2_0167_ESMFold_hypothetical_protein	3k5f-assembly1.cif.gz_A	3k5f-assembly1.cif.gz_A Human BACE-1 COMPLEX WITH AYH011	9.799E-06	1.000	144	3	262	263	6	346	373	369	0.989	0.914
LOKIASV2_0167_ESMFold_hypothetical_protein	4dvf-assembly1.cif.gz_A	4dvf-assembly1.cif.gz_A Crystal structure of BACE1 with its inhibitor	1.499E-05	1.000	144	3	262	263	5	342	374	363	0.989	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	3rsx-assembly1.cif.gz_A	3rsx-assembly1.cif.gz_A Structure of Bace-1 (Beta-Secretase) in Complex with 6-(Thiophen-3-yl)quinolin-2-amine	1.667E-05	1.000	144	3	262	263	5	344	375	370	0.989	0.907
LOKIASV2_0167_ESMFold_hypothetical_protein	6ej2-assembly1.cif.gz_A	6ej2-assembly1.cif.gz_A BACE1 compound 28	2.991E-05	1.000	144	3	262	263	8	347	377	367	0.989	0.902
LOKIASV2_0167_ESMFold_hypothetical_protein	3r1g-assembly1.cif.gz_B	3r1g-assembly1.cif.gz_B Structure Basis of Allosteric Inhibition of BACE1 by an Exosite-Binding Antibody	1.499E-05	1.000	144	3	262	263	9	351	381	373	0.989	0.900
LOKIASV2_0167_ESMFold_hypothetical_protein	4i11-assembly1.cif.gz_A	4i11-assembly1.cif.gz_A Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.	1.090E-05	1.000	144	3	262	263	7	352	397	368	0.989	0.872
LOKIASV2_0167_ESMFold_hypothetical_protein	3vla-assembly1.cif.gz_A	3vla-assembly1.cif.gz_A Crystal structure of edgp	3.386E-06	1.000	144	3	262	263	8	395	413	413	0.989	0.939
LOKIASV2_0167_ESMFold_hypothetical_protein	1sdu-assembly1.cif.gz_A	1sdu-assembly1.cif.gz_A Crystal structures of HIV protease V82A and L90M mutants reveal changes in indinavir binding site.	1.170E-03	1.000	143	21	110	263	10	92	99	93	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2rkg-assembly1.cif.gz_B	2rkg-assembly1.cif.gz_B HIV-1 PR resistant mutant + LPV	1.301E-03	1.000	143	21	110	263	10	93	100	94	0.342	0.840
LOKIASV2_0167_ESMFold_hypothetical_protein	3buf-assembly1.cif.gz_A	3buf-assembly1.cif.gz_A BACE-1 complexed with compound 2	1.667E-05	1.000	143	3	262	263	8	332	359	352	0.989	0.905
LOKIASV2_0167_ESMFold_hypothetical_protein	3rsv-assembly1.cif.gz_A	3rsv-assembly1.cif.gz_A Structure of Bace-1 (Beta-Secretase) in complex with (R)-3-(2-amino-6-o-tolylquinolin-3-yl)-N-((R)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-2-methylpropanamide	9.292E-06	1.000	143	3	262	263	5	333	364	354	0.989	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	3zlq-assembly1.cif.gz_A	3zlq-assembly1.cif.gz_A BACE2 XAPERONE COMPLEX	1.212E-05	1.000	143	20	262	263	15	336	367	338	0.924	0.877
LOKIASV2_0167_ESMFold_hypothetical_protein	3dm6-assembly1.cif.gz_A	3dm6-assembly1.cif.gz_A Beta-secretase 1 complexed with statine-based inhibitor	4.657E-06	1.000	143	3	262	263	6	341	369	358	0.989	0.911
LOKIASV2_0167_ESMFold_hypothetical_protein	4zpf-assembly1.cif.gz_A	4zpf-assembly1.cif.gz_A BACE1 in complex with 8-(3-((1-aminopropan-2-yl)oxy)benzyl)-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one	5.462E-06	1.000	143	3	262	263	7	342	371	364	0.989	0.906
LOKIASV2_0167_ESMFold_hypothetical_protein	4j17-assembly1.cif.gz_A	4j17-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-4-difluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide	5.967E-05	1.000	143	3	262	263	8	348	379	368	0.989	0.900
LOKIASV2_0167_ESMFold_hypothetical_protein	1axa-assembly1.cif.gz_B	1axa-assembly1.cif.gz_B ACTIVE-SITE MOBILITY IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE AS DEMONSTRATED BY CRYSTAL STRUCTURE OF A28S MUTANT	2.461E-03	1.000	142	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3vv8-assembly1.cif.gz_A	3vv8-assembly1.cif.gz_A Crystal structure of beta secetase in complex with 2-amino-3-methyl-6-((1S,2R)-2-(3'-methylbiphenyl-4-yl)cyclopropyl)pyrimidin-4(3H)-one	1.581E-05	1.000	142	3	262	263	5	327	358	354	0.989	0.902
LOKIASV2_0167_ESMFold_hypothetical_protein	3zks-assembly1.cif.gz_A	3zks-assembly1.cif.gz_A BACE2 XAPERONE COMPLEX WITH INHIBITOR	1.033E-05	1.000	142	20	262	263	14	329	360	339	0.924	0.878
LOKIASV2_0167_ESMFold_hypothetical_protein	7d5b-assembly1.cif.gz_A	7d5b-assembly1.cif.gz_A BACE2 xaperone complex with N-{3-[(5R)-3-amino-2,5-dimethyl-1,1-dioxo-5,6-dihydro-2H-1lambda6,2,4-thiadiazin-5-yl]-4-fluorophenyl}-5-fluoropyridine-2-carboxamide	2.550E-05	1.000	142	3	262	263	7	338	369	361	0.989	0.900
LOKIASV2_0167_ESMFold_hypothetical_protein	3in4-assembly1.cif.gz_A	3in4-assembly1.cif.gz_A Bace1 with Compound 38	8.811E-06	1.000	142	3	262	263	6	343	370	366	0.989	0.914
LOKIASV2_0167_ESMFold_hypothetical_protein	3tpl-assembly1.cif.gz_A	3tpl-assembly1.cif.gz_A APO Structure of BACE1	1.090E-05	1.000	142	3	262	263	9	341	371	362	0.989	0.898
LOKIASV2_0167_ESMFold_hypothetical_protein	3ufl-assembly1.cif.gz_A	3ufl-assembly1.cif.gz_A Discovery of Pyrrolidine-based b-Secretase Inhibitors: Lead Advancement through Conformational Design for Maintenance of Ligand Binding Efficiency	9.799E-06	1.000	142	3	262	263	7	342	373	359	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	2ewy-assembly1.cif.gz_A	2ewy-assembly1.cif.gz_A Crystal structure of human BACE2 in complex with a hydroxyethylenamine transition-state inhibitor	1.955E-05	1.000	142	8	262	263	7	342	374	357	0.970	0.898
LOKIASV2_0167_ESMFold_hypothetical_protein	4i0h-assembly2.cif.gz_B	4i0h-assembly2.cif.gz_B SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitors.	9.799E-06	1.000	142	3	262	263	6	343	375	362	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	1ym2-assembly1.cif.gz_A	1ym2-assembly1.cif.gz_A Crystal structure of human beta secretase complexed with NVP-AUR200	1.149E-05	1.000	142	20	262	263	17	345	376	350	0.924	0.875
LOKIASV2_0167_ESMFold_hypothetical_protein	6jsn-assembly1.cif.gz_A	6jsn-assembly1.cif.gz_A Crystal Structure of BACE1 in complex with N-{3-[(5R)-3-amino-5-methyl-9,9-dioxo-2,9lambda6-dithia-4-azaspiro[5.5]undec-3-en-5-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide	1.667E-05	1.000	142	3	262	263	8	349	381	365	0.989	0.898
LOKIASV2_0167_ESMFold_hypothetical_protein	3u6a-assembly3.cif.gz_C	3u6a-assembly3.cif.gz_C Rational Design and Synthesis of Aminopiperazinones as Beta Secretase (BACE) Inhibitors	8.811E-06	1.000	142	3	262	263	8	353	384	373	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	3u6a-assembly2.cif.gz_B	3u6a-assembly2.cif.gz_B Rational Design and Synthesis of Aminopiperazinones as Beta Secretase (BACE) Inhibitors	1.278E-05	1.000	142	3	262	263	7	355	386	372	0.989	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	4ybi-assembly1.cif.gz_A	4ybi-assembly1.cif.gz_A Crystal structure of BACE with amino thiazine inhibitor LY2811376	7.513E-06	1.000	142	20	262	263	18	357	388	361	0.924	0.876
LOKIASV2_0167_ESMFold_hypothetical_protein	2fgu-assembly1.cif.gz_B	2fgu-assembly1.cif.gz_B X-ray crystal structure of HIV-1 Protease T80S variant in complex with the inhibitor saquinavir used to explore the role of invariant Thr80 in HIV-1 protease structure, function, and viral infectivity.	1.372E-03	1.000	141	21	110	263	10	92	99	93	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1heg-assembly1.cif.gz_E-2	1heg-assembly1.cif.gz_E-2 The crystal structures at 2.2 angstroms resolution of hydroxyethylene-based inhibitors bound to human immunodeficiency virus type 1 protease show that the inhibitors are present in two distinct orientations	2.461E-03	1.000	141	21	106	263	10	88	99	86	0.327	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	5kr2-assembly3.cif.gz_C	5kr2-assembly3.cif.gz_C Protease PR5-SQV	2.098E-03	1.000	141	21	110	263	10	92	99	92	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1msn-assembly1.cif.gz_B	1msn-assembly1.cif.gz_B The HIV protease (mutant Q7K L33I L63I V82F I84V) complexed with KNI-764 (an inhibitor)	1.789E-03	1.000	141	21	110	263	10	92	99	93	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3wb5-assembly1.cif.gz_A	3wb5-assembly1.cif.gz_A Crystal Structure of beta secetase in complex with (6S)-2-amino-3,6-dimethyl-6-[(1R,2R)-2-phenylcyclopropyl]-3,4,5,6-tetrahydropyrimidin-4-one	2.991E-05	1.000	141	3	262	263	5	331	361	363	0.989	0.906
LOKIASV2_0167_ESMFold_hypothetical_protein	4j1k-assembly1.cif.gz_A	4j1k-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5R,6S)-2-amino-5-fluoro-4-methyl-6-trifluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide	3.154E-05	1.000	141	3	262	263	8	337	368	356	0.989	0.897
LOKIASV2_0167_ESMFold_hypothetical_protein	5i3x-assembly1.cif.gz_A	5i3x-assembly1.cif.gz_A Crystal structure of BACE1 in complex with aminoquinoline inhibitor 6	3.326E-05	1.000	141	3	262	263	5	340	373	359	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	3tpl-assembly2.cif.gz_B	3tpl-assembly2.cif.gz_B APO Structure of BACE1	2.418E-05	1.000	141	3	262	263	8	345	377	361	0.989	0.897
LOKIASV2_0167_ESMFold_hypothetical_protein	5v0n-assembly3.cif.gz_C	5v0n-assembly3.cif.gz_C BACE1 in complex with inhibitor 5g	1.348E-05	1.000	141	3	262	263	5	348	377	372	0.989	0.912
LOKIASV2_0167_ESMFold_hypothetical_protein	4cpu-assembly1.cif.gz_B	4cpu-assembly1.cif.gz_B Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol	1.990E-03	1.000	140	21	110	263	10	92	99	93	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1k1u-assembly1.cif.gz_B	1k1u-assembly1.cif.gz_B Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance	2.461E-03	1.000	140	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4u7q-assembly1.cif.gz_B	4u7q-assembly1.cif.gz_B Structure of wild-type HIV protease in complex with photosensitive inhibitor PDI-6	2.461E-03	1.000	140	21	106	263	10	88	99	87	0.327	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	3bug-assembly1.cif.gz_A	3bug-assembly1.cif.gz_A BACE-1 complexed with compound 3	4.575E-05	1.000	140	3	262	263	5	330	357	357	0.989	0.913
LOKIASV2_0167_ESMFold_hypothetical_protein	3inh-assembly1.cif.gz_A	3inh-assembly1.cif.gz_A Bace1 with the aminohydantoin Compound R-58	5.462E-06	1.000	140	3	262	263	6	337	366	354	0.989	0.907
LOKIASV2_0167_ESMFold_hypothetical_protein	2ph6-assembly1.cif.gz_A	2ph6-assembly1.cif.gz_A Crystal Structure of Human Beta Secretase Complexed with inhibitor	4.114E-05	1.000	140	3	262	263	7	340	371	361	0.989	0.900
LOKIASV2_0167_ESMFold_hypothetical_protein	3msj-assembly3.cif.gz_C	3msj-assembly3.cif.gz_C Structure of bace (beta secretase) in complex with inhibitor	4.825E-05	1.000	140	3	262	263	8	344	375	369	0.989	0.899
LOKIASV2_0167_ESMFold_hypothetical_protein	3nsh-assembly2.cif.gz_B	3nsh-assembly2.cif.gz_B BACE-1 in complex with ELN475957	1.581E-05	1.000	140	3	262	263	6	344	376	359	0.989	0.902
LOKIASV2_0167_ESMFold_hypothetical_protein	3zkq-assembly1.cif.gz_A	3zkq-assembly1.cif.gz_A BACE2 XAPERONE COMPLEX	1.421E-05	1.000	140	20	262	263	18	344	376	344	0.924	0.870
LOKIASV2_0167_ESMFold_hypothetical_protein	5qct-assembly3.cif.gz_C	5qct-assembly3.cif.gz_C Crystal structure of BACE complex with BMC001	1.090E-05	1.000	140	4	262	263	5	349	378	369	0.985	0.913
LOKIASV2_0167_ESMFold_hypothetical_protein	2avv-assembly2.cif.gz_E	2avv-assembly2.cif.gz_E Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease with drug resistant mutations L24I, I50V, and G73S	1.696E-03	1.000	139	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4dqe-assembly1.cif.gz_B	4dqe-assembly1.cif.gz_B Crystal Structure of (G16C/L38C) HIV-1 Protease in Complex with DRV	1.301E-03	1.000	139	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3oxv-assembly2.cif.gz_D	3oxv-assembly2.cif.gz_D Crystal Structure of HIV-1 I50V, A71 Protease in Complex with the protease inhibitor amprenavir.	1.789E-03	1.000	139	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1tsq-assembly1.cif.gz_A	1tsq-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2V SUBSTRATE VARIANT OF NC-P1 DECAMER PEPTIDE IN COMPLEX WITH V82A/D25N HIV-1 PROTEASE MUTANT	2.886E-03	1.000	139	21	106	263	10	88	99	87	0.327	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	2zjl-assembly1.cif.gz_A	2zjl-assembly1.cif.gz_A Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(5-bromo-2,3-dimethoxy-benzyl)-piperidin-4-yl]-4-mercapto-butyramide	1.854E-05	1.000	139	3	262	263	7	313	344	343	0.989	0.892
LOKIASV2_0167_ESMFold_hypothetical_protein	3zki-assembly2.cif.gz_B	3zki-assembly2.cif.gz_B BACE2 MUTANT STRUCTURE WITH LIGAND	1.421E-05	1.000	139	3	262	263	4	330	361	348	0.989	0.906
LOKIASV2_0167_ESMFold_hypothetical_protein	3l3a-assembly1.cif.gz_A	3l3a-assembly1.cif.gz_A Bace-1 with the aminopyridine Compound 32	1.854E-05	1.000	139	3	262	263	6	338	365	357	0.989	0.912
LOKIASV2_0167_ESMFold_hypothetical_protein	6nv9-assembly1.cif.gz_A	6nv9-assembly1.cif.gz_A BACE1 in complex with a macrocyclic inhibitor	2.174E-05	1.000	139	3	262	263	6	344	373	369	0.989	0.909
LOKIASV2_0167_ESMFold_hypothetical_protein	3ivi-assembly2.cif.gz_B	3ivi-assembly2.cif.gz_B Design and Synthesis of Potent BACE-1 Inhibitors with Cellular Activity: Structure-Activity Relationship of P1 Substituents	1.581E-05	1.000	139	3	262	263	6	348	378	369	0.989	0.907
LOKIASV2_0167_ESMFold_hypothetical_protein	7b1q-assembly1.cif.gz_A	7b1q-assembly1.cif.gz_A Crystal Structure of Human BACE-1 in Complex with Compound NB-360 (compound 54)	2.293E-05	1.000	139	3	262	263	6	347	379	361	0.989	0.902
LOKIASV2_0167_ESMFold_hypothetical_protein	2fdd-assembly1.cif.gz_B	2fdd-assembly1.cif.gz_B Crystal structure of HIV protease D545701 bound with GW0385	1.789E-03	1.000	138	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	5kr0-assembly1.cif.gz_B	5kr0-assembly1.cif.gz_B Protease E35D-APV	2.213E-03	1.000	138	21	110	263	10	92	99	93	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4obg-assembly2.cif.gz_C	4obg-assembly2.cif.gz_C Crystal Structure of Nelfinavir-Resistant, Inactive HIV-1 Protease (D30N/N88D) in Complex with the p1-p6 substrate.	1.990E-03	1.000	138	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2qak-assembly1.cif.gz_A	2qak-assembly1.cif.gz_A HIV-1 PR mutant in complex with nelfinavir	1.109E-03	1.000	138	21	110	263	10	92	99	96	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	5t84-assembly1.cif.gz_B	5t84-assembly1.cif.gz_B HIV-1 protease, unbound subtype B L63P construct	1.789E-03	1.000	138	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	7wcq-assembly1.cif.gz_A-2	7wcq-assembly1.cif.gz_A-2 Crystal structure of HIV-1 protease in complex with lactam derivative 1	1.789E-03	1.000	138	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3ru1-assembly1.cif.gz_A	3ru1-assembly1.cif.gz_A Structure of Bace-1 (Beta-Secretase) in Complex with 3-(2-Aminoquinolin-3-yl)-N-(cyclohexylmethyl)propanamide	2.689E-05	1.000	138	3	262	263	5	332	363	359	0.989	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	3s7l-assembly1.cif.gz_A	3s7l-assembly1.cif.gz_A Pyrazolyl and Thienyl Aminohydantoins as Potent BACE1 Inhibitors	2.293E-05	1.000	138	3	262	263	6	342	369	366	0.989	0.913
LOKIASV2_0167_ESMFold_hypothetical_protein	3zkx-assembly1.cif.gz_A	3zkx-assembly1.cif.gz_A TERNARY BACE2 XAPERONE COMPLEX	1.278E-05	1.000	138	20	262	263	15	339	370	341	0.924	0.878
LOKIASV2_0167_ESMFold_hypothetical_protein	2xfj-assembly1.cif.gz_A	2xfj-assembly1.cif.gz_A Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(ethylamino)-5-(2-oxo-1-pyrrolidinyl)benzamide	1.348E-05	1.000	138	1	262	263	1	344	373	371	0.996	0.922
LOKIASV2_0167_ESMFold_hypothetical_protein	3uqr-assembly2.cif.gz_B	3uqr-assembly2.cif.gz_B Crystal structure of BACE1 with its inhibitor	2.689E-05	1.000	138	3	262	263	6	342	374	360	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	3ivh-assembly1.cif.gz_A	3ivh-assembly1.cif.gz_A Design and Synthesis of Potent BACE-1 Inhibitors with Cellular Activity: Structure-Activity Relationship of P1 Substituents	1.581E-05	1.000	138	3	262	263	6	349	379	364	0.989	0.908
LOKIASV2_0167_ESMFold_hypothetical_protein	3qi1-assembly1.cif.gz_A	3qi1-assembly1.cif.gz_A Design and synthesis of hydroxyethylamine (hea) BACE-1 inhibitors: prime side chromane-containing inhibitors	1.348E-05	1.000	138	3	262	263	7	353	382	371	0.989	0.908
LOKIASV2_0167_ESMFold_hypothetical_protein	5mco-assembly1.cif.gz_A	5mco-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH ACTIVE SITE INHIBITOR GRL-8234 AND EXOSITE PEPTIDE	2.174E-05	1.000	138	3	262	263	10	351	383	366	0.989	0.893
LOKIASV2_0167_ESMFold_hypothetical_protein	4h3i-assembly1.cif.gz_A	4h3i-assembly1.cif.gz_A Structure of BACE Bound to 3-(5-((7aR)-2-imino-6-(3-methoxypyridin-2-yl)-3-methyl-4-oxooctahydro-1H-pyrrolo[3,4-d]pyrimidin-7a-yl)thiophen-3-yl)benzonitrile	1.033E-05	1.000	138	5	262	263	6	355	387	378	0.981	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	3ia9-assembly3.cif.gz_B	3ia9-assembly3.cif.gz_B Crystal structure of a chemically synthesized [D25N]HIV-1 protease molecule complexed with MVT-101 reduced isostere inhibitor	3.970E-03	1.000	137	21	110	263	10	91	97	90	0.342	0.845
LOKIASV2_0167_ESMFold_hypothetical_protein	1ody-assembly1.cif.gz_B	1ody-assembly1.cif.gz_B HIV-1 PROTEASE COMPLEXED WITH AN INHIBITOR LP-130	2.333E-03	1.000	137	21	110	263	10	92	99	93	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	7f1g-assembly1.cif.gz_A	7f1g-assembly1.cif.gz_A BACE2 xaperone complex with N-{3-[(4R,5R,6R)-2-amino-5-fluoro-4,6-dimethyl-5,6-dihydro-4H-1,3-thiazin-4-yl]-4-fluorophenyl}-2H,3H-[1,4]dioxino[2,3-c]pyridine-7-carboxamide	3.326E-05	1.000	137	5	262	263	6	331	362	355	0.981	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	3ooz-assembly1.cif.gz_A	3ooz-assembly1.cif.gz_A Bace1 in complex with the aminohydantoin Compound 102	2.418E-05	1.000	137	3	262	263	5	341	368	360	0.989	0.916
LOKIASV2_0167_ESMFold_hypothetical_protein	3igb-assembly1.cif.gz_A	3igb-assembly1.cif.gz_A Bace-1 with Compound 3	5.179E-06	1.000	137	3	262	263	6	340	369	354	0.989	0.908
LOKIASV2_0167_ESMFold_hypothetical_protein	3zov-assembly1.cif.gz_A	3zov-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND	9.626E-05	1.000	137	3	262	263	8	340	371	358	0.989	0.898
LOKIASV2_0167_ESMFold_hypothetical_protein	4dpi-assembly1.cif.gz_A	4dpi-assembly1.cif.gz_A BACE-1 in complex with HEA-macrocyclic inhibitor, MV078512	3.154E-05	1.000	137	3	262	263	5	343	373	363	0.989	0.909
LOKIASV2_0167_ESMFold_hypothetical_protein	3ckr-assembly1.cif.gz_A	3ckr-assembly1.cif.gz_A Crystal structure of BACE-1 in complex with inhibitor	1.499E-05	1.000	137	3	262	263	9	347	379	370	0.989	0.894
LOKIASV2_0167_ESMFold_hypothetical_protein	4i0j-assembly1.cif.gz_A	4i0j-assembly1.cif.gz_A SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitors	1.278E-05	1.000	137	3	262	263	7	343	388	360	0.989	0.869
LOKIASV2_0167_ESMFold_hypothetical_protein	6dh8-assembly1.cif.gz_A	6dh8-assembly1.cif.gz_A Crystal structure of HIV-1 Protease NL4-3 I50V Mutant in complex with UMass6	1.887E-03	1.000	136	21	110	263	10	92	99	93	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1gnm-assembly1.cif.gz_B	1gnm-assembly1.cif.gz_B HIV-1 PROTEASE MUTANT WITH VAL 82 REPLACED BY ASP (V82D) COMPLEXED WITH U89360E (INHIBITOR)	1.609E-03	1.000	136	21	110	263	10	92	99	95	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2hc0-assembly1.cif.gz_B	2hc0-assembly1.cif.gz_B Structure of HIV protease 6X mutant in complex with AB-2.	1.233E-03	1.000	136	21	107	263	10	89	99	93	0.331	0.808
LOKIASV2_0167_ESMFold_hypothetical_protein	2i4x-assembly1.cif.gz_B	2i4x-assembly1.cif.gz_B HIV-1 Protease I84V, L90M with GS-8374	2.737E-03	1.000	136	21	110	263	10	92	99	93	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	6mk9-assembly1.cif.gz_A	6mk9-assembly1.cif.gz_A X-ray crystal structure of darunavir-resistant-P51 HIV-1 protease in complex with GRL-121	3.570E-03	1.000	136	21	110	263	10	92	99	90	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4njv-assembly1.cif.gz_B	4njv-assembly1.cif.gz_B Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with ritonavir	2.886E-03	1.000	136	21	110	263	10	92	99	93	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	6opz-assembly1.cif.gz_B	6opz-assembly1.cif.gz_B HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, I54L, A71V, L76V, V82F, I84V Mutant in complex with darunavir	1.696E-03	1.000	136	21	104	263	10	86	99	88	0.319	0.778
LOKIASV2_0167_ESMFold_hypothetical_protein	3spk-assembly1.cif.gz_B	3spk-assembly1.cif.gz_B Tipranavir in Complex with a Human Immunodeficiency Virus Type 1 Protease Variant	1.789E-03	1.000	136	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	5v4y-assembly1.cif.gz_A-2	5v4y-assembly1.cif.gz_A-2 X-ray crystal structure of wild type HIV-1 protease in complex with GRL-09510	1.990E-03	1.000	136	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2z54-assembly1.cif.gz_B	2z54-assembly1.cif.gz_B The Influence of I47A Mutation on Reduced Susceptibility to the Protease Inhibitor Lopinavir	1.696E-03	1.000	136	21	106	263	10	88	99	90	0.327	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	3s8i-assembly1.cif.gz_A	3s8i-assembly1.cif.gz_A The retroviral-like protease (RVP) domain of human DDI1	3.267E-04	1.000	136	146	263	263	3	118	124	130	0.449	0.935
LOKIASV2_0167_ESMFold_hypothetical_protein	5i3y-assembly1.cif.gz_A	5i3y-assembly1.cif.gz_A Crystal structure of BACE1 in complex with aminoquinoline inhibitor 9	4.114E-05	1.000	136	3	262	263	5	338	369	359	0.989	0.905
LOKIASV2_0167_ESMFold_hypothetical_protein	3buh-assembly1.cif.gz_A	3buh-assembly1.cif.gz_A BACE-1 complexed with compound 4	4.338E-05	1.000	136	3	262	263	8	338	370	360	0.989	0.895
LOKIASV2_0167_ESMFold_hypothetical_protein	4j1h-assembly1.cif.gz_A	4j1h-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,6R)-2-amino-4-methyl-6-trifluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide	9.626E-05	1.000	136	3	262	263	8	339	370	358	0.989	0.897
LOKIASV2_0167_ESMFold_hypothetical_protein	3s7m-assembly1.cif.gz_A	3s7m-assembly1.cif.gz_A Pyrazolyl and Thienyl Aminohydantoins as Potent BACE1 Inhibitors	2.418E-05	1.000	136	3	262	263	6	344	371	372	0.989	0.914
LOKIASV2_0167_ESMFold_hypothetical_protein	6wny-assembly1.cif.gz_A	6wny-assembly1.cif.gz_A Crystal structure of BACE1 in complex with (Z)-fluoro-olefin containing compound 15	3.699E-05	1.000	136	3	262	263	5	348	380	366	0.989	0.905
LOKIASV2_0167_ESMFold_hypothetical_protein	3nwx-assembly1.cif.gz_A	3nwx-assembly1.cif.gz_A X-ray structure of ester chemical analogue [O-Ile50,O-Ile50']HIV-1 protease complexed with KVS-1 inhibitor	3.044E-03	1.000	135	21	106	263	10	86	96	87	0.327	0.802
LOKIASV2_0167_ESMFold_hypothetical_protein	8esy-assembly1.cif.gz_A	8esy-assembly1.cif.gz_A D30N mutant HIV protease in complex with benzoxaborolone analog of darunavir	3.570E-03	1.000	135	21	110	263	10	91	98	91	0.342	0.837
LOKIASV2_0167_ESMFold_hypothetical_protein	2hpf-assembly1.cif.gz_B	2hpf-assembly1.cif.gz_B COMPARISON OF THE STRUCTURES OF HIV-2 PROTEASE COMPLEXES IN THREE CRYSTAL SPACE GROUPS WITH AN HIV-1 PROTEASE COMPLEX STRUCTURE	1.233E-03	1.000	135	21	110	263	10	92	99	90	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2pyn-assembly1.cif.gz_B	2pyn-assembly1.cif.gz_B HIV-1 PR mutant in complex with nelfinavir	1.372E-03	1.000	135	21	110	263	10	92	99	96	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1tsu-assembly1.cif.gz_B	1tsu-assembly1.cif.gz_B CRYSTAL STRUCTURE OF DECAMER NCP1 SUBSTRATE PEPTIDE IN COMPLEX WITH WILD-TYPE D25N HIV-1 PROTEASE VARIANT	2.461E-03	1.000	135	21	107	263	10	89	99	90	0.331	0.808
LOKIASV2_0167_ESMFold_hypothetical_protein	3wb4-assembly1.cif.gz_A	3wb4-assembly1.cif.gz_A Crystal Structure of beta secetase in complex with 2-amino-3,6-dimethyl-6-(2-phenylethyl)-3,4,5,6-tetrahydropyrimidin-4-one	5.967E-05	1.000	135	3	262	263	5	329	360	354	0.989	0.903
LOKIASV2_0167_ESMFold_hypothetical_protein	1tqf-assembly1.cif.gz_A	1tqf-assembly1.cif.gz_A Crystal structure of human Beta secretase complexed with inhibitor	1.667E-05	1.000	135	3	262	263	7	340	371	357	0.989	0.900
LOKIASV2_0167_ESMFold_hypothetical_protein	5v0n-assembly2.cif.gz_B	5v0n-assembly2.cif.gz_B BACE1 in complex with inhibitor 5g	5.088E-05	1.000	135	3	262	263	6	342	373	364	0.989	0.903
LOKIASV2_0167_ESMFold_hypothetical_protein	3nsh-assembly3.cif.gz_C	3nsh-assembly3.cif.gz_C BACE-1 in complex with ELN475957	1.421E-05	1.000	135	3	262	263	6	347	376	362	0.989	0.910
LOKIASV2_0167_ESMFold_hypothetical_protein	6nw3-assembly2.cif.gz_B	6nw3-assembly2.cif.gz_B BACE1 in complex with a macrocyclic inhibitor	5.366E-05	1.000	135	3	262	263	6	349	381	369	0.989	0.903
LOKIASV2_0167_ESMFold_hypothetical_protein	6c4g-assembly1.cif.gz_A	6c4g-assembly1.cif.gz_A Plasmepsin V from Plasmodium vivax bound to a transition state mimetic (WEHI-601)	1.758E-05	1.000	135	1	263	263	1	386	394	409	1.000	0.980
LOKIASV2_0167_ESMFold_hypothetical_protein	3em6-assembly1.cif.gz_B	3em6-assembly1.cif.gz_B Crystal structure of I50L/A71V mutant of hiv-1 protease in complex with inhibitor darunavir	2.786E-04	1.000	134	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3ggu-assembly1.cif.gz_B	3ggu-assembly1.cif.gz_B HIV PR drug resistant patient's variant in complex with darunavir	1.170E-03	1.000	134	21	110	263	10	92	99	96	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1rl8-assembly1.cif.gz_B	1rl8-assembly1.cif.gz_B Crystal structure of the complex of resistant strain of hiv-1 protease(v82a mutant) with ritonavir	1.301E-03	1.000	134	21	110	263	10	92	99	96	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3u7s-assembly1.cif.gz_B	3u7s-assembly1.cif.gz_B HIV PR drug resistant patient's variant in complex with darunavir	4.656E-03	1.000	134	21	110	263	10	92	99	91	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2iqg-assembly1.cif.gz_A	2iqg-assembly1.cif.gz_A Crystal Structure of Hydroxyethyl Secondary Amine-based Peptidomimetic Inhibitor of Human Beta-Secretase (BACE)	2.836E-05	1.000	134	3	262	263	6	343	375	359	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	2qzk-assembly1.cif.gz_A	2qzk-assembly1.cif.gz_A Crystal structure of human Beta Secretase complexed with I21	4.338E-05	1.000	134	3	262	263	6	345	376	361	0.989	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	1t7i-assembly1.cif.gz_A	1t7i-assembly1.cif.gz_A The structural and thermodynamic basis for the binding of TMC114, a next-generation HIV-1 protease inhibitor.	1.609E-03	1.000	133	21	110	263	10	92	99	96	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	5c9d-assembly1.cif.gz_B	5c9d-assembly1.cif.gz_B Crystal structure of a retropepsin-like aspartic protease from Rickettsia conorii	5.559E-04	1.000	133	2	123	263	5	120	120	130	0.464	0.967
LOKIASV2_0167_ESMFold_hypothetical_protein	3inf-assembly1.cif.gz_A	3inf-assembly1.cif.gz_A Bace1 with the aminohydantoin Compound 37	9.292E-06	1.000	133	3	262	263	6	341	367	357	0.989	0.916
LOKIASV2_0167_ESMFold_hypothetical_protein	3rth-assembly1.cif.gz_A	3rth-assembly1.cif.gz_A Structure of Bace-1 (Beta-Secretase) in Complex with 6-(2-(3,3-Dimethylbut-1-ynyl)phenyl)quinolin-2-amine	1.033E-05	1.000	133	4	262	263	4	340	371	355	0.985	0.908
LOKIASV2_0167_ESMFold_hypothetical_protein	4wy6-assembly1.cif.gz_A	4wy6-assembly1.cif.gz_A Crystal structure of human BACE-1 bound to Compound 36	5.658E-05	1.000	133	3	262	263	7	342	373	362	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	4fco-assembly1.cif.gz_A	4fco-assembly1.cif.gz_A Crystal structure of bace1 with its inhibitor	1.758E-05	1.000	133	3	262	263	7	343	374	356	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	4i1c-assembly1.cif.gz_A	4i1c-assembly1.cif.gz_A Design and synthesis of thiophene dihydroisoquinolins as novel BACE-1 inhibitors	2.174E-05	1.000	133	5	262	263	4	341	378	362	0.981	0.894
LOKIASV2_0167_ESMFold_hypothetical_protein	2q11-assembly1.cif.gz_A	2q11-assembly1.cif.gz_A Structure of BACE complexed to compound 1	2.174E-05	1.000	133	3	262	263	6	357	388	371	0.989	0.907
LOKIASV2_0167_ESMFold_hypothetical_protein	7hvp-assembly1.cif.gz_B	7hvp-assembly1.cif.gz_B X-RAY CRYSTALLOGRAPHIC STRUCTURE OF A COMPLEX BETWEEN A SYNTHETIC PROTEASE OF HUMAN IMMUNODEFICIENCY VIRUS 1 AND A SUBSTRATE-BASED HYDROXYETHYLAMINE INHIBITOR	2.333E-03	1.000	132	21	106	263	10	87	97	90	0.327	0.804
LOKIASV2_0167_ESMFold_hypothetical_protein	3el9-assembly1.cif.gz_B	3el9-assembly1.cif.gz_B Crystal structure of atazanavir (ATV) in complex with a multidrug HIV-1 protease (V82T/I84V)	2.886E-03	1.000	132	21	106	263	10	88	99	90	0.327	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	3lzs-assembly1.cif.gz_B	3lzs-assembly1.cif.gz_B Crystal Structure of HIV-1 CRF01_AE Protease in Complex with Darunavir	2.595E-03	1.000	132	21	110	263	10	92	99	93	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	7m9p-assembly1.cif.gz_A	7m9p-assembly1.cif.gz_A HIV-1 Protease (I84V) in Complex with LR3-55	3.044E-03	1.000	132	21	110	263	10	92	99	93	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	6oou-assembly1.cif.gz_A	6oou-assembly1.cif.gz_A Crystal structure of HIV-1 Protease NL4-3 L89V Mutant in complex with darunavir	3.044E-03	1.000	132	21	107	263	10	89	99	90	0.331	0.808
LOKIASV2_0167_ESMFold_hypothetical_protein	4q1x-assembly1.cif.gz_B	4q1x-assembly1.cif.gz_B Mutations Outside the Active Site of HIV-1 Protease Alter Enzyme Structure and Dynamic Ensemble of the Active Site to Confer Drug Resistance	3.832E-04	1.000	132	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2qhc-assembly1.cif.gz_B	2qhc-assembly1.cif.gz_B The Influence of I47A Mutation on Reduced Susceptibility to the Protease Inhibitor Lopinavir	2.737E-03	1.000	132	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4frj-assembly1.cif.gz_A	4frj-assembly1.cif.gz_A Crystal structure of BACE1 in complex with aminooxazoline xanthene 9l	6.636E-05	1.000	132	3	262	263	5	342	373	364	0.989	0.906
LOKIASV2_0167_ESMFold_hypothetical_protein	5he7-assembly1.cif.gz_A	5he7-assembly1.cif.gz_A BACE-1 in complex with (4aR,7aS)-7a-(2,4-difluorophenyl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-yl)-2-imino-3-methyloctahydro-4H-pyrrolo[3,4-d]pyrimidin-4-one	1.581E-05	1.000	132	20	262	263	18	353	385	359	0.924	0.873
LOKIASV2_0167_ESMFold_hypothetical_protein	2zhr-assembly2.cif.gz_B	2zhr-assembly2.cif.gz_B Crystal structure of BACE1 in complex with OM99-2 at pH 5.0	3.154E-05	1.000	132	20	262	263	16	354	385	360	0.924	0.881
LOKIASV2_0167_ESMFold_hypothetical_protein	4i0d-assembly1.cif.gz_A	4i0d-assembly1.cif.gz_A Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 Inhibitors	1.090E-05	1.000	132	20	262	263	16	342	387	340	0.924	0.845
LOKIASV2_0167_ESMFold_hypothetical_protein	1qdm-assembly3.cif.gz_C	1qdm-assembly3.cif.gz_C CRYSTAL STRUCTURE OF PROPHYTEPSIN, A ZYMOGEN OF A BARLEY VACUOLAR ASPARTIC PROTEINASE.	6.519E-04	1.000	132	2	262	263	1	423	427	433	0.992	0.991
LOKIASV2_0167_ESMFold_hypothetical_protein	3bxr-assembly1.cif.gz_B	3bxr-assembly1.cif.gz_B Crystal Structures Of Highly Constrained Substrate And Hydrolysis Products Bound To HIV-1 Protease. Implications For Catalytic Mechanism	2.886E-03	1.000	131	21	110	263	10	91	97	93	0.342	0.845
LOKIASV2_0167_ESMFold_hypothetical_protein	6o54-assembly1.cif.gz_X	6o54-assembly1.cif.gz_X Crystal Structure of multi-drug resistant HIV-1 protease PR-S17 (D25N)	3.570E-03	1.000	131	21	107	263	10	89	99	88	0.331	0.808
LOKIASV2_0167_ESMFold_hypothetical_protein	6oot-assembly1.cif.gz_B	6oot-assembly1.cif.gz_B HIV-1 Protease NL4-3 L89V, L90M Mutant in complex with darunavir	3.044E-03	1.000	131	21	107	263	10	89	99	90	0.331	0.808
LOKIASV2_0167_ESMFold_hypothetical_protein	3oud-assembly1.cif.gz_B	3oud-assembly1.cif.gz_B MDR769 HIV-1 protease complexed with CA/p2 hepta-peptide	2.737E-03	1.000	131	21	104	263	10	86	99	85	0.319	0.778
LOKIASV2_0167_ESMFold_hypothetical_protein	3t3c-assembly1.cif.gz_B	3t3c-assembly1.cif.gz_B Structure of HIV PR resistant patient derived mutant (comprising 22 mutations) in complex with DRV	2.595E-03	1.000	131	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2qu2-assembly1.cif.gz_A	2qu2-assembly1.cif.gz_A BACE1 with Compound 1	1.758E-05	1.000	131	3	262	263	6	344	364	361	0.989	0.931
LOKIASV2_0167_ESMFold_hypothetical_protein	3tpr-assembly1.cif.gz_A	3tpr-assembly1.cif.gz_A Crystal structure of BACE1 complexed with an inhibitor	4.575E-05	1.000	131	3	262	263	5	337	368	357	0.989	0.905
LOKIASV2_0167_ESMFold_hypothetical_protein	3hd8-assembly1.cif.gz_A	3hd8-assembly1.cif.gz_A Crystal structure of the Triticum aestivum xylanase inhibitor-IIA in complex with bacillus subtilis xylanase	1.033E-05	1.000	131	3	263	263	4	356	370	364	0.992	0.954
LOKIASV2_0167_ESMFold_hypothetical_protein	2p83-assembly2.cif.gz_B	2p83-assembly2.cif.gz_B Potent and selective isophthalamide S2 hydroxyethylamine inhibitor of BACE1	2.293E-05	1.000	131	3	262	263	6	340	372	364	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	6oos-assembly2.cif.gz_C	6oos-assembly2.cif.gz_C HIV-1 Protease NL4-3 L90M Mutant in complex with darunavir	3.210E-03	1.000	130	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2p3d-assembly1.cif.gz_B	2p3d-assembly1.cif.gz_B Crystal Structure of the multi-drug resistant mutant subtype F HIV protease complexed with TL-3 inhibitor	3.210E-03	1.000	130	21	104	263	10	86	99	87	0.319	0.778
LOKIASV2_0167_ESMFold_hypothetical_protein	7bgu-assembly2.cif.gz_D	7bgu-assembly2.cif.gz_D Mason-Pfizer Monkey Virus Protease mutant C7A/D26N/C106A in complex with peptidomimetic inhibitor	5.460E-03	1.000	130	21	107	263	11	97	108	91	0.331	0.806
LOKIASV2_0167_ESMFold_hypothetical_protein	5c9b-assembly1.cif.gz_C	5c9b-assembly1.cif.gz_C Crystal structure of a retropepsin-like aspartic protease from Rickettsia conorii	4.041E-04	1.000	130	2	124	263	7	119	124	124	0.468	0.911
LOKIASV2_0167_ESMFold_hypothetical_protein	7d5u-assembly1.cif.gz_A	7d5u-assembly1.cif.gz_A BACE2 xaperone complex with N-{3-[(9S)-7-amino-2,2-difluoro-9-(prop-1-yn-1-yl)-6-oxa-8-azaspiro[3.5]non-7-en-9-yl]-4-fluorophenyl}-5-cyanopyridine-2-carboxamide	7.380E-05	1.000	130	3	262	263	5	339	370	362	0.989	0.905
LOKIASV2_0167_ESMFold_hypothetical_protein	5clm-assembly1.cif.gz_A	5clm-assembly1.cif.gz_A 1,4-Oxazine BACE1 inhibitors	2.836E-05	1.000	130	3	262	263	5	345	376	359	0.989	0.907
LOKIASV2_0167_ESMFold_hypothetical_protein	7mas-assembly2.cif.gz_C	7mas-assembly2.cif.gz_C Drug Resistant HIV-1 Protease (L10F, M46I, I50V, F53L, L63P, G73S) in Complex with DRV	1.789E-03	1.000	129	21	110	263	10	92	99	92	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	7n6v-assembly1.cif.gz_B	7n6v-assembly1.cif.gz_B Crystal structure of HIV-1 Protease multiple mutants PRS17 with Revertant mutation V48G bound to inhibitor Amprenavir	3.570E-03	1.000	129	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	6opu-assembly1.cif.gz_A	6opu-assembly1.cif.gz_A HIV-1 Protease NL4-3 K45I, M46I, V82F, I84V Mutant in complex with darunavir	3.385E-03	1.000	129	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4q1w-assembly1.cif.gz_B	4q1w-assembly1.cif.gz_B Mutations Outside the Active Site of HIV-1 Protease Alter Enzyme Structure and Dynamic Ensemble of the Active Site to Confer Drug Resistance	4.998E-04	1.000	129	140	246	263	2	90	99	107	0.407	0.899
LOKIASV2_0167_ESMFold_hypothetical_protein	5c9b-assembly1.cif.gz_A	5c9b-assembly1.cif.gz_A Crystal structure of a retropepsin-like aspartic protease from Rickettsia conorii	4.739E-04	1.000	129	2	124	263	7	121	126	131	0.468	0.913
LOKIASV2_0167_ESMFold_hypothetical_protein	5c9b-assembly1.cif.gz_B	5c9b-assembly1.cif.gz_B Crystal structure of a retropepsin-like aspartic protease from Rickettsia conorii	4.041E-04	1.000	129	2	124	263	7	122	127	131	0.468	0.913
LOKIASV2_0167_ESMFold_hypothetical_protein	4j1c-assembly1.cif.gz_A	4j1c-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-5,5-difluoro-4-fluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide	1.553E-04	1.000	129	4	262	263	7	340	371	354	0.985	0.900
LOKIASV2_0167_ESMFold_hypothetical_protein	4i0h-assembly3.cif.gz_C	4i0h-assembly3.cif.gz_C SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitors.	4.575E-05	1.000	129	3	262	263	6	345	374	370	0.989	0.909
LOKIASV2_0167_ESMFold_hypothetical_protein	2q64-assembly1.cif.gz_B	2q64-assembly1.cif.gz_B HIV-1 PR mutant in complex with nelfinavir	1.887E-03	1.000	128	21	104	263	10	86	99	90	0.319	0.778
LOKIASV2_0167_ESMFold_hypothetical_protein	3zkg-assembly1.cif.gz_A	3zkg-assembly1.cif.gz_A BACE2 MUTANT APO STRUCTURE	9.626E-05	1.000	128	20	262	263	17	333	364	336	0.924	0.871
LOKIASV2_0167_ESMFold_hypothetical_protein	5f01-assembly1.cif.gz_A	5f01-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH (1SR,2SR)-2-((R)-2-amino-5,5-difluoro-4-methyl-5,6-dihydro-4H-1,3-oxazin-4-yl)-N-(3-chloroquinolin-8-yl)cyclopropanecarboxamide	2.836E-05	1.000	128	3	262	263	8	353	384	370	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	3skg-assembly1.cif.gz_A	3skg-assembly1.cif.gz_A Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with (2S)-2-((3R)-3-acetamido-3-isobutyl-2-oxo-1-pyrrolidinyl)-N-((1S,2R)-1-(3,5-difluorobenzyl)-2-hydroxy-2-(1,2,3,4-tetrahydro-3-isoquinolinyl)ethyl)-4-phenylbutanamide	3.699E-05	1.000	128	20	262	263	16	356	386	361	0.924	0.883
LOKIASV2_0167_ESMFold_hypothetical_protein	4r95-assembly1.cif.gz_A	4r95-assembly1.cif.gz_A BACE-1 in complex with 2-(((1R,3S)-3-(((R)-4-(2-cyclohexylethyl)-2-iminio-1-methyl-5-oxoimidazolidin-4-yl)methyl)cyclohexyl)amino)quinolin-1-ium	2.991E-05	1.000	128	5	262	263	6	355	387	376	0.981	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	3dcr-assembly1.cif.gz_B	3dcr-assembly1.cif.gz_B X-ray structure of HIV-1 protease and hydrated form of ketomethylene isostere inhibitor	6.073E-03	1.000	127	21	110	263	10	91	97	92	0.342	0.845
LOKIASV2_0167_ESMFold_hypothetical_protein	3hbo-assembly3.cif.gz_B	3hbo-assembly3.cif.gz_B Crystal structure of chemically synthesized [D-Ala51/51']HIV-1 protease	9.289E-03	1.000	127	21	110	263	10	91	97	90	0.342	0.845
LOKIASV2_0167_ESMFold_hypothetical_protein	1k2c-assembly1.cif.gz_B	1k2c-assembly1.cif.gz_B Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance	2.737E-03	1.000	127	21	110	263	10	92	99	96	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1odw-assembly1.cif.gz_B	1odw-assembly1.cif.gz_B Native HIV-1 Proteinase	7.250E-04	1.000	127	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3s56-assembly1.cif.gz_B	3s56-assembly1.cif.gz_B HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug saquinavir	6.182E-04	1.000	127	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	5c9f-assembly1.cif.gz_B	5c9f-assembly1.cif.gz_B Crystal structure of a retropepsin-like aspartic protease from Rickettsia conorii	1.052E-03	1.000	127	2	124	263	7	118	124	126	0.468	0.903
LOKIASV2_0167_ESMFold_hypothetical_protein	4rgh-assembly1.cif.gz_A	4rgh-assembly1.cif.gz_A Human DNA Damage-Inducible Protein: From Protein Chemistry and 3D Structure to Deciphering its Cellular Role	3.446E-04	1.000	127	146	263	263	4	122	128	134	0.449	0.930
LOKIASV2_0167_ESMFold_hypothetical_protein	3ixk-assembly1.cif.gz_A	3ixk-assembly1.cif.gz_A Potent beta-secretase 1 inhibitor	4.338E-05	1.000	127	3	262	263	6	342	373	358	0.989	0.903
LOKIASV2_0167_ESMFold_hypothetical_protein	7d2x-assembly1.cif.gz_A	7d2x-assembly1.cif.gz_A Crystal Structure of BACE1 in complex with N-{3-[(4R)-2-amino-4-(prop-1-yn-1-yl)-5,6-dihydro-4H-1,3-oxazin-4-yl]-4-fluorophenyl}-5-cyanopyridine-2-carboxamide	5.366E-05	1.000	127	3	262	263	7	344	375	353	0.989	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	5hdv-assembly1.cif.gz_A	5hdv-assembly1.cif.gz_A BACE-1 incomplex with (7aR)-7a-(5-cyanothiophen-2-yl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-yl)-3-methyl-4-oxooctahydro-2H-pyrrolo[3,4-d]pyrimidin-2-iminium	1.955E-05	1.000	127	20	262	263	18	352	384	352	0.924	0.872
LOKIASV2_0167_ESMFold_hypothetical_protein	1qdm-assembly2.cif.gz_B	1qdm-assembly2.cif.gz_B CRYSTAL STRUCTURE OF PROPHYTEPSIN, A ZYMOGEN OF A BARLEY VACUOLAR ASPARTIC PROTEINASE.	1.071E-04	1.000	127	2	262	263	1	426	430	450	0.992	0.991
LOKIASV2_0167_ESMFold_hypothetical_protein	3nyg-assembly1.cif.gz_A	3nyg-assembly1.cif.gz_A X-ray structure of ester chemical analogue [O-Gly51,O-Gly51']HIV-1 protease complexed with MVT-101 inhibitor	2.737E-03	1.000	126	21	110	263	10	90	96	91	0.342	0.844
LOKIASV2_0167_ESMFold_hypothetical_protein	3upj-assembly1.cif.gz_B	3upj-assembly1.cif.gz_B HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 PROTEASE MUTANT WITH LYS 57 REPLACED BY LEU (K57L) COMPLEX WITH U096333 [4-HYDROXY-3-[1-(PHENYL)PROPYL]-7-METHOXYCOUMARIN]	2.333E-03	1.000	126	21	110	263	8	90	97	90	0.342	0.856
LOKIASV2_0167_ESMFold_hypothetical_protein	1gnn-assembly1.cif.gz_B	1gnn-assembly1.cif.gz_B HIV-1 PROTEASE MUTANT WITH VAL 82 REPLACED BY ASN (V82N) COMPLEXED WITH U89360E (INHIBITOR)	1.372E-03	1.000	126	21	110	263	10	92	99	95	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4qgi-assembly1.cif.gz_B	4qgi-assembly1.cif.gz_B X-ray crystal structure of HIV-1 protease variant G48T/L89M in complex with Saquinavir	1.109E-03	1.000	126	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2ze1-assembly1.cif.gz_A	2ze1-assembly1.cif.gz_A X-ray structure of Bace-1 in complex with compound 6g	8.208E-05	1.000	126	3	262	263	5	335	360	357	0.989	0.919
LOKIASV2_0167_ESMFold_hypothetical_protein	3hd8-assembly2.cif.gz_C	3hd8-assembly2.cif.gz_C Crystal structure of the Triticum aestivum xylanase inhibitor-IIA in complex with bacillus subtilis xylanase	3.901E-05	1.000	126	3	263	263	4	355	368	364	0.992	0.957
LOKIASV2_0167_ESMFold_hypothetical_protein	2viz-assembly1.cif.gz_A	2viz-assembly1.cif.gz_A Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(2-oxo- 1-pyrrolidinyl)-5-(propyloxy)benzamide	4.825E-05	1.000	126	20	262	263	14	341	370	345	0.924	0.886
LOKIASV2_0167_ESMFold_hypothetical_protein	4i0h-assembly1.cif.gz_A	4i0h-assembly1.cif.gz_A SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitors.	2.418E-05	1.000	126	3	262	263	6	343	374	359	0.989	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	2oah-assembly1.cif.gz_A-2	2oah-assembly1.cif.gz_A-2 Crystal Structure of Human Beta Secretase Complexed with inhibitor	4.338E-05	1.000	126	5	262	263	8	347	378	362	0.981	0.899
LOKIASV2_0167_ESMFold_hypothetical_protein	4j0t-assembly1.cif.gz_A	4j0t-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Ethoxy-pyridine-2-carboxylic acid [3-((R)-2-amino-5,5-difluoro-4-methyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide	2.991E-05	1.000	126	3	262	263	8	350	381	370	0.989	0.900
LOKIASV2_0167_ESMFold_hypothetical_protein	7ry7-assembly1.cif.gz_A-2	7ry7-assembly1.cif.gz_A-2 Structure of Plasmepsin X (PM10, PMX) from Plasmodium falciparum 3D7	6.293E-05	1.000	126	20	262	263	126	425	433	322	0.924	0.693
LOKIASV2_0167_ESMFold_hypothetical_protein	1a9m-assembly1.cif.gz_B	1a9m-assembly1.cif.gz_B G48H MUTANT OF HIV-1 PROTEASE IN COMPLEX WITH A PEPTIDIC INHIBITOR U-89360E	9.972E-04	1.000	125	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	6opv-assembly1.cif.gz_A	6opv-assembly1.cif.gz_A HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, V82F, I84V Mutant in complex with darunavir	4.910E-03	1.000	125	21	106	263	10	88	99	90	0.327	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	3u71-assembly1.cif.gz_A-2	3u71-assembly1.cif.gz_A-2 Crystal Structure Analysis of South African wild type HIV-1 Subtype C Protease	2.886E-03	1.000	125	21	104	263	10	86	99	88	0.319	0.778
LOKIASV2_0167_ESMFold_hypothetical_protein	3el0-assembly1.cif.gz_B	3el0-assembly1.cif.gz_B Crystal structure of the inhibitor Nelfinavir (NFV) in complex with a multi-drug resistant HIV-1 protease variant (L10I/G48V/I54V/V64I/V82A) (Refer: FLAP+ in citation)	5.862E-04	1.000	124	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2g69-assembly1.cif.gz_A-2	2g69-assembly1.cif.gz_A-2 Structure of Unliganded HIV-1 Protease F53L Mutant	1.696E-03	1.000	124	21	106	263	10	88	99	92	0.327	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	1hwr-assembly1.cif.gz_A	1hwr-assembly1.cif.gz_A MOLECULAR RECOGNITION OF CYCLIC UREA HIV PROTEASE INHIBITORS	7.646E-04	1.000	124	140	246	263	2	90	99	107	0.407	0.899
LOKIASV2_0167_ESMFold_hypothetical_protein	2sam-assembly1.cif.gz_A-2	2sam-assembly1.cif.gz_A-2 STRUCTURE OF THE PROTEASE FROM SIMIAN IMMUNODEFICIENCY VIRUS: COMPLEX WITH AN IRREVERSIBLE NON-PEPTIDE INHIBITOR	2.737E-03	1.000	124	21	110	263	10	92	99	90	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	5t1u-assembly1.cif.gz_A	5t1u-assembly1.cif.gz_A Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functionality	4.338E-05	1.000	124	3	262	263	7	349	380	365	0.989	0.903
LOKIASV2_0167_ESMFold_hypothetical_protein	3ou4-assembly1.cif.gz_B	3ou4-assembly1.cif.gz_B MDR769 HIV-1 protease complexed with TF/PR hepta-peptide	5.178E-03	1.000	123	21	104	263	10	86	99	86	0.319	0.778
LOKIASV2_0167_ESMFold_hypothetical_protein	4z50-assembly2.cif.gz_C	4z50-assembly2.cif.gz_C Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20D25N with Tucked Flap	6.753E-03	1.000	123	21	106	263	10	88	99	86	0.327	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	6uj1-assembly2.cif.gz_B	6uj1-assembly2.cif.gz_B BACE2 mutant in complex with a macrocyclic compound	1.129E-04	1.000	123	20	262	263	16	334	357	342	0.924	0.894
LOKIASV2_0167_ESMFold_hypothetical_protein	5cop-assembly1.cif.gz_B	5cop-assembly1.cif.gz_B X-ray crystal structure of wild type HIV-1 protease in complex with GRL-097	7.511E-03	1.000	122	21	110	263	10	92	99	93	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3ixo-assembly1.cif.gz_B	3ixo-assembly1.cif.gz_B Crystal Structure of uncomplexed HIV_1 Protease Subtype A	6.404E-03	1.000	122	21	110	263	10	92	99	94	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3jw2-assembly1.cif.gz_B	3jw2-assembly1.cif.gz_B HIV-1 Protease Mutant G86S with DARUNAVIR	8.063E-04	1.000	122	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1meu-assembly1.cif.gz_B	1meu-assembly1.cif.gz_B HIV-1 MUTANT (V82F, I84V) PROTEASE COMPLEXED WITH DMP323	2.595E-03	1.000	122	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1tcx-assembly1.cif.gz_B	1tcx-assembly1.cif.gz_B HIV TRIPLE MUTANT PROTEASE COMPLEXED WITH INHIBITOR SB203386	1.170E-03	1.000	122	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	5fiv-assembly1.cif.gz_A-2	5fiv-assembly1.cif.gz_A-2 STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITH AN EFFICIENT INHIBITOR OF FIV PR	8.967E-04	1.000	122	146	242	263	9	99	112	102	0.369	0.812
LOKIASV2_0167_ESMFold_hypothetical_protein	5c9f-assembly1.cif.gz_C	5c9f-assembly1.cif.gz_C Crystal structure of a retropepsin-like aspartic protease from Rickettsia conorii	9.972E-04	1.000	122	2	124	263	7	126	132	131	0.468	0.909
LOKIASV2_0167_ESMFold_hypothetical_protein	3l38-assembly1.cif.gz_A	3l38-assembly1.cif.gz_A Bace1 in complex with the aminopyridine Compound 44	3.326E-05	1.000	122	3	262	263	6	338	364	356	0.989	0.915
LOKIASV2_0167_ESMFold_hypothetical_protein	6i45-assembly1.cif.gz_A-2	6i45-assembly1.cif.gz_A-2 Crystal structure of I13V/I62V/V77I South African HIV-1 subtype C protease containing a D25A mutation	3.570E-03	1.000	121	21	104	263	10	86	99	88	0.319	0.778
LOKIASV2_0167_ESMFold_hypothetical_protein	3nu9-assembly1.cif.gz_B	3nu9-assembly1.cif.gz_B Crystal Structure of HIV-1 Protease Mutant I84V with Antiviral Drug Amprenavir	9.972E-04	1.000	121	140	246	263	2	90	99	107	0.407	0.899
LOKIASV2_0167_ESMFold_hypothetical_protein	2p3c-assembly1.cif.gz_B	2p3c-assembly1.cif.gz_B Crystal Structure of the subtype F wild type HIV protease complexed with TL-3 inhibitor	6.073E-03	1.000	121	21	104	263	10	86	99	87	0.319	0.778
LOKIASV2_0167_ESMFold_hypothetical_protein	2q3k-assembly1.cif.gz_A	2q3k-assembly1.cif.gz_A Crystal Structure of Lysine Sulfonamide Inhibitor Reveals the Displacement of the Conserved Flap Water Molecule in HIV-1 Protease	1.170E-03	1.000	121	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2r5p-assembly1.cif.gz_B	2r5p-assembly1.cif.gz_B Crystal Structure Analysis of HIV-1 Subtype C Protease Complexed with Indinavir	8.967E-04	1.000	121	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3l5d-assembly1.cif.gz_A	3l5d-assembly1.cif.gz_A Structure of BACE Bound to SCH723873	6.636E-05	1.000	121	20	262	263	18	354	386	359	0.924	0.873
LOKIASV2_0167_ESMFold_hypothetical_protein	7o0g-assembly1.cif.gz_A	7o0g-assembly1.cif.gz_A Structure of the foamy viral protease-reverse transcriptase in complex with RNA/DNA hybrid.	3.764E-03	1.000	121	148	246	263	5	85	733	99	0.376	0.111
LOKIASV2_0167_ESMFold_hypothetical_protein	1z1r-assembly1.cif.gz_A	1z1r-assembly1.cif.gz_A HIV-1 protease complexed with Macrocyclic peptidomimetic inhibitor 2	6.073E-03	1.000	120	21	110	263	10	91	97	94	0.342	0.845
LOKIASV2_0167_ESMFold_hypothetical_protein	2mip-assembly2.cif.gz_C	2mip-assembly2.cif.gz_C CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) TYPE 2 PROTEASE IN COMPLEX WITH A REDUCED AMIDE INHIBITOR AND COMPARISON WITH HIV-1 PROTEASE STRUCTURES	5.178E-03	1.000	120	21	110	263	10	92	99	90	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	6opt-assembly1.cif.gz_A	6opt-assembly1.cif.gz_A HIV-1 Protease NL4-3 V82F, I84V Mutant in complex with darunavir	1.233E-03	1.000	120	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1z8c-assembly1.cif.gz_B	1z8c-assembly1.cif.gz_B Crystal structure of the complex of mutant HIV-1 protease (l63P, A71V, V82T, I84V) with a hydroxyethylamine peptidomimetic inhibitor BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2	1.233E-03	1.000	120	140	246	263	2	90	99	107	0.407	0.899
LOKIASV2_0167_ESMFold_hypothetical_protein	6pz4-assembly1.cif.gz_A	6pz4-assembly1.cif.gz_A co-crystal structure of BACE with inhibitor AM-6494	6.293E-05	1.000	120	3	262	263	5	348	380	367	0.989	0.905
LOKIASV2_0167_ESMFold_hypothetical_protein	4j0z-assembly1.cif.gz_A	4j0z-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,5R)-2-amino-5-fluoro-4-fluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide	6.998E-05	1.000	120	3	262	263	8	350	381	368	0.989	0.900
LOKIASV2_0167_ESMFold_hypothetical_protein	5b18-assembly1.cif.gz_B	5b18-assembly1.cif.gz_B Crystal Structure of a Darunavir Resistant HIV-1 Protease	1.149E-02	1.000	119	21	110	263	10	92	99	90	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4obk-assembly1.cif.gz_B	4obk-assembly1.cif.gz_B Crystal structure of inactive HIV-1 protease in complex with the P1-P6 substrate variant (L449F/S451N)	1.301E-03	1.000	119	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	6ogv-assembly1.cif.gz_A-2	6ogv-assembly1.cif.gz_A-2 X-ray crystal structure of darunavir-resistant HIV-1 protease (P30) in apo state	1.233E-03	1.000	119	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4qj9-assembly1.cif.gz_A	4qj9-assembly1.cif.gz_A Crystal structure of inactive HIV-1 protease in complex with p1-p6 substrate variant (R452S)	1.372E-03	1.000	119	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	6fiv-assembly1.cif.gz_A-2	6fiv-assembly1.cif.gz_A-2 STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITH AN EFFICIENT INHIBITOR OF FIV PR	8.063E-04	1.000	119	139	242	263	2	99	112	109	0.395	0.875
LOKIASV2_0167_ESMFold_hypothetical_protein	2hs2-assembly1.cif.gz_B	2hs2-assembly1.cif.gz_B Crystal structure of M46L mutant of HIV-1 protease complexed with TMC114 (darunavir)	1.233E-03	1.000	118	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4npt-assembly1.cif.gz_A-2	4npt-assembly1.cif.gz_A-2 Crystal Structure of HIV-1 Protease Multiple Mutant P51 Complexed with Darunavir	5.460E-03	1.000	118	21	104	263	10	86	99	87	0.319	0.778
LOKIASV2_0167_ESMFold_hypothetical_protein	1zpk-assembly1.cif.gz_B	1zpk-assembly1.cif.gz_B Crystal structure of the complex of mutant HIV-1 protease (A71V, V82T, I84V) with a hydroxyethylamine peptidomimetic inhibitor BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2	1.372E-03	1.000	118	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1b11-assembly1.cif.gz_A	1b11-assembly1.cif.gz_A STRUCTURE OF FELINE IMMUNODEFICIENCY VIRUS PROTEASE COMPLEXED WITH TL-3-093	7.250E-04	1.000	118	137	242	263	1	100	113	111	0.403	0.885
LOKIASV2_0167_ESMFold_hypothetical_protein	2i1a-assembly2.cif.gz_D	2i1a-assembly2.cif.gz_D A Retroviral Protease-Like Domain in the Eukaryotic Protein Ddi1	1.525E-03	1.000	118	146	263	263	3	108	113	130	0.449	0.938
LOKIASV2_0167_ESMFold_hypothetical_protein	5c9f-assembly1.cif.gz_D	5c9f-assembly1.cif.gz_D Crystal structure of a retropepsin-like aspartic protease from Rickettsia conorii	2.333E-03	1.000	118	2	124	263	7	119	126	127	0.468	0.897
LOKIASV2_0167_ESMFold_hypothetical_protein	1az5-assembly1.cif.gz_A-2	1az5-assembly1.cif.gz_A-2 UNLIGANDED SIV PROTEASE STRUCTURE IN AN "OPEN" CONFORMATION	8.353E-03	1.000	117	21	104	263	10	82	95	84	0.319	0.768
LOKIASV2_0167_ESMFold_hypothetical_protein	4dqf-assembly1.cif.gz_A	4dqf-assembly1.cif.gz_A Crystal Structure of (G16A/L38A) HIV-1 Protease in Complex with DRV	1.301E-03	1.000	117	146	246	263	8	88	97	101	0.384	0.835
LOKIASV2_0167_ESMFold_hypothetical_protein	4dqf-assembly1.cif.gz_B	4dqf-assembly1.cif.gz_B Crystal Structure of (G16A/L38A) HIV-1 Protease in Complex with DRV	1.609E-03	1.000	117	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2fxd-assembly1.cif.gz_B	2fxd-assembly1.cif.gz_B X-ray crystal structure of HIV-1 protease IRM mutant complexed with atazanavir (BMS-232632)	1.233E-03	1.000	117	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1hvs-assembly1.cif.gz_B	1hvs-assembly1.cif.gz_B STRUCTURAL BASIS OF DRUG RESISTANCE FOR THE V82A MUTANT OF HIV-1 PROTEASE: BACKBONE FLEXIBILITY AND SUBSITE REPACKING	1.887E-03	1.000	117	140	246	263	2	90	99	107	0.407	0.899
LOKIASV2_0167_ESMFold_hypothetical_protein	1k2b-assembly1.cif.gz_B	1k2b-assembly1.cif.gz_B Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance	1.789E-03	1.000	117	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3mws-assembly1.cif.gz_B	3mws-assembly1.cif.gz_B Crystal Structure of Group N HIV-1 Protease	4.186E-03	1.000	117	21	106	263	10	88	99	92	0.327	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	3r0y-assembly1.cif.gz_A	3r0y-assembly1.cif.gz_A Crystal Structures of Multidrug-resistant HIV-1 Protease in Complex with Mechanism-Based Aspartyl Protease Inhibitors	9.289E-03	1.000	117	21	104	263	10	86	99	86	0.319	0.778
LOKIASV2_0167_ESMFold_hypothetical_protein	2hb2-assembly1.cif.gz_A-2	2hb2-assembly1.cif.gz_A-2 Structure of HIV protease 6X mutant in apo form	1.696E-03	1.000	116	146	246	263	8	88	97	101	0.384	0.835
LOKIASV2_0167_ESMFold_hypothetical_protein	2fgv-assembly1.cif.gz_B	2fgv-assembly1.cif.gz_B X-ray crystal structure of HIV-1 Protease T80N variant in complex with the inhibitor saquinavir used to explore the role of invariant Thr80 in HIV-1 protease structure, function, and viral infectivity.	2.333E-03	1.000	116	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1mtb-assembly1.cif.gz_B	1mtb-assembly1.cif.gz_B Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy	2.213E-03	1.000	116	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	7bgu-assembly1.cif.gz_A	7bgu-assembly1.cif.gz_A Mason-Pfizer Monkey Virus Protease mutant C7A/D26N/C106A in complex with peptidomimetic inhibitor	1.667E-02	1.000	116	21	107	263	11	95	106	91	0.331	0.802
LOKIASV2_0167_ESMFold_hypothetical_protein	3l5c-assembly1.cif.gz_A	3l5c-assembly1.cif.gz_A Structure of BACE Bound to SCH723871	1.129E-04	1.000	116	5	262	263	6	355	387	373	0.981	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	1aid-assembly1.cif.gz_B	1aid-assembly1.cif.gz_B STRUCTURE OF A NON-PEPTIDE INHIBITOR COMPLEXED WITH HIV-1 PROTEASE: DEVELOPING A CYCLE OF STRUCTURE-BASED DRUG DESIGN	1.696E-03	1.000	115	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2avo-assembly1.cif.gz_B	2avo-assembly1.cif.gz_B Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease with drug resistant mutations L24I, I50V, AND G73S	2.098E-03	1.000	115	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2b7z-assembly1.cif.gz_A	2b7z-assembly1.cif.gz_A Structure of HIV-1 protease mutant bound to indinavir	7.920E-03	1.000	115	21	110	263	10	92	99	96	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3bc4-assembly1.cif.gz_A-2	3bc4-assembly1.cif.gz_A-2 I84V HIV-1 protease in complex with a pyrrolidine diester	1.696E-03	1.000	115	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3d3t-assembly1.cif.gz_B	3d3t-assembly1.cif.gz_B Crystal Structure of HIV-1 CRF01_AE in complex with the substrate p1-p6	1.149E-02	1.000	115	21	110	263	10	92	99	93	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	6dh5-assembly1.cif.gz_B	6dh5-assembly1.cif.gz_B Crystal structure of HIV-1 Protease NL4-3 V82I Mutant in complex with UMass6	1.990E-03	1.000	115	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1ytg-assembly1.cif.gz_A	1ytg-assembly1.cif.gz_A SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT	1.990E-03	1.000	115	140	246	263	2	90	99	107	0.407	0.899
LOKIASV2_0167_ESMFold_hypothetical_protein	3s8i-assembly1.cif.gz_B	3s8i-assembly1.cif.gz_B The retroviral-like protease (RVP) domain of human DDI1	6.182E-04	1.000	115	146	263	263	5	115	121	135	0.449	0.917
LOKIASV2_0167_ESMFold_hypothetical_protein	3l5c-assembly2.cif.gz_B	3l5c-assembly2.cif.gz_B Structure of BACE Bound to SCH723871	5.967E-05	1.000	115	20	262	263	18	356	387	351	0.924	0.876
LOKIASV2_0167_ESMFold_hypothetical_protein	4ejk-assembly1.cif.gz_A	4ejk-assembly1.cif.gz_A HIV Protease (PR) dimer in closed form with pepstatin in active site and fragment 1F1-N in the outside/top of flap	1.990E-03	1.000	114	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	6opw-assembly1.cif.gz_A	6opw-assembly1.cif.gz_A HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, A71V, V82F, I84V Mutant in complex with darunavir	2.333E-03	1.000	114	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3oy4-assembly1.cif.gz_B	3oy4-assembly1.cif.gz_B Crystal Structure of HIV-1 L76V Protease in Complex with the Protease Inhibitor Darunavir.	2.098E-03	1.000	114	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2b60-assembly1.cif.gz_B	2b60-assembly1.cif.gz_B Structure of HIV-1 protease mutant bound to Ritonavir	1.990E-03	1.000	113	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3cyw-assembly1.cif.gz_B	3cyw-assembly1.cif.gz_B Effect of Flap Mutations on Structure of HIV-1 Protease and Inhibition by Saquinavir and Darunavir	1.109E-03	1.000	113	146	242	263	8	86	99	97	0.369	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	2f80-assembly1.cif.gz_B	2f80-assembly1.cif.gz_B HIV-1 Protease mutant D30N complexed with inhibitor TMC114	1.170E-03	1.000	113	146	242	263	8	86	99	97	0.369	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	2fle-assembly1.cif.gz_B	2fle-assembly1.cif.gz_B Structural analysis of asymmetric inhibitor bound to the HIV-1 Protease V82A mutant	2.886E-03	1.000	113	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2pym-assembly1.cif.gz_B	2pym-assembly1.cif.gz_B HIV-1 PR mutant in complex with nelfinavir	4.910E-03	1.000	113	21	110	263	10	92	99	95	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1bdq-assembly1.cif.gz_B	1bdq-assembly1.cif.gz_B HIV-1 (2:31-37, 47, 82) PROTEASE COMPLEXED WITH INHIBITOR SB203386	2.461E-03	1.000	112	140	246	263	2	90	99	107	0.407	0.899
LOKIASV2_0167_ESMFold_hypothetical_protein	1bdr-assembly1.cif.gz_B	1bdr-assembly1.cif.gz_B HIV-1 (2: 31, 33-37) PROTEASE COMPLEXED WITH INHIBITOR SB203386	1.887E-03	1.000	112	140	246	263	2	90	99	107	0.407	0.899
LOKIASV2_0167_ESMFold_hypothetical_protein	1bv7-assembly1.cif.gz_B	1bv7-assembly1.cif.gz_B COUNTERACTING HIV-1 PROTEASE DRUG RESISTANCE: STRUCTURAL ANALYSIS OF MUTANT PROTEASES COMPLEXED WITH XV638 AND SD146, CYCLIC UREA AMIDES WITH BROAD SPECIFICITIES	2.737E-03	1.000	112	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	7map-assembly1.cif.gz_A	7map-assembly1.cif.gz_A Drug Resistant HIV-1 Protease (L10I, V32I, L33F, K45I, M46I, I50V, A71V, V82I, I84V) in Complex with DRV	2.737E-03	1.000	112	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	7mar-assembly2.cif.gz_B	7mar-assembly2.cif.gz_B Drug Resistant HIV-1 Protease (L10F, M46I, I47V, I50V, F53L, L63P, I72V, G73S, V82I, I85V) in Complex with DRV	2.886E-03	1.000	112	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	2o4n-assembly1.cif.gz_B	2o4n-assembly1.cif.gz_B Crystal Structure of HIV-1 Protease (TRM Mutant) in Complex with Tipranavir	2.595E-03	1.000	112	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	5yrs-assembly1.cif.gz_A	5yrs-assembly1.cif.gz_A X-ray Snapshot of HIV-1 Protease in Action: Observation of Tetrahedral Intermediate and Its SIHB with Catalytic Aspartate	1.089E-02	1.000	112	21	110	263	10	92	99	96	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	6opy-assembly1.cif.gz_B	6opy-assembly1.cif.gz_B HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, A71V, L76V, V82F, I84V Mutant in complex with darunavir	2.886E-03	1.000	111	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3oqd-assembly1.cif.gz_A-2	3oqd-assembly1.cif.gz_A-2 Crystal Structures of Multidrug-Resistant Clinical Isolate 769 HIV-1 Protease Variants	1.372E-03	1.000	111	146	242	263	8	86	99	97	0.369	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	2hah-assembly1.cif.gz_A-2	2hah-assembly1.cif.gz_A-2 The structure of FIV 12S protease in complex with TL-3	1.170E-03	1.000	111	146	242	263	9	99	112	103	0.369	0.812
LOKIASV2_0167_ESMFold_hypothetical_protein	2fiv-assembly1.cif.gz_A	2fiv-assembly1.cif.gz_A Crystal structure of feline immunodeficiency virus protease complexed with a substrate	1.609E-03	1.000	111	139	242	263	3	100	113	109	0.395	0.867
LOKIASV2_0167_ESMFold_hypothetical_protein	4j0p-assembly1.cif.gz_A	4j0p-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-4-methyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide	1.473E-04	1.000	111	4	262	263	7	345	376	361	0.985	0.902
LOKIASV2_0167_ESMFold_hypothetical_protein	5w5w-assembly1.cif.gz_A	5w5w-assembly1.cif.gz_A HIV Protease (PR) in open form with Mg2+ in active site and HIVE-9 in eye site	2.595E-03	1.000	110	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	5yoj-assembly1.cif.gz_B	5yoj-assembly1.cif.gz_B Structure of A17 HIV-1 Protease in Complex with Inhibitor KNI-1657	1.525E-03	1.000	110	146	242	263	8	86	99	97	0.369	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	5c9b-assembly1.cif.gz_D	5c9b-assembly1.cif.gz_D Crystal structure of a retropepsin-like aspartic protease from Rickettsia conorii	2.333E-03	1.000	110	2	124	263	7	110	115	124	0.468	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	2az9-assembly1.cif.gz_A-2	2az9-assembly1.cif.gz_A-2 HIV-1 Protease NL4-3 1X mutant	3.570E-03	1.000	109	140	246	263	2	90	99	107	0.407	0.899
LOKIASV2_0167_ESMFold_hypothetical_protein	3lzu-assembly1.cif.gz_A	3lzu-assembly1.cif.gz_A Crystal Structure of a Nelfinavir Resistant HIV-1 CRF01_AE Protease variant (N88S) in Complex with the Protease Inhibitor Darunavir.	2.213E-03	1.000	109	140	246	263	2	90	99	107	0.407	0.899
LOKIASV2_0167_ESMFold_hypothetical_protein	3pwm-assembly1.cif.gz_B	3pwm-assembly1.cif.gz_B HIV-1 Protease Mutant L76V with Darunavir	1.789E-03	1.000	109	146	242	263	8	86	99	97	0.369	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	3el4-assembly1.cif.gz_B	3el4-assembly1.cif.gz_B Crystal structure of inhibitor saquinavir (SQV) complexed with the multidrug HIV-1 protease variant L63P/V82T/I84V	3.970E-03	1.000	108	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4nkk-assembly1.cif.gz_A	4nkk-assembly1.cif.gz_A Crystal structure of a multi-drug resistant clinical isolate-769 HIV-1 protease variant that is resistant to the dimerization inhibitory activity of TLF-PafF	2.333E-03	1.000	108	146	242	263	8	86	99	97	0.369	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	4npu-assembly1.cif.gz_B	4npu-assembly1.cif.gz_B Crystal Structure of HIV-1 Protease Multiple Mutant P51	2.886E-03	1.000	108	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3uhl-assembly2.cif.gz_C	3uhl-assembly2.cif.gz_C Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex with p2-NC substrate analog	3.044E-03	1.000	108	140	246	263	2	90	99	108	0.407	0.899
LOKIASV2_0167_ESMFold_hypothetical_protein	2o4l-assembly1.cif.gz_B	2o4l-assembly1.cif.gz_B Crystal Structure of HIV-1 Protease (Q7K, I50V) in Complex with Tipranavir	2.098E-03	1.000	107	146	242	263	8	86	99	97	0.369	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	2j9j-assembly1.cif.gz_B	2j9j-assembly1.cif.gz_B Atomic-resolution Crystal Structure of Chemically-Synthesized HIV-1 Protease Complexed with Inhibitor JG-365	1.212E-02	1.000	106	21	104	263	10	84	96	84	0.319	0.781
LOKIASV2_0167_ESMFold_hypothetical_protein	7n6x-assembly1.cif.gz_A	7n6x-assembly1.cif.gz_A Crystal structure of HIV-1 Protease multiple mutants PRS17 bound to inhibitor Amprenavir	1.525E-03	1.000	106	146	242	263	8	86	99	97	0.369	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	6opx-assembly1.cif.gz_A	6opx-assembly1.cif.gz_A HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, L76V, V82F, I84V Mutant in complex with darunavir	4.186E-03	1.000	106	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3oqa-assembly1.cif.gz_A-2	3oqa-assembly1.cif.gz_A-2 Crystal Structures of Multidrug-Resistant Clinical Isolate 769 HIV-1 Protease Variants	2.595E-03	1.000	106	146	244	263	8	88	99	99	0.376	0.818
LOKIASV2_0167_ESMFold_hypothetical_protein	2i1a-assembly2.cif.gz_C	2i1a-assembly2.cif.gz_C A Retroviral Protease-Like Domain in the Eukaryotic Protein Ddi1	2.333E-03	1.000	106	137	263	263	4	105	112	137	0.483	0.911
LOKIASV2_0167_ESMFold_hypothetical_protein	4he9-assembly1.cif.gz_B	4he9-assembly1.cif.gz_B Crystal Structure of HIV-1 protease mutants I54M complexed with inhibitor GRL-0519	2.333E-03	1.000	105	146	242	263	8	86	99	97	0.369	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	7maq-assembly2.cif.gz_A	7maq-assembly2.cif.gz_A Drug Resistant HIV-1 Protease (L10F, V32I, L33F, K45I, A71V, V82I, I84V) in Complex with DRV	4.186E-03	1.000	105	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	1tw7-assembly1.cif.gz_B	1tw7-assembly1.cif.gz_B Wide Open 1.3A Structure of a Multi-drug Resistant HIV-1 Protease Represents a Novel Drug Target	2.461E-03	1.000	105	146	242	263	8	86	99	97	0.369	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	1yti-assembly1.cif.gz_A	1yti-assembly1.cif.gz_A SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT	9.796E-03	1.000	105	21	110	263	10	92	99	93	0.342	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	5c9d-assembly1.cif.gz_A	5c9d-assembly1.cif.gz_A Crystal structure of a retropepsin-like aspartic protease from Rickettsia conorii	4.186E-03	1.000	105	1	127	263	1	113	115	135	0.483	0.983
LOKIASV2_0167_ESMFold_hypothetical_protein	5yq8-assembly2.cif.gz_D	5yq8-assembly2.cif.gz_D Crystal structure of retroviral protease-like domain of Ddi1 from Leishmania major	5.758E-03	1.000	105	146	263	263	4	120	125	129	0.449	0.936
LOKIASV2_0167_ESMFold_hypothetical_protein	4z2z-assembly1.cif.gz_B	4z2z-assembly1.cif.gz_B New crystal structure of yeast Ddi1 aspartyl protease reveals substrate engagement mode	2.333E-03	1.000	105	138	263	263	16	131	138	142	0.479	0.841
LOKIASV2_0167_ESMFold_hypothetical_protein	1sh9-assembly1.cif.gz_B	1sh9-assembly1.cif.gz_B Comparing the Accumulation of Active Site and Non-active Site Mutations in the HIV-1 Protease	5.758E-03	1.000	104	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	4yoa-assembly1.cif.gz_A	4yoa-assembly1.cif.gz_A Crsystal structure HIV-1 Protease MDR769 L33F Complexed with darunavir	2.737E-03	1.000	104	146	242	263	8	86	99	97	0.369	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	6s1v-assembly1.cif.gz_A	6s1v-assembly1.cif.gz_A Crystal structure of dimeric M-PMV protease D26N mutant in complex with inhibitor	1.347E-02	1.000	104	21	107	263	11	92	103	92	0.331	0.796
LOKIASV2_0167_ESMFold_hypothetical_protein	2azb-assembly1.cif.gz_A-2	2azb-assembly1.cif.gz_A-2 HIV-1 Protease NL4-3 3X mutant in complex with inhibitor, TL-3	6.073E-03	1.000	103	146	246	263	8	88	97	101	0.384	0.835
LOKIASV2_0167_ESMFold_hypothetical_protein	1aaq-assembly1.cif.gz_B	1aaq-assembly1.cif.gz_B HYDROXYETHYLENE ISOSTERE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE: STRUCTURE-ACTIVITY ANALYSIS USING ENZYME KINETICS, X-RAY CRYSTALLOGRAPHY, AND INFECTED T-CELL ASSAYS	3.044E-03	1.000	103	140	242	263	2	86	99	103	0.392	0.859
LOKIASV2_0167_ESMFold_hypothetical_protein	3jvy-assembly1.cif.gz_B	3jvy-assembly1.cif.gz_B HIV-1 Protease Mutant G86A with DARUNAVIR	3.385E-03	1.000	103	146	242	263	8	86	99	97	0.369	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	3vf5-assembly1.cif.gz_B	3vf5-assembly1.cif.gz_B Crystal Structure of HIV-1 Protease Mutant I47V with novel P1'-Ligands GRL-02031	3.385E-03	1.000	103	146	242	263	8	86	99	97	0.369	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	1bdl-assembly1.cif.gz_B	1bdl-assembly1.cif.gz_B HIV-1 (2:31-37) PROTEASE COMPLEXED WITH INHIBITOR SB203386	5.460E-03	1.000	102	140	246	263	2	90	99	107	0.407	0.899
LOKIASV2_0167_ESMFold_hypothetical_protein	2i1a-assembly1.cif.gz_B	2i1a-assembly1.cif.gz_B A Retroviral Protease-Like Domain in the Eukaryotic Protein Ddi1	8.809E-03	1.000	102	146	263	263	5	108	115	129	0.449	0.904
LOKIASV2_0167_ESMFold_hypothetical_protein	6o5a-assembly1.cif.gz_A	6o5a-assembly1.cif.gz_A Crystal Structure of multi-drug resistant HIV-1 protease PR-S17 with a substrate analog p2-NC in P61	2.886E-03	1.000	101	140	242	263	2	86	99	103	0.392	0.859
LOKIASV2_0167_ESMFold_hypothetical_protein	6p9b-assembly1.cif.gz_B	6p9b-assembly1.cif.gz_B HIV-1 Protease multiple drug resistant mutant PRS5B with Amprenavir	7.122E-03	1.000	101	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	3ogq-assembly1.cif.gz_A	3ogq-assembly1.cif.gz_A Crystal Structure of 6s-98S FIV Protease with Lopinavir bound	6.753E-03	1.000	101	146	242	263	9	99	112	102	0.369	0.812
LOKIASV2_0167_ESMFold_hypothetical_protein	5ys4-assembly1.cif.gz_A	5ys4-assembly1.cif.gz_A Crystal structure of retroviral protease-like domain of Ddi1 from Leishmania major	2.886E-03	1.000	101	137	263	263	6	114	120	140	0.483	0.908
LOKIASV2_0167_ESMFold_hypothetical_protein	4obz-assembly1.cif.gz_D	4obz-assembly1.cif.gz_D Structure of Cathepsin D with inhibitor 2-(3,4-dimethoxyphenyl)-N-[N-(4-methylbenzyl)carbamimidoyl]acetamide	2.213E-03	1.000	100	111	262	263	59	233	237	191	0.578	0.738
LOKIASV2_0167_ESMFold_hypothetical_protein	1bv9-assembly1.cif.gz_A	1bv9-assembly1.cif.gz_A HIV-1 PROTEASE (I84V) COMPLEXED WITH XV638 OF DUPONT PHARMACEUTICALS	9.289E-03	0.999	99	146	246	263	8	90	99	101	0.384	0.838
LOKIASV2_0167_ESMFold_hypothetical_protein	5ys4-assembly1.cif.gz_D	5ys4-assembly1.cif.gz_D Crystal structure of retroviral protease-like domain of Ddi1 from Leishmania major	2.213E-03	0.999	99	137	263	263	2	109	115	146	0.483	0.939
LOKIASV2_0167_ESMFold_hypothetical_protein	5ys4-assembly3.cif.gz_F	5ys4-assembly3.cif.gz_F Crystal structure of retroviral protease-like domain of Ddi1 from Leishmania major	4.186E-03	0.999	99	137	263	263	2	112	115	142	0.483	0.965
LOKIASV2_0167_ESMFold_hypothetical_protein	5ys4-assembly2.cif.gz_C	5ys4-assembly2.cif.gz_C Crystal structure of retroviral protease-like domain of Ddi1 from Leishmania major	3.570E-03	0.999	99	146	263	263	6	111	117	136	0.449	0.906
LOKIASV2_0167_ESMFold_hypothetical_protein	4rgh-assembly1.cif.gz_B	4rgh-assembly1.cif.gz_B Human DNA Damage-Inducible Protein: From Protein Chemistry and 3D Structure to Deciphering its Cellular Role	4.656E-03	0.999	99	146	263	263	5	113	120	136	0.449	0.908
LOKIASV2_0167_ESMFold_hypothetical_protein	7sjx-assembly1.cif.gz_B	7sjx-assembly1.cif.gz_B Cryo-EM Structure of the PR-RT components of the HIV-1 Pol Polyprotein	6.753E-03	0.999	98	146	246	263	8	90	503	101	0.384	0.165
LOKIASV2_0167_ESMFold_hypothetical_protein	7bgt-assembly2.cif.gz_C	7bgt-assembly2.cif.gz_C Mason-Pfizer Monkey Virus Protease mutant C7A/D26N/C106A in complex with peptidomimetic inhibitor	3.153E-02	0.999	96	21	107	263	11	93	104	90	0.331	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	5ys4-assembly3.cif.gz_E	5ys4-assembly3.cif.gz_E Crystal structure of retroviral protease-like domain of Ddi1 from Leishmania major	5.178E-03	0.999	96	137	263	263	3	106	112	140	0.483	0.929
LOKIASV2_0167_ESMFold_hypothetical_protein	7efy-assembly1.cif.gz_A-2	7efy-assembly1.cif.gz_A-2 Crystal structure of retroviral protease-like domain of Ddi1 from Cryptosporidium hominis	4.656E-03	0.999	96	137	263	263	2	110	113	138	0.483	0.965
LOKIASV2_0167_ESMFold_hypothetical_protein	2je4-assembly1.cif.gz_B	2je4-assembly1.cif.gz_B Atomic-resolution crystal structure of chemically-synthesized HIV-1 protease in complex with JG-365	1.421E-02	0.998	95	146	246	263	8	89	98	101	0.384	0.837
LOKIASV2_0167_ESMFold_hypothetical_protein	6s1v-assembly1.cif.gz_B	6s1v-assembly1.cif.gz_B Crystal structure of dimeric M-PMV protease D26N mutant in complex with inhibitor	3.507E-02	0.998	95	21	107	263	11	94	105	91	0.331	0.800
LOKIASV2_0167_ESMFold_hypothetical_protein	6s1u-assembly1.cif.gz_B	6s1u-assembly1.cif.gz_B Crystal structure of dimeric M-PMV protease C7A/D26N/C106A mutant in complex with inhibitor	3.153E-02	0.998	95	19	107	263	9	94	106	92	0.338	0.811
LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly2.cif.gz_L	7d66-assembly2.cif.gz_L Crystal structure of retroviral protease-like domain of Ddi1 from Toxoplasma gondii	8.353E-03	0.998	95	146	263	263	3	117	123	134	0.449	0.935
LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly2.cif.gz_K	7d66-assembly2.cif.gz_K Crystal structure of retroviral protease-like domain of Ddi1 from Toxoplasma gondii	1.757E-02	0.998	95	21	132	263	5	123	123	123	0.426	0.967
LOKIASV2_0167_ESMFold_hypothetical_protein	7sjx-assembly1.cif.gz_A	7sjx-assembly1.cif.gz_A Cryo-EM Structure of the PR-RT components of the HIV-1 Pol Polyprotein	1.033E-02	0.998	95	146	246	263	8	90	634	101	0.384	0.131
LOKIASV2_0167_ESMFold_hypothetical_protein	7bgu-assembly2.cif.gz_C	7bgu-assembly2.cif.gz_C Mason-Pfizer Monkey Virus Protease mutant C7A/D26N/C106A in complex with peptidomimetic inhibitor	3.698E-02	0.998	93	21	107	263	11	93	104	93	0.331	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	8dci-assembly1.cif.gz_B	8dci-assembly1.cif.gz_B Crystal Structure of a highly resistant HIV-1 protease Clinical isolate PR10x (inhibitor-free)	7.920E-03	0.997	92	146	242	263	8	86	99	97	0.369	0.798
LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly2.cif.gz_I	7d66-assembly2.cif.gz_I Crystal structure of retroviral protease-like domain of Ddi1 from Toxoplasma gondii	8.809E-03	0.997	91	146	263	263	2	118	124	136	0.449	0.944
LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly1.cif.gz_F	7d66-assembly1.cif.gz_F Crystal structure of retroviral protease-like domain of Ddi1 from Toxoplasma gondii	6.753E-03	0.996	89	146	263	263	3	115	121	132	0.449	0.934
LOKIASV2_0167_ESMFold_hypothetical_protein	6s1u-assembly1.cif.gz_A	6s1u-assembly1.cif.gz_A Crystal structure of dimeric M-PMV protease C7A/D26N/C106A mutant in complex with inhibitor	4.112E-02	0.994	87	21	107	263	11	92	103	93	0.331	0.796
LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly2.cif.gz_G	7d66-assembly2.cif.gz_G Crystal structure of retroviral protease-like domain of Ddi1 from Toxoplasma gondii	9.796E-03	0.994	87	146	263	263	3	114	120	134	0.449	0.933
LOKIASV2_0167_ESMFold_hypothetical_protein	4z2z-assembly1.cif.gz_A	4z2z-assembly1.cif.gz_A New crystal structure of yeast Ddi1 aspartyl protease reveals substrate engagement mode	1.421E-02	0.994	87	146	263	263	13	117	123	136	0.449	0.854
LOKIASV2_0167_ESMFold_hypothetical_protein	1fmb-assembly1.cif.gz_A	1fmb-assembly1.cif.gz_A EIAV PROTEASE COMPLEXED WITH THE INHIBITOR HBY-793	5.364E-02	0.993	86	146	246	263	8	95	104	103	0.384	0.846
LOKIASV2_0167_ESMFold_hypothetical_protein	6s1w-assembly1.cif.gz_B	6s1w-assembly1.cif.gz_B Crystal structure of dimeric M-PMV protease D26N mutant	4.112E-02	0.993	86	21	107	263	11	97	108	99	0.331	0.806
LOKIASV2_0167_ESMFold_hypothetical_protein	2i1a-assembly1.cif.gz_A	2i1a-assembly1.cif.gz_A A Retroviral Protease-Like Domain in the Eukaryotic Protein Ddi1	3.153E-02	0.993	86	146	263	263	4	108	114	135	0.449	0.921
LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly2.cif.gz_H	7d66-assembly2.cif.gz_H Crystal structure of retroviral protease-like domain of Ddi1 from Toxoplasma gondii	1.421E-02	0.992	85	148	263	263	4	113	119	132	0.441	0.924
LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly2.cif.gz_J	7d66-assembly2.cif.gz_J Crystal structure of retroviral protease-like domain of Ddi1 from Toxoplasma gondii	1.580E-02	0.992	85	146	263	263	3	114	120	131	0.449	0.933
LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly1.cif.gz_E	7d66-assembly1.cif.gz_E Crystal structure of retroviral protease-like domain of Ddi1 from Toxoplasma gondii	3.698E-02	0.984	80	146	263	263	3	107	110	131	0.449	0.955
LOKIASV2_0167_ESMFold_hypothetical_protein	7d66-assembly1.cif.gz_B	7d66-assembly1.cif.gz_B Crystal structure of retroviral protease-like domain of Ddi1 from Toxoplasma gondii	2.549E-02	0.981	79	146	263	263	3	114	120	135	0.449	0.933
LOKIASV2_0167_ESMFold_hypothetical_protein	1lyb-assembly3.cif.gz_D	1lyb-assembly3.cif.gz_D CRYSTAL STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN D: IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN	1.347E-02	0.975	77	107	262	263	55	237	241	190	0.593	0.759
LOKIASV2_0167_ESMFold_hypothetical_protein	2hvp-assembly1.cif.gz_A-2	2hvp-assembly1.cif.gz_A-2 THREE-DIMENSIONAL STRUCTURE OF ASPARTYL PROTEASE FROM HUMAN IMMUNODEFICIENCY VIRUS HIV-1	8.653E-02	0.949	72	21	104	263	5	81	94	86	0.319	0.819
LOKIASV2_0167_ESMFold_hypothetical_protein	1b5f-assembly1.cif.gz_A	1b5f-assembly1.cif.gz_A NATIVE CARDOSIN A FROM CYNARA CARDUNCULUS L.	1.149E-02	0.855	64	3	215	263	4	203	239	248	0.810	0.837
LOKIASV2_0167_ESMFold_hypothetical_protein	6s1w-assembly1.cif.gz_A	6s1w-assembly1.cif.gz_A Crystal structure of dimeric M-PMV protease D26N mutant	1.637E-01	0.442	49	146	242	263	9	83	97	101	0.369	0.773
LOKIASV2_0167_ESMFold_hypothetical_protein	3sqf-assembly2.cif.gz_B	3sqf-assembly2.cif.gz_B Crystal structure of monomeric M-PMV retroviral protease	1.324E-01	0.411	48	148	242	263	3	86	94	104	0.361	0.894
LOKIASV2_0167_ESMFold_hypothetical_protein	6ywy-assembly1.cif.gz_C	6ywy-assembly1.cif.gz_C The structure of the mitoribosome from Neurospora crassa with bound tRNA at the P-site	7.120E+00	0.126	34	183	205	263	50	72	307	23	0.087	0.075
LOKIASV2_0167_ESMFold_hypothetical_protein	7pkt-assembly1.cif.gz_b	7pkt-assembly1.cif.gz_b Large subunit of the Chlamydomonas reinhardtii mitoribosome	8.350E+00	0.116	33	183	206	263	55	78	304	24	0.091	0.079
LOKIASV2_0167_ESMFold_hypothetical_protein	5udf-assembly1.cif.gz_D	5udf-assembly1.cif.gz_D Structure of the N-terminal domain of lipoprotein-releasing system transmembrane protein LolE from Acinetobacter baumannii	1.051E+00	0.098	31	3	102	263	42	148	203	132	0.380	0.527
LOKIASV2_0167_ESMFold_hypothetical_protein	4ce4-assembly1.cif.gz_E	4ce4-assembly1.cif.gz_E 39S large subunit of the porcine mitochondrial ribosome	8.806E+00	0.098	31	183	208	263	5	30	208	26	0.099	0.125
LOKIASV2_0167_ESMFold_hypothetical_protein	3r42-assembly1.cif.gz_A	3r42-assembly1.cif.gz_A Crystal structure of the yeast vps23 UEV domain in complex with a vps27 PSDP peptide	2.333E+00	0.082	29	181	222	263	39	78	156	43	0.160	0.256
LOKIASV2_0167_ESMFold_hypothetical_protein	5udf-assembly1.cif.gz_C	5udf-assembly1.cif.gz_C Structure of the N-terminal domain of lipoprotein-releasing system transmembrane protein LolE from Acinetobacter baumannii	1.608E+00	0.082	29	3	102	263	42	150	205	134	0.380	0.532
LOKIASV2_0167_ESMFold_hypothetical_protein	5n77-assembly1.cif.gz_E	5n77-assembly1.cif.gz_E Crystal structure of the cytosolic domain of the CorA magnesium channel from Escherichia coli in complex with magnesium	3.043E+00	0.076	28	183	232	263	73	115	255	50	0.190	0.169
LOKIASV2_0167_ESMFold_hypothetical_protein	5yzp-assembly1.cif.gz_A	5yzp-assembly1.cif.gz_A Crystal structure of p204 HINa domain	9.125E-02	0.069	27	1	238	263	14	193	195	250	0.905	0.923
LOKIASV2_0167_ESMFold_hypothetical_protein	5n78-assembly1.cif.gz_C	5n78-assembly1.cif.gz_C Crystal structure of the cytosolic domain of the CorA Mg2+ channel from Escherichia coli in complex with magnesium and cobalt hexammine	4.185E+00	0.069	27	183	225	263	73	108	254	43	0.163	0.142
LOKIASV2_0167_ESMFold_hypothetical_protein	5ly5-assembly1.cif.gz_A-2	5ly5-assembly1.cif.gz_A-2 Arcadin-1 from Pyrobaculum calidifontis	1.371E+00	0.063	26	183	263	263	8	76	77	81	0.308	0.896
LOKIASV2_0167_ESMFold_hypothetical_protein	5n78-assembly1.cif.gz_A	5n78-assembly1.cif.gz_A Crystal structure of the cytosolic domain of the CorA Mg2+ channel from Escherichia coli in complex with magnesium and cobalt hexammine	3.968E+00	0.063	26	183	232	263	73	115	257	50	0.190	0.167
LOKIASV2_0167_ESMFold_hypothetical_protein	3luq-assembly1.cif.gz_D	3luq-assembly1.cif.gz_D The Crystal Structure of a PAS Domain from a Sensory Box Histidine Kinase Regulator from Geobacter sulfurreducens to 2.5A	8.806E+00	0.051	24	173	206	263	56	93	110	38	0.129	0.345
LOKIASV2_0167_ESMFold_hypothetical_protein	6qsa-assembly1.cif.gz_A	6qsa-assembly1.cif.gz_A Cryogenic temperature structure of blue light-irradiated AtPhot2LOV2 recorded after an accumulated dose of 48 kGy	8.806E+00	0.051	24	171	206	263	48	87	116	41	0.137	0.345
LOKIASV2_0167_ESMFold_hypothetical_protein	1m4q-assembly1.cif.gz_A	1m4q-assembly1.cif.gz_A STRUCTURE OF THE TSG101 UEV DOMAIN IN COMPLEX WITH A HIV-1 PTAP "LATE DOMAIN" PEPTIDE, CNS ENSEMBLE	7.508E+00	0.045	23	174	228	263	26	80	144	59	0.209	0.382
LOKIASV2_0167_ESMFold_hypothetical_protein	8b6h-assembly1.cif.gz_DR	8b6h-assembly1.cif.gz_DR Cryo-EM structure of cytochrome c oxidase dimer (complex IV) from respiratory supercomplex of Tetrahymena thermophila	8.350E+00	0.040	22	70	103	263	178	222	243	45	0.129	0.185
LOKIASV2_0167_ESMFold_hypothetical_protein	6wle-assembly1.cif.gz_B	6wle-assembly1.cif.gz_B Crystal structure of the Zeitlupe light-state mimic G46A	8.806E+00	0.034	21	171	215	263	65	113	130	50	0.171	0.377
LOKIASV2_0167_ESMFold_hypothetical_protein	5nwm-assembly1.cif.gz_A	5nwm-assembly1.cif.gz_A Insight into the molecular recognition mechanism of the coactivator NCoA1 by STAT6	7.120E+00	0.034	21	174	220	263	62	105	132	47	0.179	0.333
LOKIASV2_0167_ESMFold_hypothetical_protein	8t08-assembly1.cif.gz_f	8t08-assembly1.cif.gz_f Preholo-Proteasome from Pre1-1 Pre4-1 Double Mutant	2.736E+00	0.034	21	148	224	263	32	99	237	87	0.293	0.287
LOKIASV2_0167_ESMFold_hypothetical_protein	7tbn-assembly2.cif.gz_B	7tbn-assembly2.cif.gz_B LOV2-DARPIN fusion : D11	8.350E+00	0.034	21	171	228	263	56	117	372	65	0.221	0.167
LOKIASV2_0167_ESMFold_hypothetical_protein	3u96-assembly1.cif.gz_A	3u96-assembly1.cif.gz_A Crystal Structure of YopHQ357F(Catalytic Domain, Residues 163-468) in complex with pNCS	4.185E+00	0.029	20	170	227	263	99	168	282	73	0.221	0.248
LOKIASV2_0167_ESMFold_hypothetical_protein	6j6u-assembly1.cif.gz_B	6j6u-assembly1.cif.gz_B Rat PTPRZ D1-D2 domain	3.384E+00	0.029	20	181	242	263	374	451	514	82	0.236	0.152
LOKIASV2_0167_ESMFold_hypothetical_protein	3tqy-assembly1.cif.gz_D	3tqy-assembly1.cif.gz_D Structure of a single-stranded DNA-binding protein (ssb), from Coxiella burnetii	2.212E+00	0.024	19	2	80	263	8	96	98	98	0.300	0.908
LOKIASV2_0167_ESMFold_hypothetical_protein	5z7d-assembly1.cif.gz_A	5z7d-assembly1.cif.gz_A p204HINab-dsDNA complex structure	4.040E-01	0.024	19	1	259	263	14	277	395	327	0.985	0.668
LOKIASV2_0167_ESMFold_hypothetical_protein	1ae3-assembly1.cif.gz_A-2	1ae3-assembly1.cif.gz_A-2 MUTANT R82C OF GENE V PROTEIN (SINGLE-STRANDED DNA BINDING PROTEIN)	5.459E+00	0.020	18	182	239	263	12	60	86	58	0.221	0.570
LOKIASV2_0167_ESMFold_hypothetical_protein	1vqe-assembly1.cif.gz_A-2	1vqe-assembly1.cif.gz_A-2 GENE V PROTEIN MUTANT WITH VAL 35 REPLACED BY ILE 35 AND ILE 47 REPLACED BY MET 47 (V35I, I47M)	9.286E+00	0.020	18	182	222	263	12	48	86	41	0.156	0.430
LOKIASV2_0167_ESMFold_hypothetical_protein	2oq0-assembly4.cif.gz_D	2oq0-assembly4.cif.gz_D Crystal Structure of the First HIN-200 Domain of Interferon-Inducible Protein 16	1.109E+00	0.020	18	2	238	263	6	183	184	261	0.901	0.967
LOKIASV2_0167_ESMFold_hypothetical_protein	3clo-assembly1.cif.gz_B	3clo-assembly1.cif.gz_B Crystal structure of putative transcriptional regulator containing a LuxR DNA binding domain (NP_811094.1) from Bacteroides thetaiotaomicron VPI-5482 at 2.04 A resolution	8.806E+00	0.020	18	174	263	263	105	188	258	99	0.342	0.326
LOKIASV2_0167_ESMFold_hypothetical_protein	1vqh-assembly1.cif.gz_A-2	1vqh-assembly1.cif.gz_A-2 GENE V PROTEIN MUTANT WITH ILE 47 REPLACED BY MET 47 (I47M)	9.793E+00	0.016	17	182	222	263	12	48	86	41	0.156	0.430
LOKIASV2_0167_ESMFold_hypothetical_protein	1vqj-assembly1.cif.gz_A-2	1vqj-assembly1.cif.gz_A-2 GENE V PROTEIN MUTANT WITH VAL 35 REPLACED BY ILE 35 (V35I)	9.793E+00	0.016	17	182	222	263	12	48	86	41	0.156	0.430
LOKIASV2_0167_ESMFold_hypothetical_protein	6cqk-assembly3.cif.gz_C	6cqk-assembly3.cif.gz_C Crystal Structure of mitochondrial single-stranded DNA binding proteins from S. cerevisiae, Rim1 (Form1)	3.968E+00	0.016	17	2	97	263	7	88	88	111	0.365	0.932
LOKIASV2_0167_ESMFold_hypothetical_protein	7qf4-assembly1.cif.gz_AAA	7qf4-assembly1.cif.gz_AAA Structure of the R57Q mutant of miniSOG expressed in E. coli in LB medium enriched with riboflavin	8.350E+00	0.016	17	148	206	263	4	87	116	87	0.224	0.724
LOKIASV2_0167_ESMFold_hypothetical_protein	6lm2-assembly1.cif.gz_A	6lm2-assembly1.cif.gz_A Crystal structure of Zinc binding protein ZinT from E. coli	9.793E+00	0.016	17	148	225	263	83	141	184	84	0.297	0.321
LOKIASV2_0167_ESMFold_hypothetical_protein	8x70-assembly4.cif.gz_D	8x70-assembly4.cif.gz_D The Crystal Structure of IFI16 from Biortus.	1.696E+00	0.016	17	2	225	263	14	189	191	247	0.852	0.921
LOKIASV2_0167_ESMFold_hypothetical_protein	7uw8-assembly1.cif.gz_A	7uw8-assembly1.cif.gz_A Drosophila melanogaster setdb1-tuor domain	6.402E+00	0.016	17	137	222	263	11	68	221	86	0.327	0.262
LOKIASV2_0167_ESMFold_hypothetical_protein	1kaw-assembly1.cif.gz_A	1kaw-assembly1.cif.gz_A STRUCTURE OF SINGLE STRANDED DNA BINDING PROTEIN (SSB)	4.908E+00	0.014	16	2	72	263	8	67	96	75	0.270	0.625
LOKIASV2_0167_ESMFold_hypothetical_protein	4x2x-assembly1.cif.gz_A	4x2x-assembly1.cif.gz_A Crystal structure of the Murine Norovirus NS6 protease (inactive C139A mutant) with a C-terminal extension to include residues P1 prime - P4 prime of NS7	5.176E+00	0.014	16	121	223	263	54	143	166	118	0.392	0.542
LOKIASV2_0167_ESMFold_hypothetical_protein	1txl-assembly1.cif.gz_A	1txl-assembly1.cif.gz_A Crystal structure of metal-binding protein yodA from E. coli, Pfam DUF149	7.918E+00	0.014	16	148	239	263	86	170	188	106	0.350	0.452
LOKIASV2_0167_ESMFold_hypothetical_protein	4qgu-assembly1.cif.gz_B	4qgu-assembly1.cif.gz_B protein domain complex with ssDNA	2.098E+00	0.014	16	1	238	263	13	191	191	256	0.905	0.937
LOKIASV2_0167_ESMFold_hypothetical_protein	2oq0-assembly3.cif.gz_C	2oq0-assembly3.cif.gz_C Crystal Structure of the First HIN-200 Domain of Interferon-Inducible Protein 16	1.608E+00	0.014	16	2	238	263	8	192	192	262	0.901	0.964
LOKIASV2_0167_ESMFold_hypothetical_protein	7uve-assembly1.cif.gz_A	7uve-assembly1.cif.gz_A Drosophila melanogaster setdb1-tuor domain with peptide H3K9me2K14ac	7.508E+00	0.014	16	137	222	263	11	68	229	86	0.327	0.253
LOKIASV2_0167_ESMFold_hypothetical_protein	6pzj-assembly1.cif.gz_A-2	6pzj-assembly1.cif.gz_A-2 Structure of the N-terminal domain (residues 43-304) of Methyl-accepting chemotaxis protein from Leptospira interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Fiocruz L1-130)	7.918E+00	0.014	16	112	231	263	64	176	264	136	0.456	0.428
LOKIASV2_0167_ESMFold_hypothetical_protein	4aw8-assembly1.cif.gz_A	4aw8-assembly1.cif.gz_A X-ray structure of ZinT from Salmonella enterica in complex with zinc ion and PEG	6.071E+00	0.011	15	154	256	263	90	173	186	119	0.392	0.452
LOKIASV2_0167_ESMFold_hypothetical_protein	5aq6-assembly1.cif.gz_A-2	5aq6-assembly1.cif.gz_A-2 Structure of E. coli ZinT at 1.79 Angstrom	7.120E+00	0.011	15	183	261	263	102	174	190	93	0.300	0.384
LOKIASV2_0167_ESMFold_hypothetical_protein	7bu9-assembly2.cif.gz_C	7bu9-assembly2.cif.gz_C Crystal Structure of Spindlin1-H3(K4me3-K9me2) complex	2.736E+00	0.011	15	46	224	263	2	203	205	245	0.681	0.985
LOKIASV2_0167_ESMFold_hypothetical_protein	2a84-assembly1.cif.gz_A-2	2a84-assembly1.cif.gz_A-2 Crystal structure of A Pantothenate synthetase complexed with ATP	8.806E+00	0.011	15	174	227	263	224	277	277	57	0.205	0.195
LOKIASV2_0167_ESMFold_hypothetical_protein	6j6u-assembly1.cif.gz_A	6j6u-assembly1.cif.gz_A Rat PTPRZ D1-D2 domain	9.793E+00	0.011	15	181	242	263	395	472	534	80	0.236	0.146
LOKIASV2_0167_ESMFold_hypothetical_protein	1hv1-assembly1.cif.gz_A	1hv1-assembly1.cif.gz_A DISSECTING ELECTROSTATIC INTERACTIONS AND THE PH-DEPENDENT ACTIVITY OF A FAMILY 11 GLYCOSIDASE	2.885E+00	0.010	14	53	257	263	8	148	185	219	0.779	0.762
LOKIASV2_0167_ESMFold_hypothetical_protein	2nlk-assembly1.cif.gz_A	2nlk-assembly1.cif.gz_A Crystal structure of D1 and D2 catalytic domains of human Protein Tyrosine Phosphatase Gamma (D1+D2 PTPRG)	6.402E+00	0.010	14	181	244	263	414	495	553	88	0.243	0.148
LOKIASV2_0167_ESMFold_hypothetical_protein	6rm3-assembly1.cif.gz_SX0	6rm3-assembly1.cif.gz_SX0 Evolutionary compaction and adaptation visualized by the structure of the dormant microsporidian ribosome	9.286E+00	0.009	13	183	263	263	46	120	138	92	0.308	0.543
LOKIASV2_0167_ESMFold_hypothetical_protein	4igx-assembly4.cif.gz_D	4igx-assembly4.cif.gz_D Crystal structure of kirola (Act d 11) - triclinic form	7.120E+00	0.009	13	173	262	263	25	113	143	102	0.342	0.622
LOKIASV2_0167_ESMFold_hypothetical_protein	4x2w-assembly1.cif.gz_A	4x2w-assembly1.cif.gz_A Crystal structure of the Murine Norovirus NS6 protease (inactive C139A mutant) with a C-terminal extension to include residues P1 prime - P2 prime of NS7	6.402E+00	0.009	13	111	223	263	21	146	173	156	0.430	0.728
LOKIASV2_0167_ESMFold_hypothetical_protein	8x70-assembly3.cif.gz_C	8x70-assembly3.cif.gz_C The Crystal Structure of IFI16 from Biortus.	4.654E+00	0.009	13	1	238	263	13	190	193	258	0.905	0.922
LOKIASV2_0167_ESMFold_hypothetical_protein	4h75-assembly1.cif.gz_A	4h75-assembly1.cif.gz_A Crystal structure of human Spindlin1 in complex with a histone H3K4(me3) peptide	3.209E+00	0.009	13	46	220	263	3	195	199	239	0.665	0.970
LOKIASV2_0167_ESMFold_hypothetical_protein	1jly-assembly1.cif.gz_B	1jly-assembly1.cif.gz_B CRYSTAL STRUCTURE OF AMARANTHUS CAUDATUS AGGLUTININ	2.736E+00	0.009	13	6	263	263	45	297	299	322	0.981	0.846
LOKIASV2_0167_ESMFold_hypothetical_protein	8c5z-assembly1.cif.gz_A	8c5z-assembly1.cif.gz_A RPA tetrameric supercomplex with AROD-OB-1	3.384E+00	0.009	13	3	231	263	76	270	353	272	0.871	0.552
LOKIASV2_0167_ESMFold_hypothetical_protein	6e8a-assembly1.cif.gz_A-3	6e8a-assembly1.cif.gz_A-3 Crystal structure of DcrB from Salmonella enterica at 1.92 Angstroms resolution	6.402E+00	0.008	12	44	231	263	21	133	148	188	0.715	0.764
LOKIASV2_0167_ESMFold_hypothetical_protein	5ec5-assembly2.cif.gz_S	5ec5-assembly2.cif.gz_S Crystal structure of lysenin pore	6.402E+00	0.008	12	66	262	263	89	279	283	242	0.749	0.675
LOKIASV2_0167_ESMFold_hypothetical_protein	7stb-assembly1.cif.gz_F	7stb-assembly1.cif.gz_F Closed state of Rad24-RFC:9-1-1 bound to a 5' ss/dsDNA junction	3.568E+00	0.008	12	4	159	263	29	194	288	196	0.593	0.576
LOKIASV2_0167_ESMFold_hypothetical_protein	4zqd-assembly2.cif.gz_D	4zqd-assembly2.cif.gz_D Crystal Structure of the Heterodimeric HIF-2a:ARNT Complex with the Benzoxadiazole Antagonist 0X3	7.120E+00	0.008	12	58	220	263	122	265	290	186	0.620	0.497
LOKIASV2_0167_ESMFold_hypothetical_protein	7zi4-assembly1.cif.gz_D	7zi4-assembly1.cif.gz_D Cryo-EM structure of the human INO80 complex bound to a WT nucleosome	8.806E+00	0.008	12	136	263	263	115	191	439	128	0.487	0.175
LOKIASV2_0167_ESMFold_hypothetical_protein	3uj4-assembly1.cif.gz_A	3uj4-assembly1.cif.gz_A Crystal structure of the apo-inositol 1,4,5-trisphosphate receptor	8.806E+00	0.008	12	122	223	263	206	310	486	124	0.388	0.216
LOKIASV2_0167_ESMFold_hypothetical_protein	5y5w-assembly1.cif.gz_A	5y5w-assembly1.cif.gz_A Crystal structure of human Spindlin1 in complex with a histone H4K20(me3) peptide	6.751E+00	0.007	11	51	220	263	18	208	212	225	0.646	0.901
LOKIASV2_0167_ESMFold_hypothetical_protein	8oej-assembly1.cif.gz_D	8oej-assembly1.cif.gz_D Extended RPA-DNA nucleoprotein filament	3.043E+00	0.007	11	2	231	263	22	199	282	267	0.875	0.631
LOKIASV2_0167_ESMFold_hypothetical_protein	8oel-assembly1.cif.gz_D	8oel-assembly1.cif.gz_D Condensed RPA-DNA nucleoprotein filament	3.384E+00	0.007	11	2	231	263	22	203	286	270	0.875	0.636
LOKIASV2_0167_ESMFold_hypothetical_protein	4zqd-assembly1.cif.gz_B	4zqd-assembly1.cif.gz_B Crystal Structure of the Heterodimeric HIF-2a:ARNT Complex with the Benzoxadiazole Antagonist 0X3	9.793E+00	0.007	11	66	220	263	135	264	289	178	0.589	0.450
LOKIASV2_0167_ESMFold_hypothetical_protein	3p8a-assembly1.cif.gz_A	3p8a-assembly1.cif.gz_A Crystal Structure of a hypothetical protein from Staphylococcus aureus	4.908E+00	0.000	10	4	225	263	25	217	251	283	0.844	0.769
LOKIASV2_0167_ESMFold_hypothetical_protein	5ec5-assembly1.cif.gz_I	5ec5-assembly1.cif.gz_I Crystal structure of lysenin pore	8.350E+00	0.000	10	66	263	263	84	269	282	242	0.753	0.660
LOKIASV2_0167_ESMFold_hypothetical_protein	5ec5-assembly2.cif.gz_O	5ec5-assembly2.cif.gz_O Crystal structure of lysenin pore	9.793E+00	0.000	10	66	262	263	91	285	289	245	0.749	0.675
LOKIASV2_0167_ESMFold_hypothetical_protein	3p8a-assembly2.cif.gz_B	3p8a-assembly2.cif.gz_B Crystal Structure of a hypothetical protein from Staphylococcus aureus	8.806E+00	0.000	9	4	225	263	24	218	252	284	0.844	0.774
LOKIASV2_0167_ESMFold_hypothetical_protein	3uj4-assembly2.cif.gz_B	3uj4-assembly2.cif.gz_B Crystal structure of the apo-inositol 1,4,5-trisphosphate receptor	9.286E+00	0.000	9	70	223	263	166	311	490	192	0.586	0.298
LOKIASV2_0167_ESMFold_hypothetical_protein	6h1p-assembly1.cif.gz_A	6h1p-assembly1.cif.gz_A Cold-adapted beta-D-galactosidase from Arthrobacter sp. 32cB - data collected at room temperature	3.763E+00	0.000	9	4	220	263	584	811	989	291	0.825	0.231
LOKIASV2_0167_ESMFold_hypothetical_protein	6se8-assembly1.cif.gz_A	6se8-assembly1.cif.gz_A Cold-adapted beta-D-galactosidase from Arthrobacter sp. 32cB mutant E441Q	3.968E+00	0.000	9	5	220	263	597	823	1001	296	0.821	0.227
LOKIASV2_0167_ESMFold_hypothetical_protein	7t3p-assembly1.cif.gz_B	7t3p-assembly1.cif.gz_B IP3 and ATP bound type 3 IP3 receptor in the pre-active A state	8.806E+00	0.000	9	70	263	263	168	390	2066	275	0.738	0.108
LOKIASV2_0167_ESMFold_hypothetical_protein	1xcr-assembly2.cif.gz_B	1xcr-assembly2.cif.gz_B Crystal Structure of Longer Splice Variant of PTD012 from Homo sapiens reveals a novel Zinc-containing fold	9.286E+00	0.000	8	3	262	263	92	289	313	308	0.989	0.633
LOKIASV2_0167_ESMFold_hypothetical_protein	6zjp-assembly1.cif.gz_A	6zjp-assembly1.cif.gz_A Cold-adapted beta-D-galactosidase from Arthrobacter sp. 32cB mutant E517Q	6.751E+00	0.000	8	5	220	263	585	811	989	292	0.821	0.230
LOKIASV2_0167_ESMFold_hypothetical_protein	6zjv-assembly1.cif.gz_A	6zjv-assembly1.cif.gz_A Cold-adapted beta-D-galactosidase from Arthrobacter sp. 32cB mutant D207A	5.176E+00	0.000	8	5	220	263	585	811	989	296	0.821	0.230
